An article from

Nicole Gray

[email protected]

2603 articles by Nicole Gray

Filter by month:

PhRMA: US remains vaccine R&D leader
Aug. 19, 2016
Roche, Eleven Bio eye the ocular market
Aug. 19, 2016
Nutrinia raises $30M for pediatric oral insulin
Aug. 19, 2016
Chinese/Indian manufacturing facilities facing repercussions
Aug. 18, 2016
Another Indian API facility added to EU's 'do not import' list
Aug. 18, 2016
FDA expedites Aspen's prostate drug ahead of merger
Aug. 18, 2016
Trek Therapeutics in-licenses Medivir hep C drug
Aug. 18, 2016
Rasna Therapeutics taps public market with merger
Aug. 18, 2016
GSK enters pay-for-performance deal for gene therapy
Aug. 17, 2016
Ipsen hopes to be David to Allergan's Goliath
Aug. 17, 2016
JAMA: PCSK9s should cost $4536, but don't
Aug. 17, 2016
Chiasma slashes staff as problems persist
Aug. 16, 2016
Boehringer seeks real-world data to support reversal agent
Aug. 16, 2016
Cynapsus proceeds after safety OK
Aug. 16, 2016
Aurinia succeeds, but safety concerns loom
Aug. 16, 2016
Allergan to consolidate operations in NJ
Aug. 12, 2016
Mallinckrodt plans regen med acquisition
Aug. 12, 2016
Gilead licenses bi-specific tech from Danish biotech Genmab
Aug. 12, 2016
Spark Therapeutics on track to file gene therapy in 2017
Aug. 11, 2016
Medivation bullish on Xtandi as PDUFA approaches
Aug. 11, 2016
AstraZeneca bolsters stake in Moderna by $140 million
Aug. 11, 2016
Shire launches new treatment for hereditary bleeding disorder
Aug. 10, 2016
AstraZeneca's lung cancer hopeful fails in Phase 3
Aug. 10, 2016
Novartis execs indicted in bribery scandal—this time in Korea
Aug. 10, 2016
BIO president defends Orphan Drug Act after op-ed criticism
Aug. 9, 2016
Swiss Helsinn picks up late-stage cancer drug from MEI Pharma
Aug. 9, 2016
Does MannKind have a shot at a successful Afrezza re-launch?
Aug. 9, 2016
Biosimilar battle heats up as AbbVie sues Amgen over Humira copy
Aug. 8, 2016
Experimental asthma pill from Novartis posts encouraging results
Aug. 8, 2016
Merck locks up another cancer approval for Keytruda
Aug. 8, 2016
Chinese drug manufacturer lies to FDA, promptly gets banned
Aug. 4, 2016
Keryx says Auryxia shortage 'imminent'
Aug. 4, 2016
FDA hits Adaptimmune with partial hold on T-cell therapy
Aug. 4, 2016
New poll suggests Big Pharma losing battle over CA pricing ballot
Aug. 4, 2016
UK court orders coverage of Gilead's HIV drug in England
Aug. 3, 2016
With new exclusions, payers draw line on pricing
Aug. 3, 2016
Big Pharma benefits more from breakthrough therapy designations: report
Aug. 2, 2016
Celgene facing charity-related kickback allegations
Aug. 2, 2016
Lymphoma drug from Takeda, Seattle Genetics beats out existing meds in late-stage trial
Aug. 2, 2016
Private equity firm Advent buys 50% stake in InVentiv
Aug. 1, 2016
Tokai cuts workforce by 60% after phase 3 failure with prostate cancer drug
Aug. 1, 2016
Bayer leans on partnering for new growth
July 31, 2016
Editas teams up with Italian gene therapy institute
July 29, 2016
US, UK pledge to combat antibiotic resistance through new alliance
July 29, 2016
Shnaghai Fosun to buy large stake in Gland Pharma for $1.4 billion
July 28, 2016
Pfizer may sell its stake in Latin America's largest manufacturer
July 28, 2016
Phase 1 trial reveals high efficacy for hemophilia A gene therapy
July 28, 2016
GSK enters $230 million licensing deal with Janssen
July 28, 2016
Janssen: Bristol-Myers' newest Opdivo combo research partner
July 27, 2016
J&J, Genmab line up second-line use for multiple myeloma med
July 27, 2016
Tokai Pharma tumbles after Phase 3 failure
July 27, 2016
FDA strengthens warnings on class of antibiotics
July 26, 2016
Celgene abandons plans for new Revlimid indication after trial disappointment
July 26, 2016
Regulators to expedite review of Merck's Ebola vaccine
July 26, 2016
Kite eyes off-the-shelf T-cell therapies with UCLA research deal
July 26, 2016
FDA delays decision on Merck's C. diff drug
July 25, 2016
Japanese government to set new controls on specialty drugs: report
July 25, 2016
After scandal, China begins vaccine inspections nationwide
July 25, 2016
Amgen, Allergan get biosimilar lift with positive data on Herceptin copy
July 22, 2016
Theranos expands compliance team with new execs, committee
July 22, 2016
Pfizer presses on with expansion of Irish manufacturing site
July 21, 2016
Merck KGaA building $115 million life science facility in MA
July 21, 2016
Novartis CEO sees more restrictive drug pricing to come in US
July 21, 2016
Mylan gets 'all clear' from EU regulators for $7.2 billion Meda deal
July 21, 2016
What's so scary about biosimilars?
July 20, 2016
Zafgen shuts down development of obesity drug, cuts staff
July 20, 2016
US, EU regulators to review Opdivo for new cancer indication
July 19, 2016
Teva raises $15 billion through bond sale
July 19, 2016
After phase 2 success, Brainstorm sees promise for ALS drug
July 19, 2016
FDA: Flood of orphan drug applications slowing review process
July 19, 2016
PDUFA 6 procedures will include patients, biomarkers for 2018-2022
July 18, 2016
Celgene picks up broader EU approval for key cancer drug
July 18, 2016
Samsung Bioepis continues biosimilar push with EU submission of Humira copy
July 17, 2016
Santhera hopes for accelerated approval of Duchenne drug dashed
July 15, 2016
Shkreli's securities fraud case set for June 2017
July 15, 2016
FDA bans imports from four Indian and Chinese drugmakers
July 14, 2016
Cipla invests $90 million in South African biosim plant
July 14, 2016
High-profile VC firm hires former Merck exec as chief medical officer
July 14, 2016
Two for two: FDA panel gives green light to Novartis' Enbrel biosim
July 14, 2016
Lilly, Boehringer enter R&D pact to test breast cancer combo
July 14, 2016
Amgen touts new dosing option for underperforming cholesterol drug
July 13, 2016
FDA approves broader use of Pfizer's pneumonia vaccine
July 13, 2016
FDA panel unanimously recommends approval of Amgen's Humira biosimilar
July 13, 2016
Increase in US cancer center ad spending fueled by single company
July 12, 2016
Nichi-Iko expands into US with $736 million Sagent buy
July 12, 2016
EMA says benefits of Gilead's Zydelig outweigh risks
July 11, 2016
Drug manufacturer Patheon plans major IPO to pay down debt
July 11, 2016
Canadian court overrules Alexion's efforts to avoid price caps
July 11, 2016
Gilead secures European approval for new hepatitis C drug
July 11, 2016
Medicines Patent Pool expands access to HIV, hepatitis C drugs with new deals
July 11, 2016
Pfizer's leukemia drug approved by UK cost watchdog after previous rejection
July 8, 2016
Democrats exhort FDA to approve generic versions of Crestor
July 8, 2016
Pfizer planning expansion of Irish manufacturing facility
July 7, 2016
3-D drug firm Aprecia wins another $30 million in venture-funded debt
July 7, 2016
Moderna and Vertex partner to target cystic fibrosis with RNA therapies
July 7, 2016
Bial's Parkinson's drug wins approval in Europe
July 7, 2016
Pfizer, German Merck to test new combo against ovarian cancer
July 7, 2016
Valeant mulling sale of dermatology assets to Spanish Almirall: report
July 6, 2016
Japanese regulators approve PCSK9 drug from Sanofi, Regeneron
July 6, 2016
Another loss for J&J: Court sides with teenager in Risperdal case
July 6, 2016
Despite sluggish IPO market, biotechs continue to lead the way
July 6, 2016
Chinese biotech CStone raises $150 million in new financing
July 5, 2016
With insulin market set for shake-up, Novo Nordisk expands production plant
July 5, 2016
Pfizer makes bid for Bind after repayment woes
July 5, 2016
Patent Office accelerates patent review for cancer drugs in pilot program
July 1, 2016
J&J, AbbVie eye new indication for cancer drug Imbruvica
July 1, 2016
Boehringer continues to restructure, cuts 725 jobs in US
July 1, 2016
InVentiv Health comes on board as Pfizer's fourth CRO
June 30, 2016
Icagen to buy Sanofi lab, widening R&D reach
June 30, 2016
Two more Chinese drugmakers run afoul of FDA inspections
June 30, 2016
Pfizer's PCSK9 drug notches two Phase 3 wins
June 30, 2016
Shire's adult ADHD drug shows promise in late-stage study
June 30, 2016
Cancer Moonshot summit adds new partnerships to lofty goals
June 30, 2016
Roche eyes faster approval for multiple sclerosis drug
June 29, 2016
More generic drugs from India clearing FDA approval: report
June 29, 2016
Teva, Allergan sell off more drugs in quest for approval of generics deal
June 29, 2016
What does it take to succeed as a New York biotech startup?
June 29, 2016
Dr. Reddy's breaks off marketing partnership with Glaxo
June 28, 2016
Bristol-Myers eyes new indication as Opdivo nabs breakthrough tag in bladder cancer
June 28, 2016
Takeda hands back two developmental drugs to Amgen
June 27, 2016
FDA should be independent agency, former commissioners say
June 26, 2016
Industry group pushes back against proposed bill to reduce drug exclusivity
June 26, 2016
Study says Novartis heart med could prevent 28,000 US deaths per year
June 24, 2016
Eleven Bio slashes workforce after drug test failures
June 23, 2016
India targets drugmakers with wave of inspections
June 23, 2016
Opko wins approval for kidney drug after manufacturing snag
June 23, 2016
Selecta Biosciences raises $70 million in IPO, forges ahead with gout drug
June 23, 2016
Russian biosims company accuses Roche of undercutting its business
June 23, 2016
Celgene puts up $50 million to partner with four NCI cancer centers
June 23, 2016
Doctors who ate on pharma's dime prescribed drugs more often, study finds
June 22, 2016
Supreme Court asks for DOJ input on biosimilar case, delaying decision
June 22, 2016
Could label update for diabetes med Jardiance boost drug class?
June 22, 2016
Austin biotech Savara adds two lung drugs in deal for Serendex
June 22, 2016
Philips ad for lung device wins top honors at Cannes
June 21, 2016
Kite Pharma opens cell therapy plant as lead CAR-T candidate gathers steam
June 21, 2016
Incidence of Parkinson's may be increasing: Mayo Clinic study
June 21, 2016
Clinton racks up donations from pharma industry
June 20, 2016
NICE greenlights Bristol-Myers' combo drug for melanoma
June 20, 2016
Epizyme stock falls after mixed Phase 2 results for blood cancer drug
June 20, 2016
Hologic's Zika test can be used on emergency basis, FDA says
June 20, 2016
Why Novartis' new heart med could reverse slow start
June 17, 2016
Payer interest grows in outcomes-based drug deals: report
June 17, 2016
Roche's combo melanoma treatment turned down by UK cost watchdog
June 17, 2016
Venture funding for UK biotechs hits new high
June 17, 2016
EMA cites US-based Pii for manufacturing violations
June 16, 2016
Roche selling Spanish facility to CMO Famar
June 16, 2016
Lawmakers introduce bill to end REMS abuse, boost generic competition
June 16, 2016
Shkreli's stake in KaloBios cut after judge OK's bankruptcy plan
June 16, 2016
NYC-based Rgenix raises $33 million to advance cancer immunotherapy
June 15, 2016
Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit
June 15, 2016
Teva hands back global rights for heart drug to Australian Mesoblast
June 15, 2016
Success rate for clinical trials climbed in recent years: study
June 15, 2016
Infinity Pharma to lay off one-fifth of staff in wake of phase 2 setback
June 14, 2016
Merck eyes US approval with positive data on Lantus copy
June 14, 2016
Novo's diabetes drug shown to decrease heart risks, boosting competitive edge
June 14, 2016
Dr. Reddy's snaps up eight generics from Teva for $350 million
June 14, 2016
Merck, Pfizer expand trial studying CV benefit of experimental diabetes drug
June 13, 2016
Valeant weighs sale of Egyptian drug company
June 13, 2016
FDA approves world's first single-dose cholera vaccine
June 12, 2016
Lilly presents solid long-term data for baricitinib in RA patients
June 12, 2016
GSK wants to replace drugs with tiny implants
June 10, 2016
Amgen's chronic migraine-prevention drug shows promise in midstage trials
June 10, 2016
FDA wants to suspend more than 4,000 illegal Rx sites
June 10, 2016
Alexandria Center for Life Sciences offers $25M in seed funding for small biotechs
June 9, 2016
Will the approval of Inflectra be a biosimilar adoption tipping point?
June 9, 2016
Sun Pharma selling off two more US facilities
June 9, 2016
Researchers discover 11 acute myeloid leukemia subtypes
June 9, 2016
Gene therapy CMO Brammer Bio moves HQ to Massachusetts
June 9, 2016
Study: Blood-based 'liquid biopsy' cancer testing works
June 8, 2016
Vermont becomes first state with drug pricing justification law
June 8, 2016
Kite, Juno anticipating 2017 approvals for T-cell therapy
June 8, 2016
Genentech/OSI fined $67 million for skewing cancer-drug survival data
June 8, 2016
FDA approves Allergan's fixed-dose combo for hyertension
June 8, 2016
Senators request pricing info from opioid-overdose drugmakers
June 8, 2016
ASCO update: Biden announces launch of cancer data-sharing system
June 7, 2016
Alexion's Soliris fails in late-stage myasthenia gravis trial
June 7, 2016
Study: Cancer drugs most expensive in US, least accessible in China, India
June 6, 2016
Regeneron/Sanofi's dupilumab shines in phase 3 eczema trial
June 6, 2016
Study: Bristol-Myers' immunotherapy combo boosts response in lung cancer
June 6, 2016
Roche positioning Tecentriq as first-line therapy in bladder cancer
June 6, 2016
Mylan's Herceptin biosim shows comparable efficacy/safety
June 6, 2016
AstraZeneca continues to shed rights to gout drug
June 3, 2016
Novartis cancer drug wins expanded indication in Europe
June 2, 2016
FDA approves liquid biopsy test from Roche
June 2, 2016
Sanofi Pasteur starts up vaccine production at new facility in India
June 2, 2016
Sun Pharma continues to feel effect of Halol plant problems
June 2, 2016
Swiss biotech AC Immune readies US IPO
June 2, 2016
Two San Diego biotechs merge to create new oncology-focused company
June 2, 2016
Report: Investors concerned Teva overpaid for Allergan generics unit
June 2, 2016
Kite Pharma rides CAR-T momentum into ASCO
June 2, 2016
AstraZeneca discontinues 'Take it From a Fish' ad campaign
June 1, 2016
Federal judge orders Washington state to cover hep C medications
June 1, 2016
Daiichi Sankyo halts late-stage study of lung cancer drug
June 1, 2016
Next-generation eczema drugs on pace for 2017 launch
May 31, 2016
FDA knocks back Teva drug for Huntingon's, requests more information
May 31, 2016
EMA recommends approval for hepatitis C meds from Gilead, Merck
May 31, 2016
Wellcome Trust scores with startup investment in diagnostic company
May 31, 2016
Multiple sclerosis drug from Biogen, AbbVie clears FDA review
May 31, 2016
Second biosimilar of J&J's blockbuster Remicade approved in Europe
May 31, 2016
Contract researcher BioClinica reportedly weighing sale
May 27, 2016
FDA approves first implanted buprenorphine for opioid dependence
May 27, 2016
Fate of Ionis drug in doubt after GSK decides against Phase 3 study
May 27, 2016
FDA reprimands German API supplier for manufacturing violations
May 26, 2016
MIT lab shrinks drug manufacturing process into a small prototype machine
May 26, 2016
Aiming to make living tissue, Israeli companies test 3-D stem cell printing
May 26, 2016
Novartis moves toward sale of $14 billion stake in Roche
May 26, 2016
Two states sue Johnson & Johnson over vaginal mesh device problems
May 26, 2016
Kevin Young to return to Gilead as COO
May 26, 2016
In unanimous vote, FDA panel recommends Novo diabetes drug
May 25, 2016
Sandoz's biosimilar rituximab gets regulatory review in EU
May 25, 2016
While advancing cancer pipeline, Halozyme builds up through pharma collaborations
May 25, 2016
EMA reportedly reviewing clinical guidelines in wake of fatal drug trial
May 25, 2016
New ad for Bristol's Opdivo highlights testing advantage over Keytruda
May 24, 2016
Arbor Pharma buys XenoPort for $467 million
May 24, 2016
Sanofi diabetes chief to leave company as US business struggles
May 24, 2016
Lilly hopes to catch rivals with abemaciclib data
May 24, 2016
Novartis faces new challenges as top executives leave
May 24, 2016
China slashes prices of top-selling cancer, hep B drugs
May 23, 2016
Novartis' Entresto gets boost from leading US cardiology groups
May 23, 2016
Oramed's oral insulin shines in mid-stage trials
May 23, 2016
Merck KGaA/Pfizer's PD-L1 skin cancer drug shows encouraging interim results
May 20, 2016
Novartis launches ambitious clinical program for Entresto
May 19, 2016
AbbVie takes on AD at new Cambridge research facility
May 19, 2016
In reversal, Braeburn Pharma will stay in NC despite controversial law
May 19, 2016
Capsugel subsidiary flagged by Swedish regulator for GMP failures
May 19, 2016
BMS completes $280 million biologics plant expansion in MA
May 19, 2016
Novartis breast cancer drug proves efficacy, trial stopped early
May 19, 2016
AstraZeneca's gastric cancer drug falls short in phase 3
May 19, 2016
Janssen ponies up $740 million for another MacroGenics cancer drug
May 19, 2016
As big pharma moves in, biotech Galectin looks to stake claim to NASH market
May 18, 2016
Everyday low price? Walmart teams with McKesson to source generics
May 18, 2016
Orexigen struggles to stay afloat as obesity market stagnates
May 18, 2016
Celgene expands partnership with Agios into immuno-oncology
May 18, 2016
FDA looks to ease burden for compassionate drug use
May 17, 2016
Roche continues generics battle with latest lawsuit over Avastin copies
May 17, 2016
Novartis debates how to crack sales code for CAR-T therapy
May 17, 2016
Editas forges $5 million CRISPR research deal with Cystic Fibrosis Foundation
May 17, 2016
Aduro's pancreatic immunotherapy fails phase 2, sending stock tumbling
May 16, 2016
Eisai's kidney drug wins expanded indication in the U.S.
May 16, 2016
AstraZeneca looks to DNA damage-response drugs for edge in oncology
May 16, 2016
New phase 3 data boosts Pfizer's meningitis vaccine
May 15, 2016
Valeant pressured on promise to provide heart drug discount
May 13, 2016
Regneron CEO counters criticism from ICER on pricing
May 13, 2016
Oracle founder Larry Ellison donates $200 million for USC cancer center
May 12, 2016
J&J expands JLABS into Canada with new Toronto site
May 12, 2016
NIH-funded malaria vaccine shows safety, efficacy in early trial
May 12, 2016
Cigna signs value-based pricing deals with Amgen, Sanofi for PCSK9 drugs
May 12, 2016
Sanofi R&D chief, ex-FDA head cite need to improve international regulatory coordination
May 12, 2016
Opko Health's quest to redefine treatment for secondary HPT
May 12, 2016
Updated survival data added to Imbruvica's label
May 11, 2016
GSK's lupus drug finally wins NICE backing, but only after discounts
May 11, 2016
Daiichi snaps up Japanese rights to CVD stem-cell therapy
May 11, 2016
Americans may have overspent billions on brand-name drugs, study finds
May 11, 2016
Pfizer planning first triple-drug immuno-oncology study
May 11, 2016
NewLink Genetics writes off pancreatic cancer immunotherapy after phase 3 failure
May 10, 2016
Pharma opposition to Brexit cites concern for UK patients, life sciences
May 10, 2016
Wave Life Sciences touts more effective Duchenne drug
May 10, 2016
Cellectis' T-cell therapy clears leukemia in second baby
May 9, 2016
U.K. cost agency recommends new PCSK9 drugs, but only after further discounts
May 9, 2016
ICER questions high prices of multiple myeloma meds
May 9, 2016
Clovis shuts down cancer drug, will reduce staff by 35%
May 6, 2016
Regeneron reports strong Q1, but key drug faces pressure
May 6, 2016
Pfizer bets on Wave with drug development deal
May 6, 2016
New Zealand pushes back on coverage for Merck's Keytruda
May 5, 2016
Bayer's Stivarga shows efficacy in liver cancer
May 5, 2016
India may require more clinical trials for Sanofi's dengue vaccine
May 5, 2016
J&J loses another talcum powder case, ordered to pay victim $55 million
May 4, 2016
FDA warns antipsychotic can cause uncontrollable urges to gamble, have sex
May 4, 2016
Bayer's Xarelto projected to become top-selling drug in Europe by 2022
May 4, 2016
Former Turing CEO Martin Shkreli could face new federal charges
May 4, 2016
Generic drug backlog persists as FDA slowly clears applications
May 4, 2016
How Aprecia Pharma hopes to tackle patient noncompliance with 3-D printed drug
May 3, 2016
Caught by repayment demand, cancer biotech Bind Therapeutics files for bankruptcy
May 3, 2016
Colombia reportedly set to override Novartis patent on a key cancer drug
May 3, 2016
Takeda renames antidepressant after name confusion leads to errors
May 3, 2016
Multiple sclerosis drug from Biogen, AbbVie clears regulatory hurdle in EU
May 1, 2016
Crestor tumbles off patent cliff as first generic copy approved in US
May 1, 2016
Acadia wins FDA approval for first drug to treat Parkinson's disease psychosis
May 1, 2016
Amid pharma lobbying, US trade rep keeps India on priority watch list
April 29, 2016
Canadian drugmaker tells CMS it can make cheaper version of cancer drug Xtandi
April 29, 2016
New Express Scripts program aims to react faster to spikes in drug prices
April 29, 2016
Alexion eyes new manufacturing investment in Ireland
April 28, 2016
Sanford Weill and wife donate $185 million to UCSF for neuroscience research
April 28, 2016
Novartis aims for $1 billion in savings from centralization plans
April 28, 2016
NantKwest's billionaire CEO pocketed $148 million in total compensation last year
April 28, 2016
UBS venture fund raises $471 million for early-stage cancer investments
April 28, 2016
Pfizer settles Wyeth Medicaid rebate case for $784.6 million
April 28, 2016
AstraZeneca debuts new tech along with approval of COPD inhaler
April 27, 2016
Biogen's 'active woman' Tecfidera ad will go off air soon
April 27, 2016
Keeping pace with rival Keytruda, Bristol-Myers' Opdivo wins new breakthrough designation
April 27, 2016
Why Inflectra may face greater challenges than Zarxio in winning over US docs
April 27, 2016
Non-profit urges big pharma to take responsibility for drug take back programs
April 27, 2016
AstraZeneca hands off Zurampic marketing rights to Ironwood for $100 million
April 26, 2016
Viiv Healthcare expands access to HIV drug through patent pooling
April 26, 2016
Novartis may divest $14B stake in Roche, could generate M&A funding
April 26, 2016
With CEO Papa headed to Valeant, Perrigo faces new challenges
April 26, 2016
Major study shows no increased suicide risk from smoking cessation drugs
April 25, 2016
Proton pump inhibitors linked to serious kidney diseases in study
April 25, 2016
Germany mulling changes to limit prices drugmakers can charge
April 25, 2016
Chinese FDA to expedite review of new hepatitis C meds
April 25, 2016
Actelion denies reports of takeover
April 22, 2016
FDA issues critical response to Sarepta's latest DMD drug data
April 22, 2016
Boosting pipeline, AbbVie inks two deals for preclinical cancer drugs
April 22, 2016
In $205 million deal, Recipharm buys Kemwell's US, India CDMO businesses
April 21, 2016
Sanofi to invest €300 million in Belgian biologics site
April 21, 2016
CRISPR-Cas9 editing technology gets a precision upgrade
April 21, 2016
Combo of J&J Ebola vaccine, Nordic Bavarian booster yields 100% success in small-scale tests
April 21, 2016
New survey finds consumers unlikely to act on drug ads
April 21, 2016
Biosimilar update: Zarxio one year later
April 20, 2016
New analysis boosts cost-effectiveness argument for Merck's Zepatier
April 20, 2016
Indian pharma companies ramp up R&D to expand reach in US
April 20, 2016
PhaseRX, Gemphire move forward with IPOs despite challenging market
April 20, 2016
Armed with genetic data, UK biotech revisits abandoned Roche cholesterol drug
April 20, 2016
Merck vs. Merck: Trademark suit over brand name heats up
April 19, 2016
Chiasma shares nosedive after FDA rejects acromegaly drug, asks for more data
April 19, 2016
Study finds long-term health gains, cost-effectiveness benefits to new HPV vaccine
April 19, 2016
Eli Lilly cuts ties with Transition, ends diabetes drug collaboration
April 19, 2016
EMA broadens scope of safety review for Hep C antivirals
April 18, 2016
Starboard presses on with proxy efforts against Depomed
April 18, 2016
AbbVie's experimental hep c combo proves highly effective across genotypes
April 18, 2016
EASL 2016: Merck's 'no patient left behind' approach to hepatitis C
April 18, 2016
Roche rules out quality problems with Avastin in India
April 15, 2016
Glaxo investigating alleged bribes to government officials in Yemen: report
April 15, 2016
Most cancer drug labels don't include patient experiences: study
April 15, 2016
Fallout from China vaccine scandal continues with arrests of officials
April 14, 2016
Two Indian generic companies bow to pressure, end appeal for compulsory licenses
April 14, 2016
In first, FDA approves Janssen's switch to continuous manufacturing for HIV drug
April 14, 2016
Horizon expects most sales to come later in the year, precipitating share's slide
April 14, 2016
UK antitrust regulators fine Pfizer over epilepsy drug price increase
April 14, 2016
Billionaire Sean Parker stakes $250 million on cancer immunotherapy research
April 14, 2016
ICER questions cost effectiveness of multiple myeloma therapies
April 13, 2016
Federal court reverses dismissal of class-action suit against Pfizer over pain drugs
April 13, 2016
PledPharma takes on chemo-induced neuropathy with an eye to US market
April 13, 2016
With Sanofi gone, Mannkind tries to reinvigorate Afrezza marketing
April 12, 2016
Alkermes' Vivitrol gets second chance as opioid crisis deepens
April 12, 2016
California lawmakers debate bill requiring pharma companies to report 10% price increases
April 12, 2016
Celgene snaps up $50 million option for select Juno CAR-T programs
April 12, 2016
With polio near eradication, global switch to a new vaccine set to begin
April 11, 2016
Juno aims to bring CAR-T therapy to China with new joint venture
April 11, 2016
Activist hedge fund targets Depomed board
April 11, 2016
Ahead of key meeting, FDA reviewers question efficacy of Clovis' lung cancer drug
April 11, 2016
Major NGO drops India's IPCA Labs as a source of anti-malarials
April 8, 2016
FDA advisory board unanimously supports approval of Intercept's liver drug
April 8, 2016
Relypsa reportedly reviewing buyout offers on renewed interest in hyperkalemia drug
April 8, 2016
FDA approves Medtronic's Micra, first wireless pacemaker in the U.S.
April 7, 2016
Inventiv Health sets up IPO to pay down debt
April 7, 2016
Lilly invests $40 million in Irish continuous manufacturing facility
April 7, 2016
In potential $450 million licensing deal, J&J to develop prostate cancer drug
April 7, 2016
Broad Institute offering cloud-based access to trove of genomic data
April 7, 2016
Federal judge dismisses hundreds of Zoloft birth defect lawsuits
April 7, 2016
Philippines launches world's first public immunization program against dengue
April 6, 2016
New data: Pharma magazine ad spending surpasses $1.5 billion in 2015
April 6, 2016
Key panel nears vote on OCA, Intercept's potential blockbuster liver therapy
April 6, 2016
FDA chastises Shionogi for misleading copay voucher
April 6, 2016
BIO Spring 2016: Immunovia's quest to make early-stage pancreatic diagnosis a clinical reality
April 6, 2016
FDA warns on heart failure risk associated with Onglyza, Nesina
April 6, 2016
Analysis shows pharma companies aggressively increased prices on widely used drugs
April 5, 2016
Federal government appoints blue-ribbon advisory panel for cancer moonshot
April 5, 2016
Nimbus liver drug bought by Gilead for $400M cash plus incentives
April 5, 2016
With a biosim in the wings, Samsung Bioepis sues AbbVie over patent defense of Humira
April 4, 2016
ACC 2016: Boehringer's Pradaxa 'antidote' passes real-world test
April 4, 2016
ACC 2016: Novartis' Entresto reduces risk of hospitalization in HF patients
April 3, 2016
Price of success: Medivation reportedly hires JP Morgan to help fend off deal-hungry buyers
April 1, 2016
Lilly's arthritis drug baricitinib notches another success
April 1, 2016
Federal inspection report reveals major problems at Theranos lab
April 1, 2016
Urging more robust FDA response, lawmakers warn of contaminated heparin
March 31, 2016
FDA allows use of Roche's experimental test for Zika virus in endemic areas
March 31, 2016
Shire boosts CEO Ornskov's pay in light of "exceptional performance"
March 31, 2016
In cancer moonshot push, Biden and Bloomberg highlight potential of immunotherapy
March 31, 2016
FDA approves Jazz's rare liver disorder drug
March 31, 2016
Could long-term "mortgages" help patients fund short-term curative treatments?
March 30, 2016
Xenoport sells US rights to psoriasis drug to Dr. Reddy's
March 30, 2016
Denmark-based Lundbeck emerges as top-ranked company in survey of US patient groups
March 30, 2016
In reversal, FDA denies cognitive dysfunction label expansion for Brintellix
March 30, 2016
Novartis allegedly paid bribes in Turkey to secure advantages for its drugs
March 30, 2016
Eagle Pharma's Bendeka denied orphan exclusivity
March 29, 2016
Emulate raises $28 million for organ-on-chip technology
March 29, 2016
As vaccine scandal continues, WHO urges China to more strictly police regulations
March 29, 2016
Shire prevails in Lialda patent case against Allergan
March 29, 2016
Theranos blood testing inconsistent with other labs, study shows
March 29, 2016
New poll finds widespread support for cancer research funding
March 28, 2016
US gov demands more information from Novartis on purported kickbacks
March 28, 2016
Amid safety concerns, FDA adcomm set to review Acadia's Parkinson's drug
March 28, 2016
Trial begins in federal court over $60 million heist of Lilly drugs
March 24, 2016
South Korean, US researchers develop diabetes skin patch
March 24, 2016
Growing anger in China as vaccine scandal comes to light
March 24, 2016
Valeant doubled price of physician-assisted suicide drug
March 24, 2016
Biotech IPOs continue as Corvus prices public listing
March 24, 2016
Philanthropist Paul Allen launches new $100 million bioscience research initiative
March 24, 2016
NICE reverses course, endorses expanded use of J&J's Zytiga
March 23, 2016
Brexit could complicate marketing status of drugs, new licenses
March 23, 2016
J&J and Genentech partnering in two cancer studies combining Darzalex with atezo
March 23, 2016
Denying recent reports, India government say it hasn't promised to restrict compulsory licensing
March 23, 2016
Why ViiV Healthcare leads the pharma industry in corporate reputation
March 22, 2016
23andMe enabling iPhone users to share DNA data with medical researchers
March 22, 2016
BioMarin's PKU drug meets primary goal in phase 3, but falls short on secondary endpoints
March 22, 2016
Indian court temporarily blocks government ban on sales of FDCs
March 22, 2016
As FDA review approaches, Duchenne experts push for approval of Sarepta's eteplirsen
March 22, 2016
WHO suspends all TB products from India's Svizera Labs
March 21, 2016
Biden names corporate exec Greg Simon to lead Cancer Moonshot
March 21, 2016
EMA issues safety guidance for Gilead's Zydelig in wake of patient infections
March 21, 2016
OptumRx signs on with Walgreens Boots Alliance
March 18, 2016
Top Gilead cancer researcher has left company
March 18, 2016
Former Turing exec to Senate panel: We warned Shkreli about Daraprim price hike
March 18, 2016
Bayer planning new life sciences hub in Cambridge, MA
March 17, 2016
Cellectis and MabQuest team up to develop new class of anti-PD1 antibodies
March 17, 2016
Valeant's stock collapse triggers closer scrutiny
March 17, 2016
In limited study, NIH-developed dengue vaccine proves 100% effective
March 17, 2016
Despite promising clinical results, uptake challenges continue for Novartis' Entresto
March 17, 2016
Valeant acquires Orexigen's obesity drug, stock continues its slide
March 16, 2016
CDC issues new guidelines for prescribing opioids
March 16, 2016
Survey: Pharma advertising works—especially with millennials
March 16, 2016
EMA finalizes clinical trial redaction guidelines
March 16, 2016
Lilly changes endpoint for phase 3 Alzheimer's trial
March 16, 2016
Indian authorities withdraw alert on off-label use of Roche's Avastin
March 15, 2016
As U.S. biosim market grows, FDA's regulatory work has cost nearly $82 million
March 15, 2016
GW Pharma stock doubles after positive phase 3 cannabis drug results
March 15, 2016
Sanders proposes cash prize for development of lower-priced AIDS drugs
March 15, 2016
Allergan would pay $86M in 'golden parachute' taxes if senior execs dismissed
March 15, 2016
KaloBios sets up funding to clear bankruptcy, acquire Chagas drug
March 14, 2016
EU regulators investigating Gilead's Zydelig after infection deaths
March 14, 2016
Indian Health Ministry bans nearly 350 combo drugs
March 14, 2016
Boehringer turns to 'red fish' for Pradaxa boost
March 14, 2016
Sarepta's Duchenne drug gets a new date for FDA review
March 11, 2016
Bispecifics emerging as alternative cancer immunotherapy to CAR-T
March 11, 2016
Major opioid abuse bill passes 94 to 1 in Senate
March 11, 2016
Whistleblower sues Indian drug regulators for poor oversight
March 10, 2016
Merck names new manufacturing head, replacing 12-year veteran
March 10, 2016
French regulator halts manufacturing at HIV-focused biotech
March 10, 2016
Senate HELP Committee advances seven bills as counterpart to 21st Century Cures
March 10, 2016
Gilead and Merck lock horns in court over sofosbuvir patent
March 10, 2016
CRISPR patent battle begins, setting 'first to file' against 'first to invent'
March 10, 2016
Black box warning order clouds future for Bayer's Essure
March 9, 2016
Colombia health ministry recommends compulsory license for Novartis' Gleevec
March 9, 2016
FDA accepts new Keytruda data, opening door for wider indication
March 9, 2016
Kentucky Senate overwhelmingly passes biosimilar prescription bill
March 9, 2016
Senate HELP Committee to mark up 21st Century Cures legislation
March 8, 2016
Counterfeit Harvoni from India found in Israel
March 8, 2016
Industry groups, doctors ask CMS to withdraw proposed Part B experiment
March 8, 2016
Novartis' Cosentyx proves superior to Janssen's Stelara in head-to-head comparison
March 7, 2016
New study strengthens link between Zika and serious birth defects
March 7, 2016
GSK's asthma drug Nucala boosted by long-term safety study
March 7, 2016
Alaska Permanent Fund betting big on biotech startups
March 4, 2016
Endo to pay $200K penalty, overhaul marketing of opioid painkiller
March 4, 2016
FDA approves first Zika diagnostic for emergency use
March 3, 2016
In major expansion, Lupin subsidiary setting up plant in Japan
March 3, 2016
BMJ study: Single dose vials cost nearly $2B a year in wasted cancer drugs
March 3, 2016
Merck forges ahead with phase 3 trial of Humira biosimilar
March 3, 2016
Sanofi's generics divestment in the E.U. likely to be delayed
March 3, 2016
Amgen going after Novartis for Enbrel patent infringement
March 3, 2016
Bayer's Essure permanent birth control gets black-box warning
March 2, 2016
San Diego-based Conatus takes aim at unmet medical need in cirrhosis
March 2, 2016
AstraZeneca's mesothelioma drug fails monotherapy testing
March 2, 2016
Teva planning global rebrand as it works to close Allergan generics deal
March 2, 2016
Clinton ad lambastes Valeant for 'predatory' pricing
March 2, 2016
Federal investigation probing Horizon Pharma's patient assistance program
March 2, 2016
AstraZeneca sells off more 'non-core' assets, raising nearly $600M
March 1, 2016
AARP report: Average prescription drug cost rose by 10% in 2013
March 1, 2016
Roche's asthma drug stumbles on mixed phase 3 results
March 1, 2016
Boehringer/AbbVie reportedly in cancer-collaboration talks
March 1, 2016
Report: Pfizer attempting to dodge $35 billion in taxes through merger with Allergan
Feb. 29, 2016
Chinese Food and Drug Administration vows to expedite drug approvals
Feb. 29, 2016
CDC reports new cases of sexual transmission of Zika virus
Feb. 29, 2016
How the ambitious Cancer Moonshot hinges on the potential of immunotherapies
Feb. 28, 2016
Doctors Without Borders blasts $1700 price tag of Otsuka TB drug
Feb. 26, 2016
AZ's deal for Acerta already showing promise as cancer drug wins orphan nod
Feb. 25, 2016
Valeant's Pearson recovering, but timetable for return remains uncertain
Feb. 25, 2016
Sandoz issues major recall for hypertension drug made in India
Feb. 25, 2016
Banned Chinese supplier given exemption to ship chemotherapy drug to U.S.
Feb. 25, 2016
Merck's Zepatier holds its own in safety comparison to Gilead meds
Feb. 25, 2016
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
Feb. 25, 2016
Novo Nordisk notches another phase 3 success for GLP-1 drug
Feb. 25, 2016
Merck CEO Frazier acknowledges pricing 'challenges,' need for new models
Feb. 24, 2016
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Feb. 24, 2016
IBM buys Truven for $2.6 billion, continues to build its big data focus in healthcare
Feb. 24, 2016
Alibaba under siege as Chinese regulators & pharmacies fight its e-drug tracking system
Feb. 24, 2016
Why uptake of new PCSK9 cholesterol meds has been so slow
Feb. 24, 2016
Do big name journals have a 'marketing trial' problem?
Feb. 24, 2016
Startup turns to 'video game' medical tech to address brain-based disorders
Feb. 23, 2016
Alzheimer's startup Chase plots $70M in 2016 funding
Feb. 23, 2016
AstraZeneca nabs two big European nods for gout & heart meds
Feb. 23, 2016
UK firm may have just revolutionized NSAID delivery with ibuprofen patch
Feb. 23, 2016
Allergan's Q4 earnings best expectations on back of US sales
Feb. 23, 2016
FDA approves new UCB drug to treat epilepsy-related seizures
Feb. 22, 2016
Startup AvroBio touts gene therapy candidates for blood cancer, Fabry disease
Feb. 22, 2016
The flip side of the T-cell hype: Experts urge caution on huge costs, safety concerns
Feb. 21, 2016
UPDATE: Teva to hawk $1 billion in assets to clear massive Allergan generics deal
Feb. 19, 2016
The next overdose crisis? Benzo-related deaths on the rise in US
Feb. 19, 2016
Celgene hitches wagon to Bluebird, doles out $10M as biotech launches 1st CAR-T trial
Feb. 19, 2016
New Zafgen data shows obesity med's promise in diabetics—but will FDA lift its clinical hold?
Feb. 19, 2016
Eight pharma suppliers band together to improve packaging testing, compatability
Feb. 18, 2016
Pfizer issues major recall of children's Advil in Canada
Feb. 18, 2016
Armed with strong new data, Regulus aims to defy skeptics of its hep C injectable
Feb. 18, 2016
AstraZeneca scores a clutch 'breakthrough' for major bladder cancer med
Feb. 18, 2016
AMD Awareness Month: For drugmakers, value is the name of the game
Feb. 17, 2016
Pfizer downgrades Q4 outlook after $785M DOJ settlement spurred by 'serial whistleblower'
Feb. 17, 2016
FDA expands Gilead's Harvoni label for advanced cirrhosis patients
Feb. 17, 2016
Express Scripts putting all Valeant scripts under the microscope amid pricing furor
Feb. 17, 2016
Amgen launches Kyprolis in the UK for multiple myeloma
Feb. 16, 2016
HHS chief mulling controversial 'march-in' to smack down patents & tackle drug prices
Feb. 16, 2016
New PCSK9s & heart meds face slow uptake, brush up against payer review requirements
Feb. 16, 2016
Global API market ballooning, will hit $186 billion by 2020: report
Feb. 16, 2016
UK regulator smacks Glaxo with $54.4 million fine over pay-for-delay deals
Feb. 16, 2016
UK High Court delivers heavy blow to Lilly in patent spat over blockbuster Alimta
Feb. 16, 2016
Struggling Clovis to once again chase FDA favor for would-be Tagrisso competitor
Feb. 16, 2016
China's next big move to bolster domestic drug industry: Market consolidation
Feb. 16, 2016
Dr. Reddy's Q3 earnings flat despite FDA woes
Feb. 11, 2016
Taiwan earthquake leaves drug API plants unscathed
Feb. 11, 2016
In search for specialists, Teva laying off factory workers at UK plant
Feb. 11, 2016
Biopharma giants Biogen & Sanofi buy into round A for Tony Coles' Yumanity
Feb. 11, 2016
Egypt facing major drug supply crisis fueled by weak currency & political turmoil
Feb. 11, 2016
Gene editing: The latest national security threat?
Feb. 11, 2016
Competition from Lilly's Trulicity weighs on Novo's otherwise solid Q4
Feb. 10, 2016
Breaking down Super Bowl 50's pharma ads: A bold moment for gut drugs
Feb. 10, 2016
Shire gets new PDUFA date for eye drug hopeful once spurned by FDA
Feb. 10, 2016
J&J, Viacyte team up on a potential stem cell therapy 'cure' for type 1 diabetes
Feb. 10, 2016
You've got InMail: Pharma ratcheting up use of LinkedIn for marketing
Feb. 10, 2016
Sanofi CEO wants to leverage Dengue vax success to expedite Zika vaccine development
Feb. 10, 2016
BIO CEO 2016: What it will take to achieve Cancer MoonShot 2020
Feb. 10, 2016
Clinics peddling unauthorized stem cell treatments face FDA heat
Feb. 9, 2016
A besieged drug industry launches major new ad campaign to woo lawmakers
Feb. 9, 2016
BIO CEO 2016: Purdue pursues deals, boosting the NIH, Schumer slams Shkreli, & more
Feb. 9, 2016
FDA staff sounds encouraging note on Celltrion's biosim of J&J blockbuster Remicade
Feb. 7, 2016
Supernus wins court victory over Allergan in epilepsy drug patent spat
Feb. 7, 2016
OncoGenex slashes workforce after phase 3 cancer med setbacks
Feb. 7, 2016
UPDATE: LifeSci Advisors apologizes for JPM party that stoked sexism critiques
Feb. 5, 2016
A bankrupt KaloBios may still buy Chagas drug that Shkreli wanted to acquire-and-hike
Feb. 5, 2016
Lundbeck wins key FDA backing for expanding depression drug Brintellix's label
Feb. 5, 2016
Agilent accuses Twist Bioscience CEO of stealing trade secrets
Feb. 5, 2016
Glaxo, Adaptimmune ratchet up cancer collab in $500 million deal
Feb. 4, 2016
Statisticians question methods used in deadly Bial study
Feb. 4, 2016
Allergan's Texas plant primed for expansion, possible job growth
Feb. 4, 2016
Pfizer, Merck, & other pharmas reviewing vaccine portfolios to address Zika emergency
Feb. 4, 2016
Martin Shkreli goes to Washington—and refuses to say anything to Congress
Feb. 4, 2016
From blunt force to electrical currents: Cancer treatment in the 21st century
Feb. 3, 2016
New study: Pfizer's Chantix no more effective than nicotine patches
Feb. 3, 2016
Old Novartis cancer flagship Gleevec heads to pharmacies as lower-cost generic
Feb. 3, 2016
J&J heads to court over alleged talcum powder, ovarian cancer link
Feb. 3, 2016
Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial
Feb. 2, 2016
21st Century Cures progress may be hitting a partisan buzzsaw
Feb. 2, 2016
Appeals court upholds drug companies' right to manufacture generic OxyContin
Feb. 2, 2016
Obama seeks $755M for Cancer MoonShot, boosts to NIH & FDA
Feb. 2, 2016
Express Scripts ditches Valeant diabetes med as part of 2016 formulary shakeup
Feb. 1, 2016
A promising sign for 'Pfallergan' pipeline as Allergan depression med nabs 'breakthrough'
Feb. 1, 2016
Hep C market poised for pricing rumble as Merck's cheaper med approved
Feb. 1, 2016
How the brain disease model of addiction drives innovation in drug development
Jan. 29, 2016
Q4 update: Bristol-Myers outperforms and Celgene misses EPS estimates
Jan. 29, 2016
FDA alleges deleted files, hidden data at India's Wockhardt
Jan. 28, 2016
Eisai grabs an FDA approval for life-extending soft tissue cancer drug
Jan. 28, 2016
Catalent still in strategic acquisition mode after a slew of big deals
Jan. 28, 2016
Editas Medicine prepping for IPO even as biotech market struggles
Jan. 28, 2016
New study: Schizophrenia may be caused by gene-driven 'overpruning'
Jan. 28, 2016
Novartis blames slower-than-expected Entresto growth in US on insurer tardiness
Jan. 28, 2016
Top NCI scientist: 'Autologous' cell approach of firms like Kite, Juno will be main CAR-T focus
Jan. 28, 2016
Focus on Brazil: In pursuit of the Zika vaccine
Jan. 27, 2016
NEJM editor Drazen hit with big backlash over 'research parasites' comments
Jan. 26, 2016
DTC TV ad spending fell in December, but Pfizer topped peers
Jan. 26, 2016
Oxford Pharmascience hunting for a big pharma partner for painkiller marketing
Jan. 26, 2016
US temporarily halts enrollment in Cigna Medicare Advantage & drug plans
Jan. 26, 2016
Valeant CEO Pearson on the mend, but timing of return uncertain
Jan. 26, 2016
Judge amends Shkreli's bail to let him travel to DC for drug pricing hearing
Jan. 26, 2016
Roche investigating off-label Avastin use after 15 Indian patients hospitalized
Jan. 26, 2016
Zika vaccine quest begins as WHO warns of spread to most countries in the Americas
Jan. 26, 2016
Why 2 senators, including Sanders, just blocked a vote on Obama's FDA chief nominee
Jan. 25, 2016
OPDP warns Hospira about misleading YouTube video
Jan. 25, 2016
The biggest implications of ICJME's new clinical trial data sharing proposal
Jan. 25, 2016
Researchers probing links between Down syndrome and Alzheimer's
Jan. 25, 2016
Amgen wins big with Kyprolis expansion in US and Repatha approval in Japan
Jan. 25, 2016
Sanofi expected to slash jobs as diabetes franchise feels the squeeze
Jan. 25, 2016
Glaxo chief: Consumer unit can stand on its own—but don't expect a spinoff soon
Jan. 22, 2016
Novo Nordisk eyes the future, expands presence in Iran as sanctions lift
Jan. 22, 2016
Alkermes' depression drug flunks phase 3, shares nearly sliced in half
Jan. 21, 2016
Study: FDA scrutiny, other competition likely to eat into Indian pharma growth
Jan. 21, 2016
Drug firms like J&J cautious on FAAH inhibitors in wake of trial death in France
Jan. 21, 2016
Glaxo, Qualcomm reportedly mulling med tech joint venture
Jan. 21, 2016
Biden pushes Cancer MoonShot to corporate leaders in Davos, pitches faster approvals
Jan. 21, 2016
Express Scripts shares rocked by antitrust suit, Anthem breakup threat
Jan. 20, 2016
Nivalis grabs a key orphan designation for its cystic fibrosis drug
Jan. 20, 2016
Big data: The key to healthier patients, better margins, & making Cancer MoonShot 2020 a reality
Jan. 20, 2016
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
Jan. 19, 2016
Taiwan election results buoy biotech sector, president-elect seen as major ally
Jan. 19, 2016
Eleven Bio shares fall off a cliff as ophthalmic drug fails second phase 3 trial
Jan. 19, 2016
Samsung Bioepis scores first-ever Enbrel biosim approval in EU
Jan. 19, 2016
FDA harshly criticizes Sarepta's Duchenne drug just one day after rejecting BioMarin's
Jan. 15, 2016
Cipla's pipeline bursting with more than 200 drugs
Jan. 15, 2016
Glaxo heading to court over generic Paxil claims in suicide case
Jan. 15, 2016
Behind the scenes at the FDA: Why they ultimately approved Addyi
Jan. 15, 2016
Analysts skeptical about Shire's Baxalta 'growth play' strategy
Jan. 14, 2016
ASCO: Reform the 'clinical pathways' approach to cancer
Jan. 14, 2016
Pay-for-delay deals continue to fall following FTC court victory
Jan. 14, 2016
Cancer MoonShot 2020: Independence Blue Cross to cover genome sequencing costs
Jan. 13, 2016
Pharma execs dismiss protests over drug pricing, focus on deal-making at JPM16
Jan. 13, 2016
Cervical Health Awareness Month: How far we've come since Nixon declared war on cancer
Jan. 13, 2016
Glaxo to stop paying physicians to promote its drugs
Jan. 13, 2016
Roche and AbbVie move promising CLL drug towards finish line
Jan. 13, 2016
Baxter again forced to recall IV solutions due to insect presence
Jan. 12, 2016
Allergan acquires Anterios to enhance neurotoxin delivery, bolsters Botox portfolio
Jan. 12, 2016
Study: PPIs for heartburn linked to increased risk of kidney disease
Jan. 12, 2016
Supreme Court rejects Janssen appeal over $124 million Risperdal fine
Jan. 12, 2016
Seres signs on with Nestlé Health Science in gut drug partnership
Jan. 12, 2016
Novartis CEO to unveil growth program for Alcon unit amidst falling sales
Jan. 12, 2016
Lawmakers urge NIH to combat high drug prices with patent overrides
Jan. 12, 2016
Walgreens' leadership defends unconventional Valeant deal
Jan. 11, 2016
Biotech Moderna partners with CRO to advance promising RNA therapies into trials
Jan. 11, 2016
FDA accepts Sanofi/Regeneron application for RA drug
Jan. 11, 2016
New year brings higher prices for 100 Pfizer drugs
Jan. 11, 2016
Positive hemophilia B gene-therapy results boost UniQure stock
Jan. 8, 2016
Medical marijuana clinics open in New York with strict restrictions
Jan. 8, 2016
Deal-hungry J&J partners with Chinese firm to focus on hep B breakthrough
Jan. 8, 2016
Zydus Cadila slapped with FDA GMP violation letter
Jan. 7, 2016
Large cancer database upgraded to provide 3D insights
Jan. 7, 2016
In efficiency bid, Novartis selling Alcon unit to Recipharm in $20M deal
Jan. 7, 2016
Brazil trims vaccine doses as recession deepens
Jan. 7, 2016
Biogen partners with Rodin on Alzheimer's research, possible buy-out opp
Jan. 7, 2016
Number of violation letters issued by FDA hits all-time low
Jan. 7, 2016
Global breast cancer treatment market forecast to hit $17.2 billion by 2021
Jan. 6, 2016
How one pharma marketing exec hit back at the AMA's call to ban DTC drug ads
Jan. 6, 2016
ACCME vs. PharmedOut: How credible is CME in the age of Addyi?
Jan. 6, 2016
A lesson in DTC: What happened when a Vogue contributor took Addyi for a test run
Jan. 6, 2016
Actelion lines up a $160,000 price tag for PAH orphan med Uptravi
Jan. 6, 2016
Major Chinese pharma firm plots a $3 billion IPO in Hong Kong
Jan. 5, 2016
Rat study finds link between neural tube defects and low PCSK9 levels
Jan. 5, 2016
Baxalta strikes a $1.6B immuno-oncology deal ahead of potential Shire deal
Jan. 5, 2016
Teva's MS hopeful takes another big hit in phase 3
Jan. 4, 2016
New UK program gave 500 melanoma patients early access to Merck's Keytruda
Jan. 4, 2016
Take two: Dr. Reddy's relaunches generic Nexium in new blue color
Jan. 4, 2016
The year ahead: 11 execs & experts predict what's in store for biopharma in 2016
Jan. 4, 2016
FDA oncology chief Pazdur scrutinized over cancer drug approvals after wife's death
Jan. 4, 2016
Bill Ackman sells 14% of Valeant shares, citing tax purposes
Jan. 4, 2016
WellCare ditches UnitedHealth in PBM scuffle, opts for CVS
Jan. 4, 2016
Bionor Pharma's 'kick and kill' HIV therapy shows promise
Dec. 23, 2015
In unique Valeant-Walgreens distribution deal, drugmaker to retain titles to its therapies
Dec. 23, 2015
New CMS drug spending database reveals 7 drugs at least doubled in cost
Dec. 23, 2015
Actelion lines up 2016 launch for newly approved PAH orphan drug Uptravi
Dec. 23, 2015
Baxalta fielding buyout offers, but may land with Shire after all
Dec. 23, 2015
FDA approves 2015's 45th new drug, AstraZeneca's gout med
Dec. 23, 2015
11 biopharma execs & experts look back on 2015: A record year for record-breaking
Dec. 22, 2015
Health regulators step in to investigate employee complaints against Theranos
Dec. 22, 2015
Bayer pumping 335 million euros into CRISPR Therapeutics gene-editing partnership
Dec. 22, 2015
ICER: Glaxo's new asthma drug massively overpriced, should cost 70% less
Dec. 22, 2015
For pharma reps, typical in-service fare includes burgers & fries—but not pizza
Dec. 22, 2015
UC Davis & Moffitt Cancer Center suspend KaloBios cancer trial after Shkreli debacle
Dec. 22, 2015
Employers turn to new tactics to rein in drug costs
Dec. 21, 2015
Sun Pharma's Halol plant gets FDA warning, shares slump 7%
Dec. 21, 2015
Isis Pharma ditches its terrorism-tainted name, will now be Ionis Pharmaceuticals
Dec. 21, 2015
Novartis CEO: Pharma needs to share both pain and gain with payers, providers
Dec. 21, 2015
AstraZeneca's hopes for major cancer hopeful durvalumab dim
Dec. 21, 2015
Fortune reporter offers apology for previous glowing coverage of Theranos
Dec. 18, 2015
Shire-Baxalta takeover drama barreling towards its final act
Dec. 18, 2015
University of California invests $250 million in biotech venture fund
Dec. 18, 2015
Chinese FDA's crackdown on poor-quality drugs shows no signs of easing up
Dec. 18, 2015
Gilead snags 15% stake in Galapagos 3 months after AbbVie backs out
Dec. 18, 2015
Narcan is just the beginning: Unleashing the power of opioid antagonism
Dec. 18, 2015
Why genetic testing could be coming to a workplace near you
Dec. 17, 2015
Novartis poaches a Harvard oncologist to head up immuno-oncology program
Dec. 17, 2015
With eye on the future, AstraZeneca to beef up manufacturing, R&D presence in China
Dec. 17, 2015
Glaxo's IL-6 antibody shows promise in rheumatoid arthritis
Dec. 17, 2015
Advaxis soars as FDA releases patient death-related clinical hold on its drugs
Dec. 17, 2015
Ted Cruz proposes controversial plan to expedite drug approvals through 'reciprocity'
Dec. 16, 2015
Mylan to Strides: Help us cover the tab for your noncompliant plants
Dec. 16, 2015
Amgen to snatch 3 drugs back from Glaxo in key int'l markets
Dec. 16, 2015
Pharma's 1st Amendment battle rages on as Pacira, FDA reach Exparel settlement
Dec. 16, 2015
Boehringer, Sanofi prepping complex asset swap of consumer, animal health units
Dec. 15, 2015
Reckitt Benckiser taking heat from Australian, British watchdogs for pain med ads
Dec. 15, 2015
Major research institutions fail transparency requirements, and pharma's not much better
Dec. 15, 2015
Akebia strikes $350 million deal with Mitsubishi Tanabe for next-gen anemia pill
Dec. 15, 2015
In surprising setback for Merck, FDA panel refuses to back broader Zetia indication
Dec. 15, 2015
New study: Antidepressants in pregnancy may be linked to autism
Dec. 14, 2015
FTC wants even more info from Walgreens & Rite Aid on proposed merger
Dec. 14, 2015
Lilly prices cancer med Portrazza at nearly 10 times docs' recommendation
Dec. 14, 2015
Valeant, in the hot seat, beefs up its legal and crisis management muscle
Dec. 14, 2015
UPDATE: AstraZeneca buys 55% stake in Acerta for $4 billion
Dec. 14, 2015
It's official: FDA shoots past 2014's new drugs record with Roche lung cancer med nod
Dec. 14, 2015
FDA approves first-of-its-kind chemo overdose antidote, Vistogard
Dec. 14, 2015
The new PCSK9 scorecard: Praluent favored by UnitedHealth, Repatha by CVS, both by Express Scripts
Dec. 11, 2015
New study: Too many factories, too few inspectors for India's pharma industry
Dec. 11, 2015
FDA AdComm recommends Teva asthma drug for adults—but not teens
Dec. 11, 2015
The 'Soliris-killer' cometh? Alnylam plans final 2017 trials to take on world's priciest drug
Dec. 11, 2015
A lead researcher and a Boehringer SVP on the drumbeat of innovation in oral anticoagulants
Dec. 11, 2015
WSJ details the painstaking process behind pricing a major Pfizer cancer med
Dec. 10, 2015
Sanofi scores landmark approval for world's 1st Dengue vaccine in Mexico
Dec. 10, 2015
21st Century Cures orphan drug exclusivity measures could divide consumer and patients advocates
Dec. 10, 2015
EMA chief: Faster drug approvals can quell Rx sticker shock
Dec. 10, 2015
New analysis boosts Harvoni as 'safest' next-gen hep C option
Dec. 10, 2015
New study: Chemical castration doubles risk of Alzheimer's disease
Dec. 9, 2015
Flush with cash, Gilead chasing a mid-range deal like the one that gave it Sovaldi
Dec. 9, 2015
Alexion scores FDA nod for orphan drug derived from genetically engineered chickens
Dec. 9, 2015
FDA approves Baxalta's Vonvendi for von Willebrand bleeding disorder
Dec. 9, 2015
Obama FDA nominee under the microscope as regulators review pivotal Xarelto trial he ran
Dec. 8, 2015
Hillary Clinton to unveil 'exit tax' plan to combat inversion mergers like Pfizer/Allergan
Dec. 8, 2015
Laguna Pharma calls it quits after phase 3 CVD drug flop
Dec. 8, 2015
ASH15: Early-stage Keytruda trial shows unprecedented response in advanced multiple myeloma
Dec. 8, 2015
Merck & Samsung Bioepis nab 2nd major biosim approval in Korea
Dec. 8, 2015
Lilly's next-gen insulin hopes hit a buzzsaw as firm ditches late-stage diabetes candidate
Dec. 7, 2015
Merck's Keytruda gets presidential lift as Jimmy Carter announces he's cancer-free
Dec. 7, 2015
Mylan slapped with Justice Department subpoena over doxycycline pricing
Dec. 7, 2015
ASH15: J&J/AbbVie's Imbruvica cuts CLL death risk; Bluebird/Celgene buoyed by NIH myeloma data
Dec. 7, 2015
ASH15: Bluebird tanks 35% on gene therapy data; Novartis preps 2017 filing for blood cancer CAR-T
Dec. 7, 2015
Medtronic's inversion deal has already saved it more than $9 billion
Dec. 4, 2015
Inside the bold new fight for an HIV cure: An exclusive interview with amfAR CEO Kevin Robert Frost
Dec. 4, 2015
Experts at gene-editing summit warn against using CRISPR-Cas9 to cure embryos
Dec. 4, 2015
High specialty drug prices help drive renewed spike in 2014 healthcare spending
Dec. 4, 2015
Pfizer shutting down another UK R&D site, nixing more than 100 jobs
Dec. 4, 2015
Martin Shkreli's big regret: Not pricing Daraprim even higher
Dec. 4, 2015
Can Rich Heyman score a buyout hat-trick with prostate cancer drug startup ORIC?
Dec. 3, 2015
Pharma's PR problem: 53% of Americans blame pursuit of profits for high drug prices
Dec. 2, 2015
Game on: Amgen files biosimilar Humira, pulls ahead of the pack
Dec. 2, 2015
Pentagon official's emails demonstrate that Theranos concerns date back to 2012
Dec. 2, 2015
US Senate report slams Gilead over Sovaldi price, insinuates culture of profits over patients
Dec. 2, 2015
Adaptimmune heats up the immuno-oncology race & stares down Cellectis with Universal Cells deal
Dec. 2, 2015
Influential GOP lawmaker calls for tax overhaul in wake of Pfizer-Allergan inversion deal
Dec. 2, 2015
As Theranos deal fizzles, Safeway brings in Sonora Quest Labs for diagnostic tests
Dec. 2, 2015
Express Scripts banishes Turing from formulary, turns to compounder for generic Daraprim
Dec. 2, 2015
World AIDS Day: PrEP uptake main hurdle to 2030 eradication goal as Obama unleashes action plan
Dec. 1, 2015
FDA approves 3rd multiple myeloma med in a month, this time from Bristol-Myers & AbbVie
Dec. 1, 2015
World class panel of experts to tackle CRISPR, genome editing ethics during DC summit
Dec. 1, 2015
How China is getting serious about developing quality drugs right at home
Dec. 1, 2015
SCOTUS rejects Medtronic's patent-infringement restoration request against J&J
Dec. 1, 2015
New York Stem Cell Foundation doubling its footprint in Manhattan
Dec. 1, 2015
What's driving the rapid rise in dermatology drug prices?
Nov. 30, 2015
Roche severs 'superbug' antibiotic R&D pact with Polyphor
Nov. 30, 2015
Allergan beefs up its CNS portfolio ahead of Pfizer merger
Nov. 30, 2015
In rare setback, Bristol-Myers' Opdivo denied expanded melanoma label
Nov. 30, 2015
Could CRO revenues become a victim of the Pfizer-Allergan merger?
Nov. 30, 2015
UPDATE: BioMarin Duchenne drug appears destined for failure after brutal FDA meeting
Nov. 25, 2015
Defiant Ackman doubles down on stake in embattled Valeant
Nov. 25, 2015
Robots, sound waves, and software: How AZ is beefing up tech at its UK R&D hub
Nov. 24, 2015
After Pfizer-Allergan, few large inversion deal options for cash-rich companies
Nov. 24, 2015
America's favorite pharma stock is Israel's Teva
Nov. 24, 2015
Pricey hep C drugs found to be cost-effective in early disease and beyond
Nov. 24, 2015
Int'l experts reprimand WHO over Ebola crisis response
Nov. 24, 2015
In blow to Sanofi/Regeneron, CVS favors Amgen's competing PCSK9 med for its formulary
Nov. 24, 2015
Bristol-Myers' unstoppable Opdivo now approved for advanced kidney cancer
Nov. 24, 2015
Bristol-Myers, U.N. strike generic hep C drug production pact for poor nations
Nov. 24, 2015
Roche's immuno-oncology blockbuster hopeful shines in early melanoma trial
Nov. 24, 2015
How biopharma companies can thrive in the era of megamergers and shrinking budgets
Nov. 24, 2015
Horizon Pharma ditches $1 billion hostile bid for Depomed
Nov. 23, 2015
Samsung Bioepis close to major EU approval for Enbrel biosimilar
Nov. 23, 2015
FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro
Nov. 23, 2015
New data: Celldex brain cancer vaccine boosts long-term survival in advanced disease
Nov. 23, 2015
AstraZeneca, Sanofi strike massive compound-sharing open research pact
Nov. 23, 2015
KaloBios has been 'rescued' by Martin Shkreli—who is now its CEO
Nov. 20, 2015
Multidrug resistant bacteria now stronger than super-strength antibiotics
Nov. 20, 2015
Big pharma trying to quash CA drug price cap effort with massive campaign war chest
Nov. 20, 2015
FDA approves first-ever nasal spray to fight opioid overdose
Nov. 20, 2015
CAR-T companies scale up production with eye towards lowering costs
Nov. 19, 2015
IMS 2020 forecast: Drug spending will hit a whopping $1.4 trillion
Nov. 19, 2015
Sandoz chases 2-for-2 record as US biosim pioneer as FDA agrees to review copycat Neulasta
Nov. 19, 2015
Early scripts for female libido pill Addyi fall flat, Valeant left holding the bag
Nov. 19, 2015
In unexpected setback, UK cost regulators reject Amgen's PCSK9 drug
Nov. 19, 2015
Innovation update: Advancing the standard of care in rheumatoid arthritis
Nov. 19, 2015
Clovis Oncology's stock plummets on bad news about lung cancer drug
Nov. 18, 2015
Genmab's multiple myeloma drug gets FDA approval, boosts EU biotech sector
Nov. 18, 2015
Ex-Biogen exec presses ahead with new biotech
Nov. 18, 2015
Paris attack forces Isis Pharma to again consider name change
Nov. 18, 2015
AMA backs ban on direct-to-consumer pharma ads
Nov. 18, 2015
J&J nabs early approval for first-of-its-kind multiple myeloma med Darzalex
Nov. 17, 2015
Beyond trials: Real-world studies strengthen case for PrEP in HIV prevention
Nov. 17, 2015
Lucentis more effective than lasers for reversing diabetes-induced blindness in new study
Nov. 17, 2015
Senators to grill Obama's FDA commish nominee on pharma ties
Nov. 17, 2015
India's Sun Pharma reportedly plotting to snatch Japanese drug portfolio from Novartis
Nov. 17, 2015
Specialty pharma Irmat fights back, files suit against UnitedHealth Group in NY
Nov. 16, 2015
NEJM joins the fray in drug pricing debate as 2 thought leaders share divergent perspectives
Nov. 16, 2015
Billionaire Soon-Shiong's NantKwest forgoes R&D in favor of stock buyback
Nov. 16, 2015
Merck stands by its CETP inhibitor for heart disease even as others flop
Nov. 15, 2015
FDA approves Baxalta's longer-lasting hemophilia A drug
Nov. 15, 2015
In major victory, AstraZeneca wins FDA approval for potential $3B lung cancer med
Nov. 15, 2015
Roche to slash up to 1,200 jobs, shutter 4 plants in US and EU in major restructuring
Nov. 13, 2015
Bioethics group: Gilead, Sanofi flunk the clinical trial transparency test
Nov. 13, 2015
Merck's Cubicin protection efforts fail as appeals court invalidates 4 patents
Nov. 13, 2015
China FDA cracks down on pharmas in quality control effort
Nov. 13, 2015
Class-action suit alleges Endo birth control packaging errors led to unplanned pregnancies
Nov. 13, 2015
With an eye towards more collabs, Boehringer takes an axe to its R&D budget
Nov. 12, 2015
Google Life Sci, American Heart Association to pour $50M into heart research
Nov. 12, 2015
In potential mega-merger with Pfizer, Allergan chief Saunders could become CEO
Nov. 12, 2015
Horizon swipes back at Express Scripts as PBM cuts off drugmaker's specialty pharma
Nov. 12, 2015
WSJ: $350M Theranos-Safeway deal dissolving, adding to startup's recent woes
Nov. 12, 2015
Amgen flexes biologics muscle as Humira biosim nails an equivalence test for RA
Nov. 11, 2015
FDA approves Genentech's Cotellic as part of melanoma combo
Nov. 11, 2015
AstraZeneca may have a lupus blockbuster-in-waiting
Nov. 11, 2015
Sanofi intentionally slowed a drug approval to avoid a $708M payout, Genzyme shareholder suit alleges
Nov. 11, 2015
AHF: Gilead's new HIV med an attempt to evergreen, avoid patent expiration
Nov. 11, 2015
Researchers just discovered how to make blood stem cell genome editing a lot better
Nov. 10, 2015
Is Pfizer spinning its tax rate to justify a domicile-shifting merger with Allergan?
Nov. 10, 2015
Another heart failure hopeful: Cytokinetics/Amgen med shows phase 2 promise
Nov. 10, 2015
Allergan asks SCOTUS to take a hard look at pharma's controversial 'hard switch' tactic
Nov. 10, 2015
Advantage grows for Lilly's Jardiance with more stellar heart failure data
Nov. 10, 2015
AstraZeneca leapfrogs Actelion with $2.7B deal for ZS Pharma
Nov. 9, 2015
Payers: Forget specialty drug costs—generic prices are crushing our budgets, too
Nov. 9, 2015
23andMe redux? Startup DNA4Life gets FDA warning letter on DTC genetic testing kit
Nov. 9, 2015
Novo's Victoza fails the 'Jardiance test,' doesn't improve heart outcomes in trial
Nov. 9, 2015
Armed with FDA panel nod, Merck hopes long-languishing sugammadex will finally win approval
Nov. 9, 2015
Insys Therapeutics under investigation for pushing powerful pain drug
Nov. 6, 2015
Celgene takes M&A-related hit and posts Q3 loss, but optimistic about full year
Nov. 6, 2015
Sanofi tries to reclaim diabetes momentum with $4.2B deal with Korean drug maker
Nov. 6, 2015
Hello, Genvoya: Gilead does it again with approval of single-dose, once-daily HIV pill
Nov. 6, 2015
A huge untapped opportunity for pharma marketing: Social media engagement with doctors
Nov. 6, 2015
Why biotech darling Bluebird crashed on Thursday despite solid gene therapy data
Nov. 6, 2015
Harvard study: Americans' prescription med use may be ballooning along with their waistlines
Nov. 5, 2015
Pfizer late to immunotherapy game, teaming up with Merck for lung cancer treatment
Nov. 5, 2015
The Jardiance effect: Novo hopes Victoza will show heart benefit, but wary of CV study design
Nov. 5, 2015
How Roche is applying immunotherapy techniques to fight bacterial infections
Nov. 5, 2015
AstraZeneca & Teva's Cephalon to pay feds, states $54M for alleged rebate fraud
Nov. 5, 2015
As generic drug savings reach all-time high, experts ponder biosims' long-term impact
Nov. 5, 2015
Walgreens, Mylan act to avoid antitrust violations as they pursue mega-deals
Nov. 4, 2015
Doctors' 'do-not-see' policies for pharma reps may be declining—here's why
Nov. 4, 2015
Bristol-Myers to snatch Cardioxyl for $2B, aiming for a novel heart failure med
Nov. 4, 2015
With Philidor out, Valeant lays out new derm program for patients
Nov. 4, 2015
Glaxo lays out ambitious plans for 20 new drugs by 2020, market shrugs
Nov. 4, 2015
Shire snatches rare disease firm Dyax for $5.9B, won't take eyes off Baxalta prize
Nov. 3, 2015
Why Mylan is taking its Perrigo pursuit to Tel Aviv's stock exchange
Nov. 3, 2015
Why has uptake of Novartis' expected sales superstar Entresto been so slow?
Nov. 3, 2015
AstraZeneca to generics makers: Back off our 'purple pill'
Nov. 3, 2015
Express Scripts to put specialty pharmas under the microscope, focusing on Teva & AbbVie
Nov. 3, 2015
FDA alleges major violations, use of old ingredients at Chinese Pfizer plant
Nov. 2, 2015
Activist investor Ackman holds marathon call defending embattled Valeant
Nov. 2, 2015
Merck chief Frazier's R&D-based drug price defense a tough sell for pharma
Nov. 2, 2015
Can Novartis take on Boehringer and Glaxo with its new COPD combo?
Nov. 2, 2015
The next challenge for CAR-T: Large-scale production
Nov. 2, 2015
Valeant severs ties with controversial specialty pharma after mass PBM exodus
Oct. 30, 2015
Sanofi, Novo forecasts dim prospects for insulin's unchallenged dominance
Oct. 30, 2015
CA residents to vote on major drug price cap referendum in 2016
Oct. 30, 2015
Vertex inches closer to profitability as CF drug sales smash estimates
Oct. 30, 2015
Meet Baxter's new CEO: Covidien vet José Almeida
Oct. 30, 2015
Hep C and long-term costs: Why safety is suddenly part of the value equation
Oct. 30, 2015
Merck lowers cost of Remicade in UK as biosimilars enter market
Oct. 29, 2015
Senate efforts to advance 21st Century Cures aims appear stymied
Oct. 29, 2015
FDA approves Amgen's first-in-class oncolytic viral therapy
Oct. 29, 2015
Despite concerns, Express Scripts sticks with AbbVie's hep C therapy
Oct. 29, 2015
Theranos filed $200M stock offer days before critical news report
Oct. 29, 2015
Gilead beats Q3 estimates substantially, shares slide anyways
Oct. 28, 2015
A 1st gen Pfizer Alzheimer's drug may help keep patients out of the nursing home
Oct. 28, 2015
How 2 biotechs are chasing a pioneering peanut allergy med
Oct. 28, 2015
Glaxo faces another cardio R&D failure for a lead candidate
Oct. 28, 2015
FDA inspection calls Theranos 'nanotainers' uncleared devices, cites quality assurance problems
Oct. 27, 2015
A mixed bag for Merck despite data showing Keytruda extends lung cancer survival
Oct. 27, 2015
Drug shortages & patent expiration: Authorized generics as more than a lifecycle strategy
Oct. 27, 2015
Vertex, CRISPR Therapeutics strike gene editing pact worth up to $2.6B
Oct. 27, 2015
Amgen reviewing privacy policy for Repatha patient assistance program
Oct. 27, 2015
Alexion shocks with lower-than-expected price for just-approved orphan drug
Oct. 26, 2015
Decade-old Novartis Parkinson's drug redeemed as FDA sees no CVD risk
Oct. 26, 2015
Walgreens puts expansion of Theranos presence on hold
Oct. 26, 2015
WHO: Introduction of first malaria vaccine should be delayed
Oct. 25, 2015
FDA cautiously recommends approval of AZ's gout drug
Oct. 25, 2015
ICER: US drug prices should align with value
Oct. 25, 2015
Bristol-Myers' new HIV drug shines in mid-stage trials
Oct. 25, 2015
GNC stock plunges as Oregon sues company, alleging drug-spiked supplements
Oct. 23, 2015
Ouch: PhRMA SVP says Valeant isn't 'innovative,' acts more like a hedge fund
Oct. 22, 2015
San Diego-based compounder to offer $1 alternative to Turing's Daraprim
Oct. 22, 2015
Moderna launches yet another startup, Caperna, to develop cancer vaccines
Oct. 22, 2015
FDA approves a new pancreatic cancer drug, Merrimack's Onivyde
Oct. 22, 2015
Michigan governor urges Perrigo shareholders to reject Mylan deal
Oct. 22, 2015
FDA questions AstraZeneca about safety of phase 3 gout drug
Oct. 22, 2015
Novartis expands its immuno-oncology portfolio via M&A, partnerships
Oct. 22, 2015
Biogen cutting 11% of workforce, betting big on Alzheimer's R&D
Oct. 22, 2015
Theranos CEO goes to the lion's den, refutes accusations at WSJ Live conference
Oct. 22, 2015
REPORT: American man in India illegally exported execution drugs to Nebraska, other states
Oct. 21, 2015
The Amarin effect? FDA removes warning letter aimed at Pacira from web site
Oct. 21, 2015
Merck plans to enter hep C market, take on Gilead & AbbVie with faster-acting combo drug
Oct. 21, 2015
Valeant trading at 52-week low on report alleging 'phantom pharmacies' & fake sales
Oct. 21, 2015
Actelion: We're interested in ZS Pharma, but not dependent on M&A
Oct. 21, 2015
US, Saudia Arabia may collaborate on MERS vaccine
Oct. 21, 2015
A Boehringer SVP and BioSig's CEO dish on the 'heart' of innovation
Oct. 20, 2015
Daiichi Sankyo laying off more than 1,000 US workers
Oct. 20, 2015
Bluebird stock plunges after patient treated with company's gene therapy relapses
Oct. 20, 2015
Lilly's unconventional launch for Trulicity's consumer campaign
Oct. 20, 2015
J&J's psoriasis star Stelara found effective for Crohn's patients in phase 3
Oct. 20, 2015
Novartis cancer med Tasigna may hold promise for Parkinson's patients
Oct. 19, 2015
FDA tells Theranos to stop using its tech except for approved herpes test
Oct. 19, 2015
Shire's case for a Baxalta takeover dims as FDA spurns lead eye drug
Oct. 19, 2015
FDA approves first-ever Pradaxa 'antidote,' BI's Praxbind
Oct. 19, 2015
Bristol-Myers, Novartis score big in major blood cancer drug cost-benefit analysis
Oct. 19, 2015
Pfizer chief Read: Lackluster insurance driving pharma's pricing woes
Oct. 16, 2015
Breast Cancer Awareness Month: A look at recent innovations in breast cancer
Oct. 16, 2015
Judge sides with PhRMA, rules orphan drugs not covered by 340B discount program
Oct. 16, 2015
FDA schedules separate meetings to review BioMarin, Sarepta Duchenne drugs
Oct. 15, 2015
Bristol-Myers, Five Prime forge $1.75B immuno-oncology development deal
Oct. 15, 2015
Bombshell report puts Theranos in the hot seat, alleges blood test inaccuracies & false claims
Oct. 15, 2015
J&J bullish that its own SGLT2 diabetes med will show Jardiance-like CV benefit
Oct. 15, 2015
September DTC TV ad spending for pharma hits $231 million
Oct. 15, 2015
Chinese firm plans large-scale production of Ebola vaccine
Oct. 15, 2015
23andMe nabs $115M in new financing and a $1.1B valuation
Oct. 15, 2015
The curious case of Zafgen's stock and a phase 3 patient death
Oct. 15, 2015
Diabetes therapeutics: A hotbed of innovation and reservoir of pharma progress
Oct. 14, 2015
NY Attorney General probing Turing, Shkreli over antitrust concerns
Oct. 14, 2015
Why Bernie Sanders' opposition to Califf's FDA nomination is misguided
Oct. 14, 2015
Lilly to collaborate with ImaginAB on T-cell therapies for cancer
Oct. 14, 2015
Researchers: Bowel cancer can be categorized into four diseases
Oct. 13, 2015
FDA delays decision on Collegium's painkiller
Oct. 13, 2015
What Lilly's CVD drug failure means for other pharmas
Oct. 13, 2015
J&J bests Q3 estimates, announces $10B buyback; Earnings dogged by strong dollar
Oct. 13, 2015
Big pharmas to meet police chief who published CEOs' numbers over opioid crisis
Oct. 13, 2015
Good news on the horizon for Indian pharma as FDA ramps up approvals
Oct. 13, 2015
Reuters: Prices for top drugs in US 3 times higher than in UK
Oct. 13, 2015
Controversy erupts over pediatric OxyContin guidance
Oct. 13, 2015
AstraZeneca hits the brakes on 2 lung cancer trials after safety concerns
Oct. 12, 2015
Cigna eliminates mail-order requirement for HIV drugs
Oct. 12, 2015
Novartis pours another $15M into Israeli stem cell company
Oct. 12, 2015
Bristol-Myers' Opdivo nabs expanded lung cancer indication
Oct. 12, 2015
Senators propose adding nurses, physician assistants to Open Payments database
Oct. 9, 2015
Neurocrine's movement disorder drug shows promise, has blockbuster potential
Oct. 9, 2015
Could 'pay-for-performance' be coming to a prescription drug near you?
Oct. 9, 2015
Allergan, Valeant rethink 'acquire-and-hike' pricing strategy amid Shkreli-driven anger
Oct. 9, 2015
Roche MS drug shows big promise in harder-to-treat form of disease
Oct. 9, 2015
An inside look at Lilly's NYC expansion & focus on cancer immunotherapy
Oct. 9, 2015
Ireland-based Horizon plans big expansion, hiring spree in Chicago suburbs
Oct. 8, 2015
Pharma loves priority review vouchers—The FDA? Not so much
Oct. 8, 2015
FDA halts Advaxis immuno-oncology trials after patient death
Oct. 8, 2015
An innovation challenge: Using pharma R&D as a tool for social change
Oct. 8, 2015
FDA commish-in-waiting removes name from papers criticizing agency
Oct. 8, 2015
Study: Merck hep C combo effective in kidney disease patients
Oct. 7, 2015
Roche looks to Cotellic melanoma combo to boost Zelboraf sales
Oct. 7, 2015
Feds lose dietary supplement case against Bayer
Oct. 6, 2015
Valeant fights back against drug pricing criticism as stock tumbles
Oct. 6, 2015
The bubble burst cometh? Biotech stocks down 21% since July
Oct. 6, 2015
Alkermes generic for blockbuster schizophrenia med Abilify bags FDA nod
Oct. 6, 2015
Bristol-Myers settles SEC charges over China bribery scandal for $14.2M
Oct. 6, 2015
Spark inches closer to a pioneering US gene therapy approval
Oct. 6, 2015
Indian foreign secretary: EU ban on generic drugs 'unwarranted'
Oct. 6, 2015
CA governor signs controversial medication-assisted suicide bill
Oct. 6, 2015
Almost half of UK doctors have negative view of pharma industry
Oct. 5, 2015
TPP trade deal reached, BIO & PhRMA unhappy with drug patent compromise
Oct. 5, 2015
Amicus delays regulatory submission for Fabry drug
Oct. 5, 2015
Where are the women in HIV drug trials?
Oct. 5, 2015
Merck's Keytruda wins lung cancer indication—but it's not as broad as Opdivo's
Oct. 5, 2015
Sarepta's new strategy for winning a landmark Duchenne drug approval
Oct. 2, 2015
FTC asks Court of Appeals to reexamine Doryx 'product-hopping' case
Oct. 2, 2015
EMA nominates Guido Rasi as executive director—again
Oct. 2, 2015
TPP trade talks stuck in the mud over US drug exclusivity demands
Oct. 2, 2015
Bristol-Myers' Opdivo/Yervoy combo wins FDA approval, will cost $256,000
Oct. 2, 2015
Chasing a ghost: Why is FDA guidance on biosim interchangeability taking so long?
Oct. 2, 2015
Private artificial intelligence firm to help data mine for UK genomics project
Oct. 1, 2015
Teva exec: Pharma needs to face its pricing demons head-on
Oct. 1, 2015
WHO pushes for far more aggressive worldwide use of HIV meds
Oct. 1, 2015
Clovis set for showdown with AZ as it wins fast-track for lung cancer drug
Oct. 1, 2015
Global standoff looms between US, developing nations over WTO waiver extension
Oct. 1, 2015
Sanofi hopes to broaden diabetes portfolio as FDA accepts lixisenatide submission
Sept. 30, 2015
Can Lilly & Incyte elbow their way into a crowded market with promising RA drug?
Sept. 30, 2015
Pioneering Novavax RSV vaccine passes protection to newborns, wins $89M from Gates Foundation
Sept. 30, 2015
Aiming to cure blindness, UK team implants embryonic retinal cells in AMD patient
Sept. 30, 2015
Allergan riding high with 10% increase in branded product revenues
Sept. 29, 2015
Novartis backs graphic novel featuring a teen with a rare disease—and his dog
Sept. 29, 2015
Kyle Bass escapes USPTO sanctions on drug patent challenges, BIO balks
Sept. 29, 2015
Lilly settles Sanofi dispute, plans 2016 launch for biosim Lantus
Sept. 29, 2015
House Dems demand Valeant CEO testify on price hikes with Shkreli, stock plunges
Sept. 29, 2015
FDA approves Bayer's autoinjector for MS drug
Sept. 28, 2015
Glaxo shutting down French research lab, laying off 70 employees
Sept. 28, 2015
FDA revokes Sun Pharma's approval for epilepsy drug after compliance concerns
Sept. 28, 2015
Bristol-Myers' Opdivo boosts kidney cancer survival, Roche PD-L1 hopeful shrinks tumors
Sept. 28, 2015
The diabetes king? Novo finally gets its Tresiba long-acting insulin approval
Sept. 28, 2015
FDA warns Pathway Genomics cancer blood test 'may harm the public health'
Sept. 25, 2015
After bad news on Breo, Glaxo's monthly asthma drug wins an EU rec
Sept. 25, 2015
Arrowhead hep B treatment shows early promise, sends shares flying
Sept. 25, 2015
Novartis to tackle chronic diseases in poor countries with new program
Sept. 25, 2015
Top US cardiologists push to limit PCSK9 drug patient pool
Sept. 24, 2015
Nestlé partners with AC Immune to expand into Alzheimer's diagnostics
Sept. 24, 2015
Amgen-Allergan's Avastin biosimilar shows promise in lung cancer trials
Sept. 24, 2015
Are the EU's steep biosim discounts the ghost of US biosimilars' future?
Sept. 24, 2015
FDA approves Taiho Oncology's pill for metastatic colorectal cancer
Sept. 24, 2015
How the FDA is trying to demystify clinical trial data
Sept. 24, 2015
Has the era of the super successful pharma sales rep really come to an end?
Sept. 23, 2015
A 'reverse Turing?' Nonprofit reacquires TB drug, rolls back massive price hike
Sept. 23, 2015
Report: J&J had plan to block more FDA restrictions on Tylenol
Sept. 23, 2015
AZ using crowdsourcing to find effective cancer drug combos
Sept. 23, 2015
India's Serum Institute chases fast-track approval for dengue treatment as cases spike
Sept. 23, 2015
Study: Cancer drugs in US cost up to 6,000% of production cost
Sept. 23, 2015
UPDATE: Shkreli backtracks on 5,000% price hike after outrage, doesn't specify new cost
Sept. 22, 2015
Clinton calls out Turing & Shkreli on wild price hike, releases pharma cost cap plan
Sept. 22, 2015
Bristol-Myers' immuno-oncology star Opdivo nabs kidney cancer priority review
Sept. 22, 2015
Shire's once-daily extended-release ADHD drug now approved in Europe
Sept. 22, 2015
Mass. police chief lists big pharma CEO phone numbers as part of opioid addiction fight
Sept. 22, 2015
After Harvoni: A pangenotype hep C combo could be Gilead's next breakthrough
Sept. 22, 2015
Merck's antibody-in-development reduces risk of C. difficile re-infection
Sept. 21, 2015
2nd time's the charm for Allergan, Richter antipsychotic drug
Sept. 21, 2015
Obama's FDA chief nominee received more than $200K in industry fees
Sept. 21, 2015
Lilly/BI's Jardiance found to be first diabetes med to cut CV deaths in study
Sept. 21, 2015
Aerie Pharma's glaucoma eye drop shows promise in late-stage trial
Sept. 17, 2015
Another big pharma exec leaves for a biotech—from Glaxo to Celyad
Sept. 17, 2015
AstraZeneca forges partnership with BARDA to develop powerful antibiotics
Sept. 17, 2015
Report: Glaxo withheld critical data on antidepressant Seroxat
Sept. 17, 2015
Why several FDA reviewers recommended not approving female libido med Addyi
Sept. 17, 2015
An update on first-ever US biosim Zarxio 2 weeks after its debut
Sept. 17, 2015
Merck's once-weekly diabetes med as effective as daily Januvia in study
Sept. 17, 2015
Amgen snaps up Dutch biotech Dezima for $1.55 billion
Sept. 16, 2015
Intra-Cellular shares fly as schizophrenia drug shown effective at higher doses
Sept. 16, 2015
Veteran NIMH director leaving agency to join Google Life Sciences
Sept. 16, 2015
Meet Travis McCready, the next head of the MA Life Sciences Center
Sept. 16, 2015
AbbVie, Janssen chase first-line approval of Imbruvica for CLL
Sept. 16, 2015
Xenoport shares dive as psoriasis drug shows serious GI side effects
Sept. 16, 2015
The gender gap is especially severe in biotech lab funding
Sept. 16, 2015
The next hope for GW Pharma's cannabis med: Schizophrenia treatment
Sept. 16, 2015
Steve Brill unleashing 15-part exposé on J&J, Risperdal: 'America's Most Admired Lawbreaker'
Sept. 16, 2015
Reputation matters: Why the rift between pharma and patients is ballooning
Sept. 15, 2015
Shire may be upping the ante in pursuit of Baxalta—with faster cash
Sept. 15, 2015
Acacia planning $232 million IPO in London market
Sept. 15, 2015
Takeda floats conditional $100M boost to $2.3 billion Actos settlement
Sept. 15, 2015
10th Indian pharma plant this year makes FDA's do-not-import list
Sept. 15, 2015
UPDATE: Mylan officially takes $27B hostile bid to Perrigo shareholders
Sept. 15, 2015
Federal task force narrows aspirin use guidelines, suggests cancer benefit
Sept. 15, 2015
Lilly boosting size of Kendall Square innovation center
Sept. 14, 2015
A tale of two painkillers: Collegium gets FDA panel rec that eludes Purdue
Sept. 14, 2015
2 new studies show Gilead's Truvada extremely effective for HIV prevention
Sept. 14, 2015
Amgen goes after once-monthly dosing option for Repatha
Sept. 14, 2015
Express Scripts CEO Paz to retire next May, leaving legacy of price pushbacks
Sept. 11, 2015
Another biotech M&A? Actelion, ZS Pharma in 'strategic transaction' talks
Sept. 11, 2015
Pfizer loses major Lyrica patent case in UK, leaving door for generics wide open
Sept. 11, 2015
Gilead raises $10 billion, stoking fresh rumors of a monster acquisition
Sept. 11, 2015
Georgia opens $14M bioscience training center next to Baxalta plant
Sept. 11, 2015
How to stop a biopharma compliance breach before it happens
Sept. 10, 2015
FDA concerned about dosing risk with Collegium's opioid painkiller
Sept. 10, 2015
Russia's Putin reiterates commitment to 90% domestic drug-making by 2020
Sept. 10, 2015
Africa's largest generic drug maker is on the hunt for acquisitions
Sept. 10, 2015
ICER report says $14,000 PCSK9 meds should actually cost 70% less
Sept. 10, 2015
Biogen strikes $544M deal with Mitsubishi Tanabe for late-stage autoimmune drug
Sept. 10, 2015
PayPal co-founder Peter Thiel pours $200M into cancer stem cell biotech
Sept. 9, 2015
Merck/Samsung Bioepis win their 1st biosim approval in Korea—for copycat Enbrel
Sept. 9, 2015
Roche CEO slams 'stupid,' 'arbitrary' UK decision to cut 17 cancer meds' funding
Sept. 9, 2015
Glaxo takes a big blow as 'son of Advair' fails to extend COPD patients' lives
Sept. 9, 2015
New study claims Pfizer's Chantix not linked to depression, heart attacks after all
Sept. 8, 2015
A big win for AZ as FDA clears Brilinta for long-term use
Sept. 8, 2015
Former Hospira chief's platinum parachute: $91 million in cash
Sept. 8, 2015
Bristol-Myers is testing out a dual-threat Opdivo/Yervoy lung cancer combo
Sept. 8, 2015
Experimental treatment offers hope for CAR-T leukemia patients
Sept. 4, 2015
World's largest public stem cell bank now open in CA
Sept. 4, 2015
Valeant partners with AZ on psoriasis drug
Sept. 4, 2015
More than half of doctors have 'no access' policies for reps
Sept. 4, 2015
Moody's upgrades financial outlook for biopharma industry
Sept. 4, 2015
Regeneron scientists score rare disease breakthrough with excess bone growth discovery
Sept. 3, 2015
The key facts to know about the FDA's new 340B drug discount guidance
Sept. 3, 2015
Amgen launching PCSK9 med Repatha in Europe at steep discount to US price
Sept. 2, 2015
How 2014 became a banner year for biotech job growth in MA
Sept. 2, 2015
US biosimilar era officially dawns as Novartis' Zarxio launches Thursday
Sept. 2, 2015
Biosimilars Council chief answers 6 key questions about biosims in the US
Sept. 2, 2015
Pharma takes major offense to French law promoting off-label Avastin use
Sept. 2, 2015
Alexion wins EU nod for newly acquired enzyme-replacement drug
Sept. 2, 2015
Pharma lobbies Congress for big—and expensive—changes to patent rules
Sept. 2, 2015
Novartis and Amgen team up to take on Alzheimer's, migraines
Sept. 2, 2015
2 major insurers draw lines in the sand for pricey PCSK9 coverage
Sept. 2, 2015
Baxalta may have a new M&A-based strategy for spurning Shire
Sept. 1, 2015
Bristol-Myers sets sights on a Jakafi competitor with $1.25B fibrosis firm deal
Sept. 1, 2015
How do you solve a problem like drug shortages?
Aug. 31, 2015
Bayer lines up a phase III trial for its dual-threat heart failure hopeful
Aug. 31, 2015
Asterias stem cell therapy shows promise in spinal cord injury patients
Aug. 31, 2015
Novo Nordisk acquiring 2 US biotechs, Calibrium and MB2
Aug. 31, 2015
Oncologists question Lilly lung cancer hopeful's pricing in growing trend
Aug. 31, 2015
Stem cell researcher at major Swedish research hub cleared of misconduct
Aug. 31, 2015
FDA warns: DPP-4 inhibiting diabetes meds may cause severe joint pain
Aug. 31, 2015
An experimental anti-cholesterol drug could outperform approved PCSK9 meds
Aug. 31, 2015
Macro-level innovation: A Q&A with Bain & Company's healthcare guru
Aug. 28, 2015
FDA's new draft guidance on naming biosimilars already drawing pushback
Aug. 28, 2015
Lilly/BI snag another FDA approval for a diabetes drug—Synjardy
Aug. 28, 2015
FDA demands another study for uniQure's ultra-pricey gene therapy
Aug. 27, 2015
J&J/Genmab unveil promising data for a potential multiple myeloma superstar
Aug. 27, 2015
Massachusetts leads states' war on high drug prices
Aug. 27, 2015
FTC to FDA: Ramp up oversight on homeopathic drug makers
Aug. 27, 2015
Pfenex at the forefront: How a different biosim approach is becoming a disruptive force
Aug. 27, 2015
Novo jumping into phase III trials for major oral diabetes candidate
Aug. 27, 2015
In big win for pharma, advocates urge WH to push broader Medicaid hep C coverage
Aug. 26, 2015
Novo Nordisk planning $1.2 billion US expansion, bringing 700 jobs to NC
Aug. 26, 2015
Sarepta wins priority review for hotly anticipated Duchenne drug
Aug. 26, 2015
How Japan is trying to beef up its pharmaceutical industry
Aug. 26, 2015
Bristol-Myers, Sanofi prevail in Plavix false claims case
Aug. 26, 2015
UK's NHS commissions new TB drugs for first time in 50 years
Aug. 26, 2015
Controversial fund manager Kyle Bass loses first major pharma patent battle
Aug. 26, 2015
Could an aspirin a day keep colon cancer away?
Aug. 26, 2015
Why Gilead's hep C scripts are slowing down in Q3
Aug. 25, 2015
In huge victory for generics, court invalidates Takeda's Velcade patent
Aug. 25, 2015
Study: Common beta blockers can extend ovarian cancer patients' lives
Aug. 25, 2015
AZ poaches Genentech cancer vet Bohen, appoints him as new CMO
Aug. 25, 2015
Why BioMarin hawked a phase III cancer drug to Medivation for $570M
Aug. 25, 2015
US Army testing drug to protect soldiers' hearing
Aug. 24, 2015
Excitement over Jardiance may come at Merck's expense
Aug. 24, 2015
New tool aims to simplify cancer treatment cost/benefit analysis
Aug. 24, 2015
Sarepta, Biomarin vie for DMD approval, priority review voucher
Aug. 24, 2015
Novartis snaps up MS indication for Glaxo's Arzerra
Aug. 24, 2015
Rare disease companies' existential challenge: Patient enrollment
Aug. 21, 2015
Baxalta CEO touts new R&D model with a focus on development
Aug. 21, 2015
Biosim behemoth? Partners Samsung and Biogen will float a $1 billion IPO
Aug. 21, 2015
Jimmy Carter has cancer, and his treatment regimen includes Merck's Keytruda
Aug. 21, 2015
Lilly/BI's Jardiance could be the first diabetes med to cut heart attack, stroke risk
Aug. 21, 2015
How Addyi will change the way we talk about sex—and what it means for marketers
Aug. 21, 2015
Lundbeck shredding 1,000 jobs, 17% of workforce—and its stock is up big
Aug. 19, 2015
AbbVie snaps up priority review voucher from United Therapeutics for $350M
Aug. 19, 2015
Intarcia's diabetes pump bests Merck's Januvia in head-to-head trial
Aug. 19, 2015
Merck chief Frazier touts extra day off for workers, union not impressed
Aug. 19, 2015
Moving beyong licensing, gene therapy firm ReGenX plans $100 million IPO
Aug. 19, 2015
Tables turned: Mylan cited by FDA for quality violations at Indian plants
Aug. 19, 2015
Biogen & Columbia team up to unlock ALS genetics, with some 'Ice Bucket' cash
Aug. 19, 2015
Concordia and Par settle FTC's anti-competition charges
Aug. 19, 2015
Merck star Keytruda nabs priority review for first-line treatment of metastatic melanoma
Aug. 18, 2015
UPDATE: Sprout plots hiring binge after controversial female libido drug approval
Aug. 18, 2015
Retrophin sues outspoken founder Shkreli for $65M over alleged misuse of funds
Aug. 18, 2015
Kite Pharma does damage control, quashes drug-induced patient death rumors
Aug. 18, 2015
Roche's immunotherapy hopeful keeps rolling, this time in phase II lung cancer trial
Aug. 18, 2015
The next viruses in Gilead's crosshairs: HIV and hep B
Aug. 18, 2015
Genmab receives $2 million from Novo Nordisk for DuoBody platform
Aug. 17, 2015
Big win for Endo: Court rules against Actavis in generic painkiller patent spat
Aug. 17, 2015
Lawmakers set their sights on Valeant and its steep heart drug price hikes
Aug. 17, 2015
FDA approves OxyContin use in some children
Aug. 17, 2015
In Mylan-Perrigo hostile takeover drama, it's proxy firm vs. proxy firm
Aug. 17, 2015
Mylan reports a solid Q2, outpaces analysts' expectations
Aug. 10, 2015
The challenges of China for Western drug makers
Aug. 10, 2015
Where biotech is booming: From Boston, to Raleigh, and beyond
Aug. 7, 2015
AZ, Heptares heading into immuno-oncology partnership
Aug. 7, 2015
Novo reports stronger-than-expected Q2, raises full-year forecast
Aug. 7, 2015
Novo's chief medical officer dishes on innovation in diabetes drug development
Aug. 7, 2015
Armed with stronger label, can Sanofi's Toujeo perform better in the UK?
Aug. 6, 2015
Express Scripts' 2016 formulary: Who's in, who's out, & how did they decide?
Aug. 6, 2015
CNS-focused US cannabis patch company raises $42M in IPO
Aug. 6, 2015
Shire's pursuit of Baxalta stymied by strong takeover defenses
Aug. 6, 2015
India cancels EU trade talk meeting over widespread drug ban
Aug. 6, 2015
FDA to update Novartis' Gilenya label with brain-infection risk warning
Aug. 5, 2015
Bayer, Berkeley-based biotech labor union settle 4-year contract
Aug. 5, 2015
Bevy of factors to lift pharma sales to $1.3 trillion by 2018: Thomson Reuters
Aug. 5, 2015
Akorn accused of infringing Allergan's Lumigan patents
Aug. 5, 2015
Pfizer gains EU antitrust approval for Hospira acqusition
Aug. 5, 2015
A rare case: Young woman with Duchenne's waiting for a cure
Aug. 4, 2015
Shire buying Foresight Biotherapeutics and its pink eye drug for $300M
Aug. 4, 2015
AZ & Isis Pharma expanding collaborative gene therapy R&D
Aug. 4, 2015
Merck's hep C positioning strategy: Target toughest-to-treat patients
Aug. 4, 2015
Aprecia's Spritam becomes first FDA-approved 3D printed medication
Aug. 4, 2015
Sanofi, riding high from a strong Q2, may put its crosshairs on acquisitions
Aug. 3, 2015
All-in? AstraZeneca soldiers forward with psoriasis hopeful despite suicide link
Aug. 3, 2015
Big federal funding for vets' hep C treatments sneaked into highway bill
Aug. 3, 2015
FDA: Hospira infusion system vulnerable to hackers
Aug. 2, 2015
Biologic patent life emerges as sticking point in failed TPP talks
Aug. 2, 2015
Amgen raises full-year outlook on strong Q2 earnings
July 31, 2015
Is there a link between Teva's bribery probe and a former employee's firing?
July 31, 2015
Afrezza sales still underperforming, but MannKind remains optimistic
July 31, 2015
Kaiser CEO pens powerful op-ed on drug costs, calls for new pricing model
July 31, 2015
From Glaxo to Parexel—and now, unemployed
July 30, 2015
The Teva-Allergan deal and the power of the 'focus factor'
July 30, 2015
Uh-oh: Glaxo facing new corruption charges—this time, in Romania
July 30, 2015
Sanofi's LixiLan aces a late-stage trial, setting up diabetes showdown with Novo
July 30, 2015
Largest US benefits manager warns PCSK9 meds will 'wreak havoc' on payers
July 30, 2015
Novartis gets on risk-sharing bandwagon, spins off 3 pipeline drugs into new biotech
July 30, 2015
Why Pfizer is abandoning its OTC Lipitor program
July 30, 2015
Hospira's painkiller recall is ballooning—Is Pfizer getting nervous?
July 29, 2015
Want a better placebo effect? Stick to needles over pills
July 29, 2015
Welcome to the club: Regeneron, Sanofi to team up, join cancer immunotherapy fray
July 29, 2015
Soon-Shiong's NantKwest has a record-setting IPO and zero approved drugs
July 29, 2015
Stellar hep C sales help Gilead smash Q2 earnings estimates
July 29, 2015
Aegerion CEO resigns amid tensions with institutional investors
July 28, 2015
Could Sanofi's dengue vaccine become a game-changer?
July 28, 2015
UCSD wins legal spat against USC over control of landmark Alzheimer's project
July 28, 2015
Report finds pharma doesn't always report serious side effects to FDA in time
July 28, 2015
EU upholds massive drug ban over alleged CRO data manipulation
July 28, 2015
World Hepatitis Day: The transformation and enduring struggles of HCV treatment
July 27, 2015
Sandoz closing three German and Indian factories
July 27, 2015
AbbVie reports disappointing Q2 sales, better-than-expected profits
July 27, 2015
Biogen's comeback strategy after $18B market value loss: More acquisitions
July 27, 2015
Allergan buys Naurex for $560 million, nabs 2 antidepressants
July 27, 2015
Teva to snap up Allergan's generics unit for $40.5B, become Big Pharma behemoth
July 27, 2015
What's the most 'efficient' biopharma company of 2014?
July 24, 2015
2nd gen radiotracers and Alzheimer's diagnosis in the age of early-intervention trials
July 24, 2015
European regulators just announced a massive overhaul of pediatric waivers
July 24, 2015
Eli Lilly stacking scientists in San Diego as part of R&D growth spurt
July 24, 2015
US appeals court: Pharmacy responsibilities trump religious beliefs
July 24, 2015
BMS and Exelixis make headway against Novartis in kidney cancer
July 23, 2015
The FDA wants to figure out DTC ad claims' effect on consumers
July 23, 2015
A tough setback for AZ as major eye cancer hopeful flunks phase III
July 23, 2015
Roche renews commitment to R&D of two AD drugs
July 23, 2015
Why Abbott's profits outperformed Q2 expectations
July 23, 2015
Promising stem-cell clinical trial results for rare lung disease
July 22, 2015
Amgen's Repatha becomes world's first approved PCSK9 inhibitor
July 22, 2015
Q2 earnings update: Novartis sales slump on strong dollar, weak Alcon
July 22, 2015
FDA chastises Vista Pharma for not paying generic drug user fees
July 21, 2015
Tekmira to become Arbutus, shift focus to hep B
July 21, 2015
An Alzheimer's update: New drugs, new insights, new hope
July 21, 2015
NEJM: Early HIV therapy delays AIDS-related events & death
July 21, 2015
Researchers are about to launch the largest AIDS treatment trial ever
July 20, 2015
Bristol-Myers' rock star Opdivo continues to roll, this time in kidney cancer
July 20, 2015
Novogen gets FDA approval for Anisina orphan drug status
July 20, 2015
FDA grants AbbVie's anti-tau drug orphan status
July 20, 2015
Amgen's leukemia drug excels in phase II for new indication
July 20, 2015
NICE recommends Daiichi Sankyo's oral blood thinner
July 20, 2015
WHO prequalifies Novartis' Coartem for malaria
July 20, 2015
Innovation vs. access: The big drug battle in Trans-Pacific Partnership negotiations
July 17, 2015
FDA huddles with Google to improve adverse-event reporting
July 17, 2015
Teva gets FDA OK to market generic Axert
July 16, 2015
Stem cell breakthrough for Salk Institute researchers
July 16, 2015
BMS nabs EU approval for once-daily HIV combo pill
July 16, 2015
Sun Pharma slashing Ranbaxy's contract manufacturing unit
July 16, 2015
Sandoz closing plant in India
July 16, 2015
Sanofi restructuring business to drive growth
July 16, 2015
Why some new drugs are truly earning the 'innovative' label
July 16, 2015
ASCO scorecard upgrades rating for Lilly's Alimta
July 16, 2015
Allergan faces lost sales as Namenda generics hit market
July 16, 2015
J&J/Bavarian Nordic launching phase II Ebola vaccine trial
July 16, 2015
J&J could reopen closed factory, revive OTC business
July 15, 2015
New depression treatment approach could provide relief within hours
July 15, 2015
NHS Scotland approves funding for five new drugs
July 15, 2015
Celgene buying Receptos for $7.2 billion
July 15, 2015
EU agency to investigate HPV vaccine safety
July 15, 2015
FDA approves AZ's Iressa for lung cancer
July 14, 2015
Roche's PD-L1 drug slows bladder cancer growth in trials
July 13, 2015
Study: Type 2 diabetes linked with cognitive decline
July 13, 2015
Amgen awaiting FDA decision on cancer drug Kyprolis
July 13, 2015
Janssen-Cilag's Imbruvica approved in EU to treat rare blood cancer
July 13, 2015
Analysts back Biomarin's stock as it reaches new high
July 12, 2015
R&D head leaving Biogen for startup
July 12, 2015
In reversal, NHS making Takeda's Entyvio available to Crohn's patients
July 12, 2015
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
July 12, 2015
Study: Off-label use of antipsychotics growing in teens/young adults
July 12, 2015
A 21st century diabetes option: Will Oramed be first to market with oral insulin?
July 10, 2015
What Glaxo's strategy guru thinks the future holds for HIV markets
July 10, 2015
Walgreens taps Pessina as permanent CEO after besting Q3 expectations
July 10, 2015
Will public pressure drive the FDA to approve a so-so female libido drug?
July 10, 2015
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
July 10, 2015
AstraZeneca divests gastro drug for $215 million
July 10, 2015
Insurers are getting bigger—What does that mean for pharma's pricing power?
July 9, 2015
Senior congressman joins chorus calling for heroin antidote price cut
July 9, 2015
One big change bolstering gene therapy enthusiasm? Better viral delivery systems
July 9, 2015
Novartis files leukemia drug Arzerra in the EU
July 9, 2015
UCSD calls out USC for alleged unethical recruiting of its Alzheimer's researchers
July 9, 2015
CF Foundation gains massive windfall from Vertex's Kalydeco
July 8, 2015
CVS Health quit tobacco—and now it's quitting the Chamber of Commerce
July 8, 2015
Another Indian CRO in hot water, this time with the WHO
July 8, 2015
Lilly's lung cancer drug seen as risky by FDA—but will that matter?
July 8, 2015
Horizon Pharma in hostile pursuit of Depomed for $3 billion
July 8, 2015
Sanofi, Gilead get boosts in Japan with new Lantus & Harvoni approvals
July 7, 2015
Biogen pursuing AGTC's ophthalmology gene therapy—for up to $1 billion
July 7, 2015
Pharma's newest adversaries on CME funding are... Hotel workers?
July 7, 2015
Pharma flings accusations, dire predictions in wake of Greek financial crisis
July 7, 2015
Will Vertex finally become profitable after FDA approval for CF drug Orkambi?
July 6, 2015
J&J moves HIV vax to human trials after 50% protection rate in monkeys
July 6, 2015
Another Roche Alzheimer's drug disappoints
July 6, 2015
Promise, and caution, as gene therapy shows potential for cystic fibrosis
July 6, 2015
Big deal for biosims? Major French hospital group opts for Hospira's Remicade copy
July 6, 2015
In rare move, Purdue pulls out of abuse-deterrent OxyContin meeting with FDA
July 2, 2015
Drug makers warn EU over troubled Greece: Medicine supply 'may be in jeopardy'
July 2, 2015
FDA gives pharmacies grace period to implement 'track and trace'
July 2, 2015
New study: Glaxo flu vax linked to increased narcolepsy risk
July 2, 2015
Novo to halt Tresiba sales in Germany over pricing conflict
July 2, 2015
'Innovation' is everywhere in biopharma—but what does that actually mean?
July 2, 2015
Roche impresses with strong phase III data for MS drug candidate
July 1, 2015
DOJ wants to fine Novartis a staggering $3.35 billion for kickbacks
July 1, 2015
California governor signs mandatory vaccination bill into law
July 1, 2015
Open Payments: Docs got $6.5 billion from drug/device industries in 2014
July 1, 2015
Sanofi/MannKind might be facing a major flop with Afrezza inhaled insulin
July 1, 2015
Generics update: FDA releases new bioequivalence guidance
June 30, 2015
Novartis back in the pain game with $700M deal for Australia's Spinifex
June 30, 2015
Health advocacy groups sue FDA for Gilead's hep C data
June 30, 2015
Samsung Bioepis eyes NASDAQ IPO to fuel big name biosim R&D
June 30, 2015
Celgene & Juno just struck a blockbuster $1B collab deal—but does it make sense?
June 30, 2015
Parexel axing 850 jobs in big reorg
June 29, 2015
Pfizer goes to court in UK to fight for Lyrica patent integrity
June 29, 2015
Lilly's data mining may pay off with nearly-abandoned Alzheimer's drug
June 29, 2015
Bristol-Myers going all-in on biotech hub Cambridge for R&D
June 29, 2015
Is this the end of the line for Celladon after its gene therapy flop?
June 29, 2015
EMA validates BioMarin's Duchenne Muscular Dystrophy treatment
June 26, 2015
How Novartis' CEO wants to tackle an ever-aging world
June 26, 2015
The cost of 'Cures': FDA bill's rare disease provisions to cost $869 million
June 26, 2015
Bristol-Myers calls it quits on any new virology R&D programs
June 26, 2015
Take your medicine: CA lawmakers approve mandatory vax bill for children
June 26, 2015
REMS reform, round 2: Will the FAST Generics Act speed past the finish line this year?
June 26, 2015
Study: Combo Rx regimen can treat bipolar depression
June 25, 2015
Report: It pays big to focus on diabetes drugs
June 25, 2015
Federal panel decides meningitis B vaccination not mandatory
June 25, 2015
Alcobra flops as placebo beats its drug in phase II
June 25, 2015
Second top AstraZeneca exec heads for the exits
June 25, 2015
Takeda's CFO to swap industries, become Nestle's CFO
June 24, 2015
Will the TIPP trade agreement force the FDA & EMA to harmonize?
June 24, 2015
New generics-positive bill aims to end REMS abuse
June 24, 2015
The early winners and losers in ASCO's highly anticipated cancer drug scorecard
June 24, 2015
Google X unveils health-tracking wristband for clinical trials, research
June 24, 2015
Study: Australian gov't wasting $320 million per year on drug subsidies
June 23, 2015
Dutch or American? In takeover drama, Mylan seems to want it both ways
June 23, 2015
Pay attention: Adults now main ADHD treatment target
June 23, 2015
Immuno-oncology upstart Conkwest going public in $172.5M IPO
June 23, 2015
FDA approves Medicines Co's antiplatelet drug
June 23, 2015
Strike 2 for Teva's Copaxone in US appeals court
June 22, 2015
China rejects Gilead's hep C drug patent
June 22, 2015
Lilly, Teva to present late-stage migraine drug data
June 22, 2015
Bayer beefs up R&D investment to $4.5 billion this year
June 22, 2015
Tekmira's Ebola trials halted over efficacy concerns
June 22, 2015
Merging pains: Sun Pharma says goodbye to 18 major Ranbaxy execs
June 19, 2015
More than 1,000 online drug sites under FDA scrutiny
June 19, 2015
Amgen's colorectal cancer drug shines in phase III
June 19, 2015
Teva completes Mylan share purchases, official takeover bid could come any day
June 19, 2015
BioMarin's childhood dwarfism drug nails it in phase II
June 19, 2015
BIO2015 & 21st Century Cures: Why value matters more than ever
June 19, 2015
Report: Global Rx drug sales to reach nearly $1 trillion by 2020
June 18, 2015
Ebola vaccines require greater speed in trials
June 18, 2015
New drug compound may beat malaria with single $1 dose
June 18, 2015
Synergy Pharma shares soar from constipation drug study
June 18, 2015
Despite insider sale, Receptos stock surges on takeover rumors
June 18, 2015
GSK's decision to cast off now-valuable drugs raises questions
June 17, 2015
Bayer, Johns Hopkins team up for eye disease R&D
June 17, 2015
FDA to review Teva asthma biologic
June 17, 2015
Abbott gets involved in M&A drama, backs Perrigo buy
June 17, 2015
Study: Biopharma's pipeline-by-merger strategy isn't working
June 17, 2015
Largest US drug testing lab negotiating settlement with feds for over-testing
June 16, 2015
Biotech is booming—but is big pharma waning?
June 16, 2015
CVS further widens reach with $1.9B deal for Target's pharmacies
June 16, 2015
Avalanche gene therapy safe, modestly effective in AMD patients
June 16, 2015
Goodbye, Actavis—hello, Allergan
June 16, 2015
Study: Drug makers stay coy about FDA rejections & criticisms in their press releases
June 15, 2015
The curious case of Lilly's share price and its Alzheimer's hopeful data
June 15, 2015
1st sickle cell patient treated with Bluebird's pioneering gene therapy doing well
June 15, 2015
FDA approves Brio's brain implant for Parkinson's
June 15, 2015
How did Axovant raise $315M with one asset and no clinical data?
June 15, 2015
FDA committee endorses Glaxo's severe asthma drug
June 12, 2015
Pfizer wins another Zoloft-birth defects lawsuit
June 12, 2015
LA county to finally distribute preventive Truvada
June 12, 2015
Glaxo, Sanofi slammed with regulatory fines in India over vaccines
June 12, 2015
FDA blunders labeling for Vanda sleep drug
June 12, 2015
How 21st Century Cures could change communications between biopharma, providers, & patients
June 11, 2015
Pennsylvania's Melior wins a Parkinson's patent
June 11, 2015
GlobeImmune decimating its workforce after hep B drug flop
June 11, 2015
Massive study: Merck's diabetes mega-blockbuster doesn't increase heart failure risk
June 11, 2015
Panasonic Healthcare to snap up Bayer diabetes unit for $1.1 billion
June 11, 2015
AZ chief med officer abruptly quits, CEO Soriot to oversee late-stage R&D
June 11, 2015
FDA and Amarin wrangle over free speech lawsuit
June 10, 2015
PCSK9 anti-cholesterol drug prices: How much is too much?
June 10, 2015
Sanofi diabetes drug ready to take on FDA with safety study in the rearview
June 10, 2015
Lilly stock soars on animal health spinoff inquiry
June 10, 2015
FDA finally responds to demand for Duchenne Muscular Dystrophy guidance
June 10, 2015
UPDATED: Sanofi/Regeneron's PCSK9 blockbuster-in-waiting gets prelim FDA nod
June 9, 2015
Lilly's Trulicity and Novo's IDegLira best Lantus in trials
June 9, 2015
Lilly's Lantus biosimilar will finally launch in Europe in Q3
June 9, 2015
Massive new study: The statin-memory lapse connection may be unfounded
June 9, 2015
Merck, New England Patriots boss part of investment team for ABX start up
June 9, 2015
Report: Pfizer scientist warned management about Zoloft-birth defects link last year
June 9, 2015
NIH halts drug production for pharma trials after FDA finds fungus
June 8, 2015
Amgen subpoenas journalist in fight against shareholder suit
June 8, 2015
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
June 8, 2015
Amazon, Google battle to become 'e-warehouse' of choice for genomics data
June 8, 2015
Genzyme nabs breakthrough designation for rare enzyme disorder
June 5, 2015
Australia to big pharma: Pay more taxes
June 5, 2015
EU votes not to abolish animal testing despite rising advocate pressure
June 5, 2015
Report: Metformin decreases glaucoma risk in older adults
June 5, 2015
Vertex shareholders say 'no' to sky-high exec bonuses
June 5, 2015
UPDATE: FDA panel recommends women's libido drug despite safety concerns
June 4, 2015
How social media analytics can help get drugs to the right places during epidemics
June 4, 2015
AstraZeneca chief slams UK over NICE's Lynparza decision
June 4, 2015
Report: Many heart attack patients neglect to take their meds afterwards
June 4, 2015
PillPack just got a $50 million infusion—could it become the Amazon of pharmacies?
June 4, 2015
Amgen, Novartis duke it out in court over landmark Neupogen biosimilar
June 4, 2015
Why pay-to-delay arrangements can actually be good for consumers, too
June 4, 2015
FDA panel to review Lilly's lung cancer combo drug
June 3, 2015
Why did Regulus Therapeutics CEO Xanthopoulos suddenly quit?
June 3, 2015
White House meeting focuses on reducing use of antibiotics
June 3, 2015
UPDATE: Defiant Teva to buy even more Mylan shares, setting up potential legal showdown
June 3, 2015
NCI launching largest-ever personalized medicine study for cancer drugs
June 3, 2015
NICE says no to AZ's Lynparza
June 2, 2015
Ex-Obama administration official joins Sanofi
June 2, 2015
AstraZeneca may continue R&D of drug linked to suicidal thoughts
June 2, 2015
Could new FDA compounding guidelines stop Avastin use in AMD?
June 2, 2015
WHO calls for report on vaccine pricing and access
June 1, 2015
Bristol-Myers sues former immunotherapy exec for allegedly violating non-compete
June 1, 2015
US orders major review as suspect anthrax samples found in multiple labs
June 1, 2015
Report: Public health threat lurking at biolabs nationwide
May 29, 2015
Biopharma execs have big presence among top-paid CEOs
May 29, 2015
Gilead on R&D hiring spree
May 29, 2015
New evidence-based consensus: Start HIV treatment at diagnosis
May 29, 2015
Otsuka's efforts to block generic Abilify fail
May 29, 2015
Merck submits NDA for new 2-in-1 hepatitis C treatment
May 29, 2015
Supreme Court: Pharma companies must finance drug take-back programs
May 28, 2015
Juno to use Editas gene-editing platform for CAR-T cancer R&D
May 28, 2015
Express Scripts pushes 'pay-for-performance' drug policy in latest challenge to pharma
May 28, 2015
Retrophin sells Sanofi priority review voucher for $245m
May 28, 2015
Report: Greece owes pharma companies more than $1.2 billion in debts
May 28, 2015
CEO of cancer vax rising star Bavarian Nordic: We are not for sale
May 27, 2015
Boehringer Ingelheim nabs US approval for COPD combo
May 27, 2015
Vertex CEO gets called out over huge $45.8 million pay package
May 27, 2015
Disadvantage, Amgen? Dosing could be deciding factor in PCSK9 marketing battle
May 27, 2015
White House: Human germline editing 'a line that should not be crossed'
May 27, 2015
Trouble for AZ as Amgen quits psoriasis blockbuster hopeful collab over suicide risk
May 26, 2015
Bayer CEO: G7 will see creation of multinational antibiotic R&D fund
May 26, 2015
Sanofi prostate drug chief's exit latest in firm's oncology exodus
May 26, 2015
'Hard switch' gets a hard no: Actavis must keep older Namenda on the market
May 26, 2015
Hypertension drug from India no longer banned in EU—but 100s of others still are
May 26, 2015
Word on the street: A massive Pfizer deal is coming
May 22, 2015
Otonomy's inner-ear drug flops in trials
May 22, 2015
Valeant chief latest pharma CEO to question M&A mania, calls it a 'bit of a bubble'
May 22, 2015
Sanofi/Regeneron's arthritis drug nails it in phase III
May 22, 2015
ProPublica opens up the Advair vault, raises safety and marketing ethics questions
May 22, 2015
UPDATE: Amgen's PCSK9 cholesterol med beats Sanofi's to an EU recommendation
May 22, 2015
J&J, Achillion strike $225 million hep C drug development pact
May 21, 2015
Study: Tylenol use during pregnancy may lower testosterone in male offspring
May 21, 2015
AbbVie, other pharma companies dominate list of 'most meaningful' places to work in US
May 21, 2015
J&J's ambitious plan: 10 new potential blockbusters filed by 2019
May 21, 2015
Valeant reportedly in acquisition talks with big Egyptian pharma
May 21, 2015
GW Pharma moves CEO to US to lay groundwork for cannabis-epilepsy med approval
May 20, 2015
Sanofi/Regeneron reports glowing phase 2b results for versatile asthma hopeful
May 20, 2015
Compounding pharmacy linked to meningitis outbreak to pay $200M to victims
May 20, 2015
Why biosimilars may not be the huge cost-saver people hope
May 20, 2015
Endo to scoop up rival Par Pharma for $8B in bid to expand generics portfolio
May 19, 2015
Unregulated stem cell clinics doing big business in the US
May 19, 2015
WHO plays hardball with Novartis & Roche, favors cheaper Avastin over Lucentis
May 19, 2015
AstraZeneca bets big on biotech with large new Swedish plant
May 19, 2015
Perrigo CEO changes tune, would consider Mylan merger—at right price
May 19, 2015
A rare win for US pharma: Indian court stops Glenmark sales of Merck diabetes copycats
May 18, 2015
Niger meningitis cases triple in 2 weeks amid dearth of vaccines
May 18, 2015
Amgen boasts promising phase II results for migraine drug
May 18, 2015
FDA sued by ADHD generics maker for revoking drug's Concerta bioequivalence
May 18, 2015
FDA warns popular Lilly, AZ, J&J, Boehringer diabetes meds could cause ketoacidosis
May 18, 2015
Why are analysts still optimistic about Orexigen's stock after the Contrave imbroglio?
May 15, 2015
One more potential Teva-related challenge for Mylan's shareholders: A huge tax bill
May 15, 2015
US class action against India's Ranbaxy cites dishonesty, manipulation of FDA rules
May 15, 2015
Hotly anticipated AZ lung cancer combo effective, but side effects remain a problem
May 15, 2015
A preview of the new lung cancer data Roche will debut at ASCO
May 15, 2015
VT senator to Veterans Affairs: Break Gilead's Sovaldi patents
May 14, 2015
Belgian biotech harnessing antibodies from... llamas?
May 14, 2015
Sanofi moving forward on Celiac disease immunotherapy development
May 14, 2015
How pharma is amping up R&D with gene sequencing
May 14, 2015
Rapid diagnostics emerging for Chagas disease
May 14, 2015
MannKind: Marketing glitches, delays explain slow Afrezza uptake
May 13, 2015
Glaxo CEO skeptical about pharma's M&A frenzy
May 13, 2015
Analysts answer: How long will it take the first Copaxone generics to gain market share?
May 13, 2015
How do you test an Ebola vaccine when almost no one has Ebola?
May 13, 2015
Challenges ahead for Vertex's controversial Kalydeco combo despite FDA panel nod
May 13, 2015
Drug-resistant typhoid 'superbug' becoming global problem
May 12, 2015
Alexion planning major expansion in Ireland
May 12, 2015
4 drugmakers dismissed from Chicago opioid lawsuit
May 12, 2015
7 drugs get SMC backing
May 12, 2015
HIV cure, not just treatment, is goal of Glaxo-UNC partnership
May 12, 2015
CA justices rule against pharma in first appellate court 'pay-for-delay' suit
May 11, 2015
What the Tories' election victory means for the NHS and UK pharma
May 11, 2015
FDA staff raises red flags over new Vertex cystic fibrosis med's cost
May 11, 2015
In challenge to pricey Gilead meds, WHO adds hep C drugs to 'essentials' list
May 11, 2015
Liberia declared Ebola-free
May 11, 2015
M&A mayhem: Q1 biopharma deal values surpass 2014's total
May 8, 2015
AbbVie, Roche nab FDA breakthrough designation for top leukemia prospect
May 8, 2015
Study: Measles vax may protect against other infections
May 8, 2015
Sheer power of CAR-T therapies leads drug makers to develop an 'off' switch
May 8, 2015
Mark your calendars: FDA will hold public meeting on off-label use this summer
May 8, 2015
Former Novo exec Schultz will become a CEO after all—just at another pharma
May 7, 2015
Glaxo reverses course, won't spinoff lucrative ViiV Healthcare HIV unit
May 7, 2015
An update on Tekmira: From Ebola promise to a strong hep B focus
May 7, 2015
Glaxo hoping for the best, prepping for the worst on Advair generics
May 7, 2015
Congress calls for gender equity in clinical trials
May 7, 2015
7 questions you might have about biosimilarity, answered
May 6, 2015
New report: Digoxin risky for certain patients
May 6, 2015
Sanofi shareholders slam big pay packages for chiefs Viehbacher, Brandicourt
May 6, 2015
DaVita settles $450 million Medicare fraud lawsuit
May 6, 2015
IMS: Global cancer drug spending soared past $100 billion in 2014
May 6, 2015
UN: New Ebola cases fall to lowest level since mid-2014
May 6, 2015
Study: FDA bends over backwards to accommodate orphan drug developers
May 5, 2015
Bayer buys rights to Isis anti-clotting drug in $155M deal
May 5, 2015
The new Medicare Part D drug spending report only tells part of the story
May 5, 2015
Vyvanse binge eating push, NPS acquisition drives steady Q1 sales for Shire
May 5, 2015
Glaxo becomes first big pharma to file for a gene therapy approval
May 5, 2015
Why did Novo's supposed CEO-in-waiting suddenly leave the firm?
May 4, 2015
Viagra bucks global slowdown trend in China, sales soar 47%
May 4, 2015
Amgen successfully defends melanoma hopeful T-Vec, gets positive FDA feedback
May 4, 2015
21st Century Cures changes would loosen Sunshine Act's CME disclosure rules
May 4, 2015
Novartis kickback case settlement will cost Express Scripts $60 million
May 4, 2015
Gilead dazzles, profits double in Q1 on strong hep C sales
May 1, 2015
Oklahoma gov OKs marijuana derivative for epilepsy clinical trial
May 1, 2015
FDA approves Glaxo's asthma drug Breo Ellipta for adults
May 1, 2015
Experts: Polio on the verge of global eradication thanks to vax campaigns
May 1, 2015
Pfizer emerges as mystery bidder for rare disease firm Swedish Orphan
May 1, 2015
Merck antibiotic combo Zerbaxa shows efficacy in complicated infections
April 30, 2015
Perrigo rejects Mylan's third takeover offer
April 30, 2015
FDA approves Kythera's double-chin injection
April 30, 2015
Amgen hiring staff for Cambridge and SF sites
April 30, 2015
Valeant CFO to resign; company beats expectations for quarter
April 30, 2015
Can the new FDA guidance on biosimilarity expedite development and approval?
April 30, 2015
Q1 reports: Dollar dogs Pfizer, cancer immunotherapies buoy Bristol-Myers, Merck
April 29, 2015
Game on: FDA approves first generics of blockbuster antipsychotic Abilify
April 29, 2015
FDA officially reject's Merck's Bridion—again
April 29, 2015
Merck gains advantage over AZ, Takeda as top diabetes med determined heart safe
April 29, 2015
Controversy ahead: HHS inspector general encourages more Part D drug rebates
April 29, 2015
Bristol-Myers, Gilead hep C combo shines in late-stage trial
April 28, 2015
Snap up a rival, then hike its drugs' prices—is this pharma's new normal?
April 28, 2015
Why tech transfer could be key to growing pharma in Africa
April 28, 2015
Good news for Lilly: Cyramza nabs yet another FDA approval
April 28, 2015
Report: Multiple sclerosis drug prices skyrocketing—even for older meds
April 27, 2015
Workers wanted: Seattle Genetics experiencing a growth spurt
April 27, 2015
Biogen ups the phase III ante on Alzheimer's breakthrough hopeful
April 27, 2015
Rare disease firm Swedish Orphan flies on mystery takeover offer
April 27, 2015
A tale of 2 takeover bids: Teva-Mylan-Perrigo M&A drama goes hostile
April 27, 2015
New study: Alcoholic hepatitis drugs not effective
April 24, 2015
Novartis chief: We're actively looking for $2-$5 billion acquisitions
April 24, 2015
Mapp Biopharma nabs federal liability protection for Ebola drug
April 24, 2015
Merck, Gilead duke it out with next-gen hep-C combos
April 24, 2015
More Q1 earnings: Novartis flies, Humira keeps AbbVie afloat, AZ feels patent sting
April 24, 2015
What biopharma needs to know about CAR-T cancer therapies
April 24, 2015
Milestone: Chinese researchers genetically modify human embryos
April 23, 2015
Are steady generic drug price hikes coming to an end?
April 23, 2015
Abbott's Mylan deal paying off big as M&A speculation sends shares soaring
April 23, 2015
Earnings roundup: Lilly bests estimates on new drugs, Abbott racks up $2.29B earnings
April 23, 2015
Inside Gilead's ambitious new hep C elimination project in Georgia
April 23, 2015
Research links poor quality medicines and potential global pandemic
April 22, 2015
Scientists to provide real-time genomic sequencing data on Ebola, MERS
April 22, 2015
Bernstein analyst to Gilead: 'Pull the trigger' and buy Vertex
April 22, 2015
How Amgen achieved its stellar Q1 earnings
April 22, 2015
US, Cuban research firms forge historic pact on lung cancer vax development
April 22, 2015
UPDATE: Teva scores a takeover talking point as Perrigo board rejects Mylan bid
April 21, 2015
Wave of the future: The Ebola crisis as a tipping point for pharmaceutical R&D
April 21, 2015
Glaxo uncovers quadrivalent flu vax potency problems, pulls it from market
April 21, 2015
Allergan laying off 577 more workers in Orange County
April 21, 2015
Teva to pay whopping $512 million fine in Provigil pay-to-delay suit
April 21, 2015
Small, early Novartis CAR-T trial shows promise in solid tumors
April 21, 2015
Sun Pharma tanks as Daiichi starts divesting $3.6B in stakes
April 21, 2015
EU's first-ever gene therapy bumps up against renewed regulatory scrutiny
April 20, 2015
Pfizer notches key victory in first of many Zoloft birth-defect cases
April 20, 2015
Merck files Keytruda for lung cancer, drug bests Bristol-Myers' Yervoy in melanoma
April 20, 2015
WHO promises reforms after 'slow and insufficient' Ebola response
April 20, 2015
Benefits manager warns Vertex's cystic fibrosis Kalydeco combo too pricey
April 17, 2015
Otsuka pulling out all the stops to deter copycats of blockbuster Abilify
April 17, 2015
Sandoz wins first FDA nod for generic of Teva MS flagship Copaxone
April 17, 2015
Bayer pumping $100M into new hemophilia-focused Berkeley testing facility
April 17, 2015
Study: Common heartburn meds linked with kidney failure risk in elderly
April 17, 2015
Star Scientific 2.0 falters in drug dev efforts after Va. gov corruption scandal
April 17, 2015
Ibrance late-stage trial stopped early amid impressive results
April 16, 2015
FDA approves first major new heart failure drug in a decade
April 16, 2015
The blood cancer boom: Nearly 250 meds in development, but plenty left to do
April 15, 2015
GW Pharma's cannabis-based epilepsy drug cuts seizure rates by 50%
April 15, 2015
Why did Rx drug spending in the US reach an all-time high in 2014?
April 15, 2015
FDA panel endorses new heart failure warnings for key AZ diabetes med
April 15, 2015
WHO calls for universal clinical trial transparency
April 15, 2015
J&J Q1 earnings highlight rising dollar's tumultuous effect on global pharmas
April 15, 2015
How NewLink Genetics defied its location and put Iowa on biotech's map
April 14, 2015
What a Celgene stake in Mesoblast means for the stem cell firm's prospects
April 14, 2015
Ichor, J&J to collaborate in $85M hep B immunotherapy deal
April 14, 2015
Roche's aggressive 2015 goal: 11 cancer immunotherapy drugs in late-stage trials
April 14, 2015
Glaxo to tweak unique US sales rep compensation plan amid complaints
April 14, 2015
Angelina Jolie-driven surge in pricey genetic test requests has payers on edge
April 13, 2015
Ebola phase III studies underpopulated as epidemic wanes
April 13, 2015
Water under the bridge: Allergan, Ackman drop hostile takeover lawsuits
April 13, 2015
Eisai plans big US layoffs in reorg
April 13, 2015
Mylan's $29B Perrigo bid seen as defensive play against M&A threat
April 13, 2015
Lawusit claims Pfizer knew about Zoloft birth defect risks
April 10, 2015
Billionaire Fidelity CEO betting big on cancer companies with personal money
April 10, 2015
Alzheon CEO calls out Biogen, says his firm will be 1st to Alzheimer's finish line
April 10, 2015
Politicians still going after Actavis for its Namenda hard-switch
April 10, 2015
Shire nabs priority review for potential blockbuster dry eye drug
April 10, 2015
Mid-cap biotechs best larger companies to emerge as 2014's growth kings
April 9, 2015
Merck's HCV drug candiate gets another breakthrough therapy designation
April 9, 2015
Silence Therapeutics raises $58 million to advance R&D
April 9, 2015
Report questions acetaminophen's efficacy in lower back, joint pain
April 9, 2015
Inside the FDA labeling fight that could upend the generics market
April 8, 2015
Report: Viagra most effective ED treatment, but has more side effects
April 8, 2015
VBI Vaccines, Sanofi Pasteur to collaborate on vaccine R&D
April 8, 2015
Hospira gets yet another FDA warning letter before Pfizer buyout
April 7, 2015
Shire bullish on 2017 approval of new, longer-lasting ADHD pill
April 7, 2015
Valeant commences its post-Salix deal job cuts
April 7, 2015
Targacept merger in jeopardy as Pfizer ends deal with buyer Catalyst
April 7, 2015
Hedge fund activist Bass takes aim at pricey Shire, Jazz drug patents
April 7, 2015
MorphoSys CEO stays bullish on cancer drug despite Celgene split
April 7, 2015
Juno, Novartis settle cancer patent spat for $12 million
April 7, 2015
Amgen CEO scores big pay package on record profits
April 7, 2015
Glaxo's post-Novartis vax deal reorg could uproot hundreds of jobs
April 6, 2015
Did Novartis try to sabotage Avastin ophthalmic trials?
April 6, 2015
Scientists milk snakes to make more stable broad spectrum anti-venom
April 6, 2015
UK scientists push back against animal testing critics
April 6, 2015
Big bonus bonanza coming up at Actavis
April 2, 2015
Partners wanted: Roche seeking collaborators in cancer immunotherapy
April 2, 2015
FDA issues final guidance on abuse-deterrent opioids
April 2, 2015
Amgen loses Neupogen biosimilar battle—again
April 1, 2015
Provocative: Analyst says hot new PD-1 cancer drugs are massively overrated
April 1, 2015
Report claims FDA is behind the times on employees' free speech
April 1, 2015
PETA hawks animal testing alternatives to CROs in San Diego
March 31, 2015
Merck Serono and Intrexon initiate $941 million CAR-T deal
March 31, 2015
UK opposition leader gives pharma a pass on his profit margin cap proposal
March 31, 2015
What UnitedHealth's $12.8B Catamaran deal means for pharma's pricing war
March 31, 2015
Glaxo settles J&J suit over allergy med advertisement claims
March 31, 2015
Alibaba, other e-retailers may foray into Rx drugs in China
March 30, 2015
In final speech, outgoing FDA chief defends US drug approvals record
March 30, 2015
Glaxo finally strikes UK deal for Bexsero that eluded Novartis
March 30, 2015
Confirmed: Sanofi's Toujeo launches in US Monday, setting up diabetes race
March 30, 2015
Novo to try for US Tresiba approval once again
March 27, 2015
J&J moving forward in China despite regulatory crackdowns
March 27, 2015
MorphoSys and Celgene call it quits
March 27, 2015
How PCSK9 cholesterol drugs will shift pharma's pricing trends
March 25, 2015
Guinea becomes focus of Merck Ebola vaccination study
March 25, 2015
Treatment for inhalational anthrax wins US approval
March 25, 2015
Regeneron's Eylea nabs yet another FDA approval for expanded label
March 25, 2015
FDA's rare disease pediatric voucher program could become permanent
March 25, 2015
RA drug that caused 'elephant man' side effect gets another chance
March 25, 2015
Merck's Keytruda bests Yervoy, shows promise as first-line melanoma med
March 25, 2015
CAR-T biotech Cellectis boosts IPO 50% to $197 million
March 25, 2015
FDA to reconsider homeopathy regulatory framework after 25 years
March 25, 2015
U of Minnesota called out for clinical trial practices—again
March 24, 2015
Regeneron CEO riding high with $42M salary, but with fewer perks
March 24, 2015
The Biogen ripple effect: Analyst recommends Genworth as proxy buy
March 24, 2015
FDA won't relabel Lilly's schizophrenia injectable after patient deaths
March 24, 2015
Paper: SSRIs impact teens' sexual function, too
March 24, 2015
3D printing debuts in pharma
March 23, 2015
Gilead warns against Sovaldi, heart drug combo after patient death
March 23, 2015
J&J's Janssen gets a mixed bag in 2nd Risperdal case
March 23, 2015
Here comes the blockbuster: Novartis' Cosentyx bests Stelara in psoriasis trials
March 23, 2015
Congress wants to make it easier to get EU-approved drugs to the US
March 23, 2015
Namenda antitrust suit heats up in NY court
March 20, 2015
9 important things to know about PCSK9 cholesterol drugs
March 20, 2015
Judge refuses to block Novartis biosimilar of Amgen drug
March 20, 2015
MannKind has a $100 million debt problem, and the clock is ticking
March 19, 2015
FDA approves first-ever med for rare bile disorder
March 19, 2015
MSF: Sovaldi profit protection measures squeeze out patients in poor nations
March 18, 2015
FDA advisory committee to talk Tekmira, Mapp Ebola vaccines in May
March 18, 2015
Celgene emerges as biotech partnering king of 2014
March 18, 2015
Glaxo's combo respiratory drug deemed safe by FDA staff
March 18, 2015
New obesity drugs jockey for market uptake
March 18, 2015
How Novo Nordisk plans to keep its eyes on the diabetes prize
March 18, 2015
US Novartis arm smacked with $110 million gender discrimination class action
March 18, 2015
Allergan CEO Pyott heading for the exits as Actavis finalizes buyout
March 18, 2015
Meet the Biogen vet who's about to become Chiasma's new CEO
March 17, 2015
Scientists may have uncovered next powerhouse antibiotic in horse dung
March 17, 2015
FDA panel: Pharmacyclics' Imbruvica cancer data strong enough to unblind
March 17, 2015
Novartis slapped with $12.6M fine for fuzzy Medicare pricing math
March 17, 2015
Could Biogen's Alzheimer's therapy become a breakthrough?
March 17, 2015
Why China's drug approval backlog spiked last year
March 17, 2015
US District Judge says FDA can revoke Ranbaxy drug approvals
March 16, 2015
Study: AZ's Brilinta shows promise, but comes with risks
March 16, 2015
Merck's anesthesia reversal drug faces 3rd likely FDA rejection
March 16, 2015
Neuralstem shares tank on discouraging ALS stem cell therapy data
March 13, 2015
The unlikely vaccine that's boosting immunooncology efforts
March 13, 2015
Bill & Melinda Gates Foundation bets big on CureVac's mRNA platform
March 13, 2015
Gilead, Vertex balk as SEC upholds shareholders' voting rights
March 13, 2015
23andMe's next big ambition: Drug development
March 13, 2015
Zogenix selling painkiller Zohydro to Pernix in huge deal
March 12, 2015
J&J's CEO nabbed a hefty raise in 2014
March 12, 2015
Public Citizen to FDA: Don't let sales reps distribute data downplaying drug risks
March 12, 2015
Will Pradaxa reversibility be the final death knell for warfarin?
March 12, 2015
J&J to pay $25 million to settle children's Tylenol, Motrin contamination case
March 12, 2015
India denies patent protection to Bayer, BI blockbusters
March 12, 2015
Concordia acquiring Covis assets for $1.2 billion
March 11, 2015
Apple's new ResearchKit raises hopes, questions for medical studies
March 11, 2015
Why CNS drug maker Acadia's shares soared on Tuesday
March 11, 2015
More black box grief for Pfizer's Chantix as FDA adds alcohol, seizure warnings
March 11, 2015
United Therapeutics nabs priority review voucher, approval for rare pediatric cancer drug
March 11, 2015
Novartis CEO: Watch out for more cost-cutting on the horizon
March 10, 2015
Is that clinical trial doc getting pharma money? Patients want to know
March 10, 2015
What's next for Kythera after unanimous FDA rec for its double-chin injection?
March 10, 2015
Ackman becomes Valeant's 5th largest shareholder with $3.3B gamble
March 9, 2015
Amgen: The biotech that's getting on the biosimilar R&D bandwagon
March 9, 2015
Bangladeshi pharma launches $10 version of Sovaldi
March 9, 2015
Bribery scandal still dogging Glaxo as pharma giant axes 110 jobs in China
March 9, 2015
Astellas nabs FDA approval for new antifungal
March 9, 2015
Merck to start hacking away at Cubist's workforce with 128 R&D layoffs
March 9, 2015
In latest blow to Lilly, German court clears Actavis generics of lung cancer blockbuster
March 9, 2015
Dawn of a new era: FDA approves first-ever biosimilar, Novartis/Sandoz's Zarxio
March 6, 2015
Flu vax committee picks next year's virus strains after 2014 debacle
March 6, 2015
FDA to pharma: Watch out for unapproved Facebook claims
March 6, 2015
Vanda's atopic dermatitis drug fall flat in mid-stage trial
March 6, 2015
UPDATE: Shire's Boston move involves 'mass layoff' of up to 600 employees
March 6, 2015
FDA launches first drug-shortages mobile app
March 5, 2015
AstraZeneca to spin off antibiotics R&D for $40 million
March 5, 2015
Genentech denies knowledge of distribution-related problems
March 5, 2015
Akorn latest to reject use of its drugs for lethal injection
March 5, 2015
21st Century Cures: Making Breakthrough Therapy designations more effective
March 5, 2015
BMS' Opdivo wins lung cancer indication more than 3 months before PDUFA date
March 4, 2015
The post-acquisition cuts begin: Valeant lays off 77 Dendreon employees
March 4, 2015
BI files its Pradaxa 'antidote' in North America, EU
March 4, 2015
Could Sangamo's gene therapy 'cure' HIV?
March 4, 2015
FDA clamps down on testosterone labeling rules
March 4, 2015
Orexigen shoots itself in foot with early disclosure of positive Contrave heart data
March 4, 2015
Celgene's Abraxane approved in EU for first-line treatement of NSCLC
March 3, 2015
AZ board to CEO Soriot: Want that big bonus? Show us the money
March 3, 2015
US lawmakers push Amphastar for answers on naloxone prices
March 3, 2015
Survey: New Genentech distribution policy delaying cancer patients' care
March 3, 2015
Gilead seals generic Sovaldi deal with Natco, NICE rec for Harvoni in UK
March 3, 2015
Sanofi's Toujeo nabs EU rec and efficacy shoutout on heels of FDA blessing
March 2, 2015
Indian advisory board proposes waiving phase III for certain drugs
March 2, 2015
A biotech is bringing a new IUD to market—but the company's a nonprofit
March 2, 2015
Ousted Sanofi chief Chris Viebacher lands at PureTech
March 2, 2015
Positive phase II Provenge data a good early sign for ambitious Valeant
Feb. 27, 2015
EU approves first new chemical entity for Parkinson's in a decade
Feb. 27, 2015
A booming Bayer projects 10% pharma-driven growth in 2015
Feb. 27, 2015
Gilead raking in billions off of foreign tax laws
Feb. 27, 2015
GSK's CEO faces another pay cut—and it's a big one
Feb. 27, 2015
How 23andMe used rigorous clinical trials to win a landmark FDA authorization
Feb. 26, 2015
Pharmacyclics surges on news of potential sale to J&J, Novartis
Feb. 26, 2015
Shire puts binge-eating disorder on the medical map
Feb. 26, 2015
Federal judge strikes down Maine's controversial prescription drug import law
Feb. 26, 2015
It's been a good year: Juno's top management nabs big bonuses
Feb. 26, 2015
CA lawmaker to pharma: Show us, with numbers, why drugs cost so much
Feb. 26, 2015
Merck, MPP team up to provide low-cost HIV pediatric meds in poor countries
Feb. 25, 2015
French government slams Sanofi over new CEO's pay
Feb. 25, 2015
Public Citizen requests FDA ban on certain antifungal meds
Feb. 25, 2015
Shire keeps acquisition train rolling with $70M Meritage Pharma deal
Feb. 25, 2015
Platinum parachute? Allergan CEO Pyott could get $100M exit fee
Feb. 25, 2015
Toronto Star retracts piece suggesting injuries linked to Merck's Gardasil
Feb. 24, 2015
BMS strengthens oncology pipeline with two big deals worth $1.6B
Feb. 24, 2015
Novartis' Farydak wins FDA approval for multiple myeloma
Feb. 24, 2015
Duchenne, orphan drug maker PTC Therapeutics fielding takeover bids
Feb. 24, 2015
Lilly's long-acting insulin not ready for prime time
Feb. 24, 2015
Is there still a place for the mighty pharmaceutical sales force?
Feb. 23, 2015
Compounding pharmacies chafe at FDA's disciplinary actions
Feb. 23, 2015
Corgenix's 15-minute Ebola test approved by WHO
Feb. 23, 2015
FDA to review Pfizer's rare lung disease drug for women
Feb. 23, 2015
Holoclar makes history: Europe approves West's first stem-cell therapy
Feb. 23, 2015
Cellectis files $115M IPO to fund unique CAR-T program
Feb. 22, 2015
Ohio seeks its own deal with Amphastar for heroin antidote
Feb. 20, 2015
New Jersey residents' parting gift to Roche: A lawsuit
Feb. 20, 2015
NewLink wins $20 million Ebola vaccine milestone from Merck
Feb. 20, 2015
New company, new name: Actavis to rebrand as Allergan post-buyout
Feb. 20, 2015
Biogen, academic collaborators discover new ALS gene
Feb. 20, 2015
UPDATE: Bayer HealthCare chief Brandicourt named Sanofi's next CEO
Feb. 19, 2015
Why so little uptake of preventive Truvada in the at-risk gay community?
Feb. 19, 2015
Team of rivals? Scientist nominated for AZ board has history of dinging pharma
Feb. 19, 2015
Gilead's Harvoni supplants Sovaldi as top-selling launch drug
Feb. 19, 2015
Why FDA's label expansion for Celgene's Revlimid could foretell a global sales surge
Feb. 19, 2015
Biotech battle: Regeneron's Eylea bests Genenetch's Lucentis in head-to-head
Feb. 19, 2015
Shanghai official to serve 19 years over GSK bribery case
Feb. 18, 2015
The more, the merrier? Endo also pursuing Salix Pharma bid
Feb. 18, 2015
CVS fires controversial warning shot in opening salvo of PCSK9 price wars
Feb. 18, 2015
Sprout Pharma submits 'women's Viagra' for approval once again
Feb. 18, 2015
FDA reopens conversation about controversial generic labeling rules
Feb. 17, 2015
Profits fall for India's largest drug maker
Feb. 17, 2015
Can AZ finally solidify a deal for its anti-infectives unit?
Feb. 17, 2015
GSK replaces US pharma ops head Connelly amid struggles
Feb. 17, 2015
NAFTA patent spat rages on between Canada and Lilly
Feb. 17, 2015
How ViiV Healthcare became a pharma favorite for patient groups
Feb. 13, 2015
Valeant arranges financing for potential Salix Pharma bid
Feb. 13, 2015
Indian pharma giants scuffle to snap up injectables maker Claris
Feb. 13, 2015
AZ to settle Nexium kickback case for $7.9M
Feb. 13, 2015
Teva's internal probe turns up 'likely' corruption
Feb. 12, 2015
Shire raises 2015 forecast on NPS acquisition
Feb. 12, 2015
EMA defends data black-out policy for AbbVie's Humira
Feb. 12, 2015
Riken stem cell saga continues as Obokata and other scientists face reprimands
Feb. 12, 2015
GSK broadens vax portfolio with $190M GlycoVaxyn deal
Feb. 12, 2015
Former Merck financial analyst to plead guilty to insider trading
Feb. 11, 2015
Nanotrending: FDA adopts another nanotech standard
Feb. 11, 2015
Another one bites the dust: FDA to revoke breakthrough status for BMS hep C med, too
Feb. 11, 2015
Former MN gov demands more trial transparency at UMN in wake of '04 suicide
Feb. 11, 2015
Patient groups rank ViiV Healthcare #1 in corporate reputation survey, again
Feb. 11, 2015
Juno forges ahead with novel cancer therapy, opens manufacturing facility
Feb. 10, 2015
Merck fights back after BC Health Ministry drops diabetes drug
Feb. 10, 2015
ICYMI: Sanofi undertakes major sales reorg of US diabetes business
Feb. 10, 2015
New research: Could Novartis CVD game-changer increase dementia risk?
Feb. 10, 2015
BIO survey finds more series A VC funding for fewer recipients
Feb. 10, 2015
Roche's blockbuster Lucentis nabs fourth FDA approval
Feb. 9, 2015
FDA warning for blockbuster hopeful edoxaban hits Daiichi where it hurts
Feb. 9, 2015
Pfizer may still be hungry after Hospira deal
Feb. 9, 2015
FDA proposes new consumer-friendly print drug ad guidance
Feb. 9, 2015
Arkansas settles Vertex Medicaid suit over pricey Kalydeco
Feb. 9, 2015
Isis earns $10 million milestone from Biogen Idec
Feb. 6, 2015
Why the FDA wants to double inspectors at Indian manufacturing facilities
Feb. 6, 2015
FDA simplifies compassionate use process in a big way
Feb. 6, 2015
NY Attorney General nabs price reduction for heroin-fighting naloxone
Feb. 6, 2015
Q4: Allergan soars past estimates, again
Feb. 6, 2015
Passing the torch: Ralph Neas' tenure at the Generic Pharmaceutical Association
Feb. 5, 2015
Promising Roche Parkinson's med causes lung toxicity in monkey trials
Feb. 5, 2015
Study: Drug makers fail to meet adverse-event reporting requirements
Feb. 5, 2015
Trans-Pacific Partnership trade talks fail to resolve patent & IP issues
Feb. 5, 2015
Pfizer on fire with early FDA nod for blockbuster Ibrance, $15B Hospira buyout
Feb. 5, 2015
Merck's hep C treatment loses FDA breakthrough status
Feb. 5, 2015
Another FDA warning letter for India-based Apotex
Feb. 4, 2015
Moody's: Patent-cliff challenges will continue to dog big pharma
Feb. 4, 2015
Merck's Belsomra for insomnia now available in US
Feb. 4, 2015
US to launch large-scale universal flu shot testing in 2016
Feb. 4, 2015
Valeant reportedly considering Salix acquisition
Feb. 4, 2015
FTC: Ranbaxy must sell acne drug to Torrent Pharma before Sun takeover
Feb. 3, 2015
FDA approves new Zohydro ER pankiller formulation
Feb. 3, 2015
Chimerix shifts from Ebola focus to adenoviruses, CMV as outbreak wanes
Feb. 3, 2015
Ireland threatens to cap drug prices
Feb. 3, 2015
Pro-life groups blame Merck, in part, for surging measles cases
Feb. 2, 2015
Valeant to make $296M 'stalking horse' bid on Seattle-based Dendreon
Feb. 2, 2015
Shire's Vyvanse nabs FDA approval for binge-eating disorder
Feb. 2, 2015
Roche's Tamiflu vindicated in new analysis of data
Feb. 2, 2015
What will the new federal budget mean for pharmaceutical R&D tax credits?
Feb. 1, 2015
Alexion COO Hallal named company's next CEO
Jan. 30, 2015
J&J's Imbruvica gets expanded label for rare blood cancer treatment
Jan. 30, 2015
Some UK cystic fibrosis patients being denied breakthough treatment
Jan. 30, 2015
J&J under continued scrutiny for off-label pediatric use of Risperdal
Jan. 30, 2015
Biogen Idec re-enters gene therapy R&D with hemophilia focus
Jan. 30, 2015
Study: Parkinson's patients' response doubles with 'expensive' placebo
Jan. 29, 2015
Pfizer dodges class-action trial with $400 million settlement
Jan. 29, 2015
Express Scripts claims it's saved US healthcare $4B through hep C deals
Jan. 29, 2015
Earnings update: Roche plateaus, Amgen stock slides despite solid performance
Jan. 29, 2015
Largest US health insurer latest to give Harvoni preferred hep C drug status
Jan. 29, 2015
Gilead to launch generic Sovaldi in India this summer
Jan. 28, 2015
E. coli-sniffing One Codex search platform scores CDC cash prize
Jan. 28, 2015
Actavis to buy Auden McKenzie for $465M
Jan. 28, 2015
Google, Biogen Idec partnering to study causes of multiple sclerosis
Jan. 28, 2015
NIH to launch Down syndrome research portal
Jan. 28, 2015
Counterfeit Roche cancer drug smuggler gets 30 months in jail
Jan. 27, 2015
Novo deploys 500 rep army to take Saxenda message to MDs
Jan. 27, 2015
Average Rx drug prices spiked 10.9% last year
Jan. 27, 2015
Rumor mill churns as Duke's Dr. Robert Califf appointed FDA deputy commish
Jan. 27, 2015
UPDATE: Pfizer gives poor nations modest discount after vax price blowback
Jan. 27, 2015
Teva wins big as FDA approves its generic Nexium
Jan. 27, 2015
GSK denies reports of imminent job cuts in China
Jan. 26, 2015
Shire pleased as NPS Pharma wins Natpara approval
Jan. 26, 2015
Sanofi tops new index that measures pharma's commitment to infectious diseases
Jan. 26, 2015
EMA suspending almost 50 drugs over flawed CRO clinical studies
Jan. 26, 2015
Novartis nabs FDA nod for group B meningitis vaccine Bexsero
Jan. 26, 2015
Hindsight: Valeant CEO admits mistakes in approach to Allergan bid
Jan. 23, 2015
Digital dawn: Online interactions with MDs leading to more prescripts
Jan. 23, 2015
EU approves Genzyme's Cerdelga for type 1 Gaucher patients
Jan. 23, 2015
Express Scripts determined to influence prices for cancer drugs
Jan. 23, 2015
Regulators get creative on Ebola vaccine testing as infections decline
Jan. 23, 2015
The M.D. perspective: Who stands to benefit from clinical trial transparency?
Jan. 22, 2015
J&J: Regulatory delays in China are stymying drug approvals
Jan. 22, 2015
UN Ebola chief requests one last $1 billion in funding to fight outbreak
Jan. 22, 2015
Chasing transparency in the pharmaceutical industry: How much is enough?
Jan. 22, 2015
Out with the old: Merck discontinues US sales of hep C med Victrelis
Jan. 22, 2015
Plaintiffs wanted: Law firms seek shareholders to launch a Sanofi kickback suit
Jan. 22, 2015
Salix Pharma reportedly exploring options, considering sale
Jan. 22, 2015
Teva wins Copaxone patent protection suit in US Supreme Court
Jan. 21, 2015
Ambitious RNA biotech Alnylam raising $450M, looking for acquisitions
Jan. 21, 2015
Colorado-based ViroCyt raises $3.5M to market its Virus Counter
Jan. 21, 2015
J&J's Q4 earnings: A solid 2014
Jan. 21, 2015
One more push: Senators reintroduce bill to expedite antibiotic approval
Jan. 20, 2015
China FDA to reverse course, allow online Rx drug sales
Jan. 20, 2015
Hospira closes North Carolina plant over cost concerns
Jan. 20, 2015
AbbVie strikes hep C discount deal with US state-based AIDS programs
Jan. 20, 2015
UPDATED: Yet another major insurance company strikes hep C deal with Gilead
Jan. 16, 2015
Pfizer warns UK MDs: Lyrica is still on patent for pain
Jan. 16, 2015
J&J: Women were inappropriately pressured to file pelvic mesh suits
Jan. 16, 2015
Pharma stocks plunge as Switzerland discontinues fixed-price peg to euro
Jan. 16, 2015
Blast from the past: Roche's dalcetrapib, HDL-raising meds could work for some patients
Jan. 15, 2015
Flu vaccine only 23% effective this season
Jan. 15, 2015
Intrexon, Ziopharma invest $100M in MD Anderson cancer immunotherapy tech
Jan. 15, 2015
UPDATED: Gilead to appeal India's rejection of Sovaldi patent protection
Jan. 15, 2015
FDA approves novel weight-loss device
Jan. 15, 2015
Johnson & Johnson to release trial data
Jan. 15, 2015
New Brilinta data supports extending use beyond one year
Jan. 15, 2015
BMJ physicians urge reexamination of widespread hep C screening
Jan. 14, 2015
Digital marketing slowly gaining traction with US doctors
Jan. 14, 2015
Actavis betting on conversion to new Namenda
Jan. 14, 2015
J&J licensing IBD drug from microbiome specialist Vedanta
Jan. 14, 2015
Merck invests $50 million in Moderna
Jan. 14, 2015
Mersana Therapeutics expands $300M R&D pact with Takeda
Jan. 13, 2015
UK's Cancer Drugs Fund gets cash infusion, but loses 16 drugs
Jan. 13, 2015
Merck goes after non-small cell lung cancer indication for Keytruda
Jan. 13, 2015
Mylan's REMS lawsuit against Celgene gaining traction
Jan. 13, 2015
Roche buys majority stake in Foundation Medicine for $1.03B
Jan. 13, 2015
Cempra announces $100M stock sale after antibiotic impresses in pneumonia trials
Jan. 12, 2015
Biogen Idec, Columbia University forge $30 million genetics research pact
Jan. 12, 2015
Done deal: Shire acquires NPS Pharma for $5.2 billion
Jan. 12, 2015
Daiichi Sankyo, DOJ reach $39 million settlement in kickback suit
Jan. 12, 2015
Novartis seeks FDA approval for two smoker's cough drugs
Jan. 9, 2015
How one hedge fund manager plans to take on big pharma patents
Jan. 9, 2015
Tensions with pharma run high as UK's Cancer Drugs Fund cuts expenses
Jan. 9, 2015
Finally approved: FDA says 'yes' to Impax's Parkinson's drug
Jan. 9, 2015
Biogen Idec's novel optical nerve repair therapy shows promise, but only some
Jan. 9, 2015
Siga ordered to pay $113M to PharmaAthene in smallpox case
Jan. 8, 2015
Novartis OTC advertising under fire after Pfizer complaint
Jan. 8, 2015
Namenda controversy continues as Actavis awaits court decision
Jan. 8, 2015
Study reveals no Gardasil-MS link
Jan. 8, 2015
The first groundbreaking antibiotic in 25 years may literally come out of the ground
Jan. 8, 2015
UPDATE: Novartis Neupogen biosimilar takes yet another step toward FDA approval
Jan. 8, 2015
AZ taps new immuno-oncology leader as two valued veterans depart
Jan. 7, 2015
Gilead acquires Phenex's FXR liver drugs in $470 million deal
Jan. 7, 2015
FDA grants drug makers 'track and trace' reprieve until May
Jan. 7, 2015
Billionaire Mark Cuban to host first Pediatric Health Pitch Day at SXSW arts fest
Jan. 7, 2015
Pharma companies unite to fight CA drug take-back program
Jan. 7, 2015
Minnesota Investment Board will not support Medtronic-Covidien inversion deal
Jan. 6, 2015
Moderna raises record $450M from investors with groundbreaking RNA tech
Jan. 6, 2015
NIH awards $28 million in grants to unlock mysteries of gene regulation
Jan. 6, 2015
J&J and Isis strike $835 million co-development deal
Jan. 6, 2015
Massachusetts mulls legal action over marketing practices for pain drugs
Jan. 5, 2015
Out with the old: Novartis completes Lilly animal health sale as part of overhaul
Jan. 5, 2015
ICYMI: 9 big biopharma predictions for 2015, according to industry experts
Jan. 5, 2015
Chiasma raising $56M to develop acromegaly drug—without Roche
Jan. 5, 2015
An 18-year record: FDA approved 41 drugs in 2014
Jan. 5, 2015
Japan first nation to approve potential Novartis blockbuster Cosentyx
Jan. 5, 2015
Neuroderm stock surges, then plunges, after positive Parkinson's data
Jan. 1, 2015
It's over: Teva and OncoGenex dissolve custirsen cancer partnership
Dec. 31, 2014
J&J investing $125M up front for MacroGenics' blood cancer drug
Dec. 23, 2014
Disgraced Japanese scientist fails to replicate stem-cell breakthrough results
Dec. 23, 2014
Vanda, Novartis reach settlement in schizophrenia drug licensing spat
Dec. 23, 2014
Tekmira, Oxford University team up to test new investigational Ebola therapy
Dec. 23, 2014
HHS's BARDA grants $30M Ebola vax development contract to NewLink
Dec. 23, 2014
Actavis considering Almirall acquisition to expand European foothold
Dec. 22, 2014
FDA approves Cubist's novel antibiotic Zerbaxa for complicated infections
Dec. 22, 2014
FDA unexpectedly approves AZ's Lynparza for advanced ovarian cancer
Dec. 22, 2014
2014's 9 biggest biopharma game-changers, according to industry experts
Dec. 19, 2014
AbbVie pins hopes for first major approval in 10 years on hep C drug
Dec. 19, 2014
GSK shingles vax shows major promise, could challenge Merck's Zostavax
Dec. 19, 2014
Glaxo assures shareholders: Dividend payout secure despite sluggish sales
Dec. 19, 2014
Amgen leukemia drug Blincyto's massive price tag: $178,000
Dec. 19, 2014
Controversial pay-to-delay deals on the decline in the EU
Dec. 19, 2014
14 pharmacy execs arrested, 2 charged with murder over 2012 meningitis deaths
Dec. 18, 2014
Actavis reveals post-merger management plans: Saunders to stay as CEO
Dec. 18, 2014
Will this Pfizer orphan drug emerge as the Duchenne victor?
Dec. 18, 2014
Report: Shire still hunting for a deal, maybe with NPS Pharma
Dec. 18, 2014
FDA approves Novartis/Alcon's Xtoro for swimmer's ear
Dec. 18, 2014
Google Ventures ventures more aggressively into healthcare, life sciences
Dec. 17, 2014
The US Patent Office just gave a big gift to biopharma companies
Dec. 17, 2014
Sanofi/Regeneron's opening move on PCSK9 marketing: 'Cholesterol Counts' campaign
Dec. 17, 2014
FDA forces Pfizer to put another warning on antipsychotic Geodon
Dec. 17, 2014
Former Onyx CEO tackles hard-to-treat CNS diseases with new biotech
Dec. 17, 2014
FDA approves two new plasma-based tests, expands use of a third
Dec. 16, 2014
Pfizer, OPKO reach growth hormone drug pact worth up to $570M
Dec. 16, 2014
The other victims of scuttled AbbVie-Shire deal? Big banks
Dec. 16, 2014
Senate bill would give 15 years' data exclusivity to drugs for unmet needs
Dec. 16, 2014
How Teva's CEO is preparing for a 2015 of patent expirations
Dec. 16, 2014
Abbott closes Veropharm deal amidst US-Russia political tension
Dec. 15, 2014
Indian Supreme Court rejects Bayer's bid to block cheap cancer generic
Dec. 15, 2014
Federal judge: Actavis must keep selling older version of Alzheimer's drug
Dec. 15, 2014
Jazz pushing potential $1B rare disease drug through rolling NDA
Dec. 15, 2014
Novartis psoriasis drug bests J&J's Stelara in head-to-head trial
Dec. 15, 2014
Lawmakers propose new antibiotics pathway to combat superbugs
Dec. 12, 2014
Gavi pledges $300M to get Ebola vaccines to hard-hit countries
Dec. 12, 2014
Compromise: Branded biologics, biosimilar firms reach hard-won agreement
Dec. 12, 2014
Philly transit authority launches class action against Gilead over Sovaldi price
Dec. 12, 2014
Teva 2015 revenue forecast $1 billion lower than expected
Dec. 12, 2014
Brave new world of digital pharma marketing has privacy advocates balking
Dec. 11, 2014
'Audition' for a job? Pfizer gets creative in its hiring approach in Sweden
Dec. 11, 2014
Mylan to foot $20M tax penalty for top execs after inversion merger
Dec. 11, 2014
Teva launches generic of Pfizer's arthritis med Celebrex in the US
Dec. 11, 2014
FDA approves new HPV super-vaccine, Merck's Gardasil 9
Dec. 11, 2014
After failed Allergan offensive, Valeant finally taking break from M&A focus
Dec. 10, 2014
HHS extends legal immunity to Ebola vaccine makers
Dec. 10, 2014
A $3B case of bad timing? Merck defends Cubist deal after judge invalidates patents
Dec. 10, 2014
Bluebird shares skyrocket on promising gene therapy-blood disorder data
Dec. 10, 2014
Feds refuse to hear Sandoz case related to biosimilar development efforts
Dec. 10, 2014
ICYMI: AARP and GPhA on what to do about generic drug price hikes
Dec. 10, 2014
Feds drop wire fraud charges against former Lilly scientists
Dec. 9, 2014
France, Germany, other EU countries suspend Indian generics approvals
Dec. 9, 2014
Pfizer creating gene therapy platform to expand rare disease efforts
Dec. 9, 2014
Microsoft co-founder Allen donates $100M to unlock mysteries of the human cell
Dec. 9, 2014
FDA: A defined biosimlar pathway is coming—soon
Dec. 8, 2014
Some more firsts for Incyte: Jakafi approved for chronic bone marrow disease
Dec. 8, 2014
Merck, BMS PD-1 drugs continue to roll, show promise for Hodgkin's lymphoma
Dec. 8, 2014
Why CRO employee turnover is still so high
Dec. 8, 2014
Merck to buy antibiotics powerhouse Cubist for $9.5 billion
Dec. 8, 2014
Big pharma meets medical marijuana? Dutch firm to build cannabinoid gum factory
Dec. 5, 2014
Google's secretive Calico looking to hire bioinformatics pro
Dec. 5, 2014
The FDA's new effort to make it easier to create generics of risky drugs
Dec. 5, 2014
GSK reverses course, retracts plan to sell older drugs
Dec. 5, 2014
Whistleblower: Sanofi, ex-CEO Viehbacher paid out $34M in kickback scheme
Dec. 4, 2014
FDA OKs Amgen's Blincyto to treat rare form of acute lymphoblastic leukemia
Dec. 4, 2014
Mice infused with human brain cells shed light on cognitive function
Dec. 4, 2014
Beyond ABC: FDA finalizes labeling rules for pregnant, lactating women
Dec. 4, 2014
Actavis to lay off 200 workers in California
Dec. 4, 2014
ICYMI: Are low-cost generic drugs a thing of the past?
Dec. 3, 2014
Security firm: Hackers trying to manipulate global markets by stealing pharma emails
Dec. 3, 2014
Patent cliff ahead: Otsuka to buy Avanir for $3.5B and a slate of new products
Dec. 3, 2014
A $945 million breakup: J&J, Astellas call off major rheumatoid arthritis deal
Dec. 3, 2014
Promising Biogen Alzheimer's drug leapfrogs from phase I to phase III
Dec. 3, 2014
Puma Biotech plummets in after hours trading after delaying breast cancer NDA
Dec. 3, 2014
Meet the healthcare and pharma industry vet who will be Teva's next chairman
Dec. 2, 2014
Mylan strikes deal to make Gilead's HIV drugs more accessible to poor nations
Dec. 2, 2014
Done deal: Pfizer completes acquistion of Baxter's vaccines
Dec. 2, 2014
Why BMS is getting ready to slash up to 1,000 jobs in China
Dec. 2, 2014
Despite deaths, Italian regulators declare Novartis flu vaccine safe—for now
Dec. 2, 2014
Report: China considering large-scale eradication of drug price caps
Dec. 1, 2014
The key to successful clinical trial recruitment? Patient empowerment
Dec. 1, 2014
EU green lights BI's Vargatef for advanced lung cancer
Dec. 1, 2014
Job cuts ahead: GSK plans US workforce restructuring
Dec. 1, 2014
Glaxo/NIH Ebola vaccine elicits immune response in human trials
Dec. 1, 2014
Generic drug price hikes move Congress to consider consumer relief measures
Nov. 26, 2014
Trouble for J&J? Amgen/AZ plaque psoriasis drug bests Stelara in phase III
Nov. 26, 2014
Lilly's once-weekly diabetes drug approved in EU
Nov. 26, 2014
FDA: No decision on Novartis' troubled panobinostat for 3 months
Nov. 26, 2014
Takeda US CEO leaving after 22 years
Nov. 26, 2014
A lead investigator reveals how Baxter's Hyqvia got its hard-won approval
Nov. 25, 2014
Top UK fund manager to launch major new biotech fund in 2015
Nov. 25, 2014
3 compounding pharmacies sue Express Scripts over blocked coverage
Nov. 25, 2014
Lundbeck CEO resigns after serious conduct breaches
Nov. 25, 2014
Novartis scientist who fabricated data fired and banned from receiving funding
Nov. 25, 2014
In search of new opportunities, Bayer considers selling $2.5B diabetes unit
Nov. 25, 2014
UK life sciences minister: Hospitals must aid in clinical trial process
Nov. 24, 2014
Hep C wars heat up as AbbVie scores likely EU approval for Harvoni challenger
Nov. 24, 2014
EU regulators weigh in on hotly debated testosterone, heart attack link
Nov. 24, 2014
AZ to ramp up biologics production with new plant, jobs in MD
Nov. 24, 2014
Merck, NewLink strike exclusive deal to scale up Ebola vaccine production
Nov. 24, 2014
Sacré bleu! Sovaldi to cost 38.8% less in France than in US
Nov. 21, 2014
EMA's updated conflict of interest policy reflects pragmatism, flexibility
Nov. 21, 2014
Judge refuses to block Ranbaxy's generic competitors
Nov. 21, 2014
Sanofi can't shake its diabetes business blues—and investors aren't happy
Nov. 21, 2014
Purdue joins burgeoning abuse-deterrent pain pill field with Hysingla approval
Nov. 21, 2014
Another first: Gilead spends $125M on priority review voucher for mystery drug
Nov. 20, 2014
These execs are on Sanofi's CEO short list
Nov. 20, 2014
In massive transparency effort, feds push for failed clinical trial data reporting
Nov. 20, 2014
Goodbye Philly, hello Boston: Shire moves US HQ, 500 jobs
Nov. 20, 2014
Novartis aims to put more 'tech' in biotech
Nov. 20, 2014
ICYMI: Inside Indian pharma's push to reform and modernize
Nov. 19, 2014
GSK, Clovis team up to study treamtents for mutant form of lung cancer
Nov. 19, 2014
Regeneron/Sanofi PCSK9 inhibitor could become cholesterol top dog
Nov. 19, 2014
India's Ranbaxy sues FDA for yanking Nexium, Valcyte generics approval
Nov. 19, 2014
Rainmaker: Gilead's Harvoni approved in the EU
Nov. 19, 2014
Has the price of developing drugs really doubled in the last 11 years?
Nov. 19, 2014
Plot twist: Controversial Merck cholesterol drugs Zetia, Vytorin work
Nov. 18, 2014
Docs breathe sigh of relief as Actavis buyout ends Valeant-Allergan drama
Nov. 18, 2014
Merck dances: Keytruda more than doubles PFS in some melanoma patients
Nov. 18, 2014
How pharma has improved patients' access to drugs since 2012
Nov. 18, 2014
FDA commish to talk drug safety at China regulatory chief confab
Nov. 18, 2014
2 DRG analysts dish on the 'unprecedented' Valeant-Allergan struggle
Nov. 17, 2014
Another big win for Roche as Avastin nabs FDA ovarian cancer indication
Nov. 17, 2014
Finally: FDA reverses course, OKs Sanofi's Lemtrada for MS
Nov. 17, 2014
EU's top drug regulator forced out by EMA panel
Nov. 16, 2014
Japanese transparency data raises eyebrows about pharma spending
Nov. 14, 2014
AstraZeneca in preclinical development for Brilinta reversal agent
Nov. 14, 2014
Apollo Global Manangement joins bidding wars for GSK's mature drugs
Nov. 14, 2014
FDA approves new Invega indication for schizoaffective disorder
Nov. 14, 2014
FDA has concerns over bioequivalence of two Concerta generics
Nov. 14, 2014
Pfizer, Gates Foundation team up to get injectable contraceptives to poor countries
Nov. 14, 2014
ICYMI: India's fixed-dose combo problem: Too much of a good thing?
Nov. 14, 2014
Let's make a deal: Allergan, Actavis talk $60 billion merger
Nov. 13, 2014
Indian pharma really feeling the pain of lagging US generic approvals
Nov. 13, 2014
Advaxis wants to investigate a compound for head & neck HPV-related cancers
Nov. 13, 2014
GSK applying for expanded Revolade indication in the EU
Nov. 13, 2014
No more half measures: Senate to add Ebola to priority review program
Nov. 13, 2014
Gilead, AbbVie hep C drugs score 97% cure rates, Regulus gets cold shoulder
Nov. 12, 2014
10 major hospitals ask Congress to scrutinize Genentech distribution changes
Nov. 12, 2014
Shire CEO: The future looks bright—who needs AbbVie?
Nov. 12, 2014
GE Healthcare and Takeda to take on liver disease R&D together
Nov. 12, 2014
Does a common 'algae virus' found in humans really make them dumb?
Nov. 12, 2014
Swing and a miss: Merck's ambitious 4-week hep C regimen fails
Nov. 11, 2014
Cigna responds to discrimination claims with cheaper HIV meds in Florida
Nov. 11, 2014
Pfizer: Nothing shady about our relationship with Missouri Attorney General
Nov. 11, 2014
Amgen gets PDUFA date for hotly anticipated PCSK9 anti-cholesterol drug
Nov. 11, 2014
Decisions, decisions: UCB to sell its generic unit to private equity firms
Nov. 10, 2014
Isis Pharma wins $10M neurodegeneration treatment milestone from Biogen
Nov. 10, 2014
Political unrest in Russia nixes deal with German pharma company
Nov. 10, 2014
Salix Pharmaceuticals' inventory woes ruined potential Allergan buyout
Nov. 10, 2014
The cost of a cure: $188B to treat all US hep C patients with pricey new drugs
Nov. 10, 2014
FDA sends Sciecure Pharma rare, scathing letter over insomnia drug sales aid
Nov. 7, 2014
This billionaire hedge fund manager may sue over busted AbbVie-Shire deal
Nov. 7, 2014
Allergan, Actavis talk merger while Valeant gets the cold shoulder
Nov. 7, 2014
Ranbaxy loses $250M while US consumers lose a Nexium generic
Nov. 7, 2014
FDA approves JNJ's Olysio in combo with Sovadi for hep C treatment
Nov. 7, 2014
Largest US pharma benefits manager may seek alcohol/tobacco-free network
Nov. 6, 2014
AZ's $2B ovarian cancer drug-in-development could be a 2-for-1 deal
Nov. 6, 2014
UPDATED: Novartis cancer hopeful panobinostat not on track for FDA approval
Nov. 6, 2014
Why GSK's promising hep C vaccine is good news for its Ebola drug
Nov. 6, 2014
FDA presents novel plan for testing and fast-tracking Ebola drugs
Nov. 6, 2014
Innovation in fixed-dose combos: HIV/AIDS therapeutics edition
Nov. 5, 2014
Some payments exempt from Sunshine Act pharma database reporting
Nov. 5, 2014
Bayer injects $25 million cash into biotech venture capital fund
Nov. 4, 2014
Allergan-Valeant standoff rages on as Allergan loses in court
Nov. 4, 2014
Regeneron posts solid Q3 on Eylea strength
Nov. 4, 2014
Lundbeck's schizophrenia drug wallops competition in novel head-to-head trial
Nov. 4, 2014
One-fifth of all drug sales in 2020 could be for pricey, specialty orphan meds
Nov. 4, 2014
India-based Wockhardt's profits plummet as it faces continued FDA export ban
Nov. 4, 2014
Diagnostics giant LabCorp buys CRO Covance for $6.1 billion
Nov. 4, 2014
BMS gets heat from advocates over pricing plan for its hep C drug
Nov. 4, 2014
Will Boehringer win an asthma indication for Spiriva Respimat?
Nov. 4, 2014
Feds probe whether US officials engaged in insider trading over Dendreon drug
Nov. 3, 2014
Scientists identify treasure trove of plasma-based cancer markers
Nov. 3, 2014
Express Scripts gearing up to snub Gilead in favor of AbbVie hep C drug
Nov. 3, 2014
Most UK diabetes patients fall short of evidence-based treatment goals
Nov. 3, 2014
FDA panel endorses approval of Daaichi's blood clot, stroke drug
Nov. 3, 2014
Scientists seek to make remote-controlled drug delivery device that works in space
Oct. 31, 2014
Abbott acquires heart-mapping company Topera for $250 million
Oct. 31, 2014
Sacked Sanofi chief's golden parachute more like a bronze parachute
Oct. 31, 2014
Pfizer's meningitis drug becomes first FDA-approved breakthrough therapy
Oct. 31, 2014
BMS's novel Opdivo exceeds expectations in late-stage lung cancer trials
Oct. 31, 2014
With Viehbacher gone, who will be the next Sanofi chief?
Oct. 30, 2014
US senators propose FDA vouchers to expedite Ebola drug development
Oct. 30, 2014
J&J to open major new Shanghai-based 'Asia Pacific Innovation Center'
Oct. 30, 2014
Diving into the future of fixed-dose combos
Oct. 30, 2014
India to ban use of plastic bottles for liquid drugs
Oct. 30, 2014
Cara Therapeutics' opioid alternative could be a true game changer
Oct. 30, 2014
Gilead shares fall on lower-than-expected Sovaldi sales
Oct. 29, 2014
Secretive Google[x] developing nano pill to detect cancer, monitor health
Oct. 29, 2014
UPDATED: Judge slashes Actos class action award from $9 billion to $36.8 million
Oct. 29, 2014
Cost-effectiveness: Treat prisoners with Sovaldi now, save money later
Oct. 29, 2014
Pfizer posts weaker-than-expected Q3 while Sanofi CEO gets the boot
Oct. 29, 2014
Pfizer pulls the plug on pain deal with Pain Therapeutics
Oct. 28, 2014
Novartis smashes in Q3 as earnings soar 45%
Oct. 28, 2014
Novartis sells off flu vaccines business to CSL for $275 million
Oct. 28, 2014
Sarepta's mega-orphan Duchenne's drug faces more roadblocks
Oct. 28, 2014
Roche to spend $3.2B on massive R&D cluster in Basel
Oct. 28, 2014
EU panel recommends approval of Clinuvel's sunburn-prevention drug
Oct. 27, 2014
Determined Shire ratchets up 2014 forecast, again
Oct. 27, 2014
FDA approves Baxter's hemophilia orphan drug
Oct. 27, 2014
EMA recommends approval of AZ's ovarian cancer drug
Oct. 27, 2014
EU reverses course, won't cede drug-related decisions to pharma
Oct. 24, 2014
EMA establishes expedited review framework for Ebola vaccines
Oct. 24, 2014
Actavis to cut more jobs, this time in New York
Oct. 24, 2014
Soliris sales drive Alexion's Q3 earnings beyond the loftiest expectations
Oct. 24, 2014
Biogen shares down as Tecfidera-treated patient dies from viral brain infection
Oct. 23, 2014
Anti-inflammatories may boost the effects of antidepressants
Oct. 23, 2014
UK patients rally online to demand lower price for Roche's Kadcyla
Oct. 23, 2014
WHO decries funding gap for tuberculosis R&D
Oct. 23, 2014
Is Regulus' injectable the next HCV blockbuster in the making?
Oct. 23, 2014
Best of BD: Biosimilars in China: The coming revolution
Oct. 22, 2014
Lilly, Boehringer fixed-dose diabetes combo could win FDA blessing soon
Oct. 22, 2014
Study: Parkinson's disease drugs make some patients want to party
Oct. 22, 2014
Glaxo, Abbott Q3 earnings best analyst expectations
Oct. 22, 2014
How the FDA plans to stop facilities from undermining inspections
Oct. 22, 2014
Mylan investor pulls $70 million as lethal injection controvery heats up
Oct. 22, 2014
Useful insights: Europe slow to embrace biosimilars of antibody-based drugs
Oct. 21, 2014
Study: Viagra could be used to protect against heart disease
Oct. 21, 2014
PhRMA fights back, blames insurance companies for drug access woes
Oct. 21, 2014
Genentech strikes rare $1.15B cancer pact with NewLink Genetics
Oct. 20, 2014
These anti-inflammatories may enhance the effects of schizophrenia treatment
Oct. 20, 2014
EMA approves J&J's Imbruvica for two rare blood cancers
Oct. 20, 2014
EU contemplates adaptive licensing in the face of Ebola threat
Oct. 20, 2014
US orders 3 state-of-the-art labs to ramp up Ebola drug ZMapp production
Oct. 20, 2014
Fearing creation of deadlier viruses, US tells scientists to halt bird flu research
Oct. 20, 2014
FDA approves Pfizer's addiction-fighting pain pill as US heroin deaths soar
Oct. 20, 2014
How new FDA flexibility in breast cancer trials can help high-risk patients
Oct. 17, 2014
HHS puts third Ebola vaccine on the fast-track
Oct. 16, 2014
New, top-shelf breast cancer drug sales lift Roche above Q3 expectations
Oct. 16, 2014
Potential Novartis psoriasis blockbuster inches closer to approval
Oct. 16, 2014
EMA considers relaxing clinical trial rules for rare-cancer patients
Oct. 16, 2014
FDA to generic drug makers: Looks matter
Oct. 16, 2014
FDA approves two competing 'breakthrough' IPF drugs in one day
Oct. 16, 2014
Astellas to collaborate with Harvard team on ophthalmological gene therapy
Oct. 16, 2014
Indian pharma: We're stymied by 'overzealous' drug regulators
Oct. 16, 2014
The Critical Path Initiative: 10 years later
Oct. 16, 2014
FDA approves telescope implant for younger end-stage AMD patients
Oct. 15, 2014
NICE to Celgene: We won't authorize NHS funding for Imnovid
Oct. 15, 2014
Pharma balks at new FDA final guidance on fixed-dose combinations
Oct. 15, 2014
FDA not likely to drop black box suicide warning for Pfizer's Chantix
Oct. 15, 2014
Patent battle brewing over Biogen's MS blockbuster Tecfidera
Oct. 15, 2014
Chinese pharma firm says it has an Ebola cure
Oct. 14, 2014
J&J forecast up big in Q3 on strong pharma sales
Oct. 14, 2014
Novartis may be fined $49M by Indian pricing authority
Oct. 14, 2014
Eisai/Helsinn's Akynzeo scores FDA approval for chemo-induced nausea
Oct. 14, 2014
Research, royalties, and recreation: What pharma paid docs in 2013
Oct. 14, 2014
Australian docs fight to ban meetings between physicians, pharma sales reps
Oct. 13, 2014
Study: Pricey specialty med costs worth it in the long run
Oct. 13, 2014
Severe asthma drug breathes new life into AstraZeneca pipeline
Oct. 10, 2014
Study: Lung cancer can hide out for 20 years
Oct. 10, 2014
Class-action gender discrimination suit against Merck to move forward
Oct. 10, 2014
Endo to buy Auxilium at a premium for $2.6 billion
Oct. 10, 2014
Here come the layoffs: Targacept-AstraZeneca R&D partnership nixed
Oct. 10, 2014
How 2 companies are revolutionizing flu vaccine manufacturing
Oct. 10, 2014
University of Utah scientists may have just discovered the key to an Ebola cure
Oct. 9, 2014
Cash for compliance: West Pharma, HealthPrize team up to boost drug adherence
Oct. 9, 2014
Groups urge stronger psych warnings for controversial Pfizer anti-smoking drug
Oct. 9, 2014
Flu vaccine development as a hotbed of innovation: Who knew?
Oct. 9, 2014
Look out, AbbVie: Here comes Amgen's Humira biosimilar
Oct. 9, 2014
Catalyst Pharma to ramp up hiring after impressive orphan drug trial
Oct. 8, 2014
Novare Pharmaceuticals launches in Boston
Oct. 8, 2014
Watching the 'Watchman:' Boston Scientific to face FDA over heart device today
Oct. 8, 2014
Tylenol for tots: FDA provides guidance on liquid acetaminophen for kids
Oct. 8, 2014
Sanofi faces bribery allegations in East African, Middle Eastern markets
Oct. 8, 2014
Acacia Pharma braces for approval of potential blockbuster post-op nausea drug
Oct. 7, 2014
British Medical Association to UK officials: Cancer, dementia treatment at risk
Oct. 7, 2014
Teva's downsizing efforts squeeze out women's health and cancer R&D
Oct. 7, 2014
First US Ebola patient being treated with experimental Chimerix antiviral
Oct. 7, 2014
Actavis shores up infectious disease franchise with Durata acquisition
Oct. 7, 2014
How pharma and patients can work together to improve drug access
Oct. 6, 2014
Baxter invests $45M in Rockwell Medical
Oct. 6, 2014
Nobel committee announces 2014 winners in Physiology or Medicine
Oct. 6, 2014
Novartis and BMS co-testing lung cancer therapies
Oct. 6, 2014
Optos to collaborate with UK government and universities
Oct. 6, 2014
Ascension Health bans Genentech sales reps from campus
Oct. 6, 2014
NICE rejects funding for Roche's leukemia drug
Oct. 3, 2014
Lilly abandons lupus drug after late-stage trial failures
Oct. 3, 2014
Study: NSAID-related GI bleeding risk increases with combo therapy
Oct. 3, 2014
Breast cancer drug sales to increase almost two-fold by 2023
Oct. 3, 2014
EMA expands clinical data access to researchers and public
Oct. 3, 2014
FDA issues final guidance on cybersecurity of medical devices
Oct. 2, 2014
Salud: NHS to endorse daily pill for heavy drinkers in England
Oct. 2, 2014
Specialty pharma ready to dispense Xtandi after expanded indication
Oct. 2, 2014
Pfizer, Kyowa Hakko Kirin partner on immuno-oncology study
Oct. 2, 2014
Bayer a top OTC player after $14.2B deal with Merck
Oct. 2, 2014
Open Payments: Pharma, device companies shelled out $3.5B in 5 months [CHART]
Oct. 1, 2014
BI spending $1.26 million to expand Respimat inhaler production
Oct. 1, 2014
UK shores up its stem cell banking system with non-profit support
Oct. 1, 2014
Acquisition update: J&J buys Alios for $1.75 billion
Oct. 1, 2014
Horizon hailed as 'world's leading gene-editing' company after acquiring Sage
Sept. 30, 2014
Report: 700-plus biosimilars in development worldwide
Sept. 30, 2014
Amag Pharma buys maternal health specialist Lumara in $1B deal
Sept. 30, 2014
Indian government: Major US think tank 'smeared' our pharma industry
Sept. 30, 2014
Access wanted: What it takes for patients to get the drugs they need
Sept. 30, 2014
Acquisition update: Daiichi Sankyo buys Ambit Biosciences for $410 million
Sept. 30, 2014
EU regulators to patients: Help us evaluate drugs
Sept. 29, 2014
Shareholders bullish on Nicox after phase III glaucoma trial
Sept. 29, 2014
AbbVie racks up another Humira approval from the FDA
Sept. 29, 2014
Merger Monday: Pfizer snaps up Innopharma in $360M deal
Sept. 29, 2014
15 new medications headed toward EU approval
Sept. 29, 2014
Actavis to continue sales of cheaper Alzheimer's drug for 60 days
Sept. 26, 2014
Almirall, AZ big winners as key committee recommends COPD combo
Sept. 26, 2014
BI scores an FDA approval for mist-based COPD drug
Sept. 26, 2014
Novartis to seek approval for potential psoriatic arthritis blockbuster
Sept. 26, 2014
BI to cut up to 600 jobs in Germany
Sept. 25, 2014
Cost concerns drive UK authority to spurn popular ulcerative colitis drugs
Sept. 25, 2014
FDA approves Celgene's potential blockbuster Otezla for psoriasis
Sept. 25, 2014
India's drug-pricing authority drops price caps on nonessential drugs
Sept. 25, 2014
Innovators wanted: FDA issues $500K challenge for better food pathogen detection
Sept. 24, 2014
UK launches beta of transparency site MyNHS
Sept. 24, 2014
How the NIH is trying to get more women to participate in clinical trials
Sept. 24, 2014
Nigerian health minister declares Nigeria 'Ebola-free'
Sept. 24, 2014
CDC: Dire outlook for Ebola in West Africa
Sept. 24, 2014
Collaborating with Chinese pharma: Inside one company's success story
Sept. 23, 2014
Does this month mark the beginning of a new era in cancer care?
Sept. 23, 2014
Wales NHS approves Celgene's Abraxane for pancreatic cancer
Sept. 23, 2014
UK public health advocates: Boys need HPV vaccine, too
Sept. 23, 2014
Merck KGaA buys lab supplies manufacturer in major $17 billion deal
Sept. 23, 2014
Amgen seeks FDA approval for breakthrough orphan leukemia drug
Sept. 23, 2014
India's Sun Pharma, Merck pen unique $80M development deal
Sept. 22, 2014
Study: Just one dose of antidepressant changes brain connectivity
Sept. 22, 2014
AZ's new formulation performs well in phase III diabetes study
Sept. 22, 2014
Gilead's Zydelig approved in the EU for rare blood cancers
Sept. 22, 2014
Pharma breathes a sigh of relief as Scots say 'No' to independence
Sept. 19, 2014
President Obama issues Executive Order to combat antibiotic resistance
Sept. 19, 2014
NICE approves comprehensive funding for GSK melanoma drug Tafinlar
Sept. 19, 2014
NICE agrees to fund Janssen's Olysio for hep C
Sept. 19, 2014
Bayer to spin off material science division into separate company
Sept. 19, 2014
Pfizer nabs exclusive option for MedGenesis Parkinson's treatment
Sept. 18, 2014
Denovo snaps up Lilly's failed cancer drug for undisclosed price
Sept. 18, 2014
Endo bids $2.2 billion for Auxilium
Sept. 18, 2014
Sanofi, MyoKardia team up to take on cardiomyopathy
Sept. 18, 2014
Gilead's pancreatic cancer hopeful crashes in phase II
Sept. 18, 2014
ICYMI: How one Shanghai pharma became a model for malaria drug production
Sept. 18, 2014
EU approves updated and expanded Gardasil labeling
Sept. 17, 2014
UK approves first therapy under new fast-track access program
Sept. 17, 2014
AstraZeneca's opioid constipation drug wins US approval
Sept. 17, 2014
AstraZeneca, Lilly plan sprint to Alzheimer's drug development
Sept. 17, 2014
Recordati to market Plethora's premature ejaculation spray
Sept. 17, 2014
Shire's ADHD blockbuster Vyvanse scores priority review for binge eating disorder
Sept. 16, 2014
FDA panel recommends NPS Pharma's orphan drug Naptara
Sept. 16, 2014
Avanir Pharma soars to 8-year high on positive Alzheimer's drug results
Sept. 16, 2014
Roche starts phase III trials for advanced wet AMD drug
Sept. 16, 2014
Roche's cheaper vision loss drug just as effective as Novartis' Lucentis
Sept. 16, 2014
Asterias, Cancer Research UK to collaborate on lung cancer vaccine
Sept. 15, 2014
FDA panel recommendation paves way for Novo Nordisk obesity drug approval
Sept. 15, 2014
Dompé bullish on novel eye disease treatment
Sept. 15, 2014
Baxter's once-monthly Hyqvia for immune disorders wins FDA approval
Sept. 15, 2014
Advocates furious over EU decision to cede authority back to pharma
Sept. 15, 2014
R&D update: PhRMA and BHA provide insight into HIV/AIDS pipeline
Sept. 12, 2014
Genmab partners with Seattle Genetics for exclusive use of ADCs
Sept. 12, 2014
Report: Psoriatic arthritis market to cross $3.7 billion by 2023
Sept. 12, 2014
EMA approves first-ever insulin biosimilar, Lilly/BI's Abrasia
Sept. 12, 2014
FDA panel cautiously supports polypill
Sept. 11, 2014
FDA approves expanded use of Xtandi for prostate cancer
Sept. 11, 2014
NICE demands more transparency from pharma
Sept. 11, 2014
Severe misconduct: Hyperion and Evotec halt diabetes drug trial
Sept. 11, 2014
New statin guidelines: Thoughts from a physician on the front lines
Sept. 11, 2014
Pfizer and Astellas Pharma to no longer co-distribute Caduet in Japan
Sept. 10, 2014
A good deal for Roche just got better: Intermune reports new Esbriet data
Sept. 10, 2014
Astrazeneca not deterred when COPD drug fails to meet primary endpoints
Sept. 10, 2014
FTC files first-ever 'pay-for-delay' lawsuit against Teva, AbbVie
Sept. 9, 2014
NICE rejects Celgene's Abraxane for pancreatic cancer
Sept. 9, 2014
Advanced Cell Tech scores US patent for dendritic cell manufacturing
Sept. 9, 2014
BMS sues Merck over historic PD-1 cancer drug Keytruda
Sept. 9, 2014
Report: Government-supported cancer services at risk in the UK
Sept. 9, 2014
The statin stumper: Are new cholesterol guidelines prudent or overzealous?
Sept. 9, 2014
Wellspring acquires OTC motion sickness drug
Sept. 8, 2014
Game on: Novartis' COPD drug bests GSK blockbuster in phase III trials
Sept. 8, 2014
Servier slammed for withholding antidepressant trial data
Sept. 8, 2014
FDA gives a qualified 'yes' to Keryx's chronic kidney disease drug
Sept. 8, 2014
FDA approves first-ever kidney injury diagnostic NephroCheck
Sept. 8, 2014
AbbVie and Infinity to collaborate on blood cancer treatment
Sept. 5, 2014
History is made: FDA approves Merck's PD-1 inhibitor Keytruda for melanoma
Sept. 5, 2014
Teamwork: Pfizer to promote Novartis' COPD drugs in the UK
Sept. 5, 2014
Viiv's 3-in-1 HIV combo drug Triumeq nabs European marketing authorization
Sept. 5, 2014
Facing patent expirations, Teva launches patient-centric MS e-health site
Sept. 5, 2014
BMS opts out of RA drug deal with Alder Biopharmaceuticals
Sept. 4, 2014
AZ, RedX Pharma to collaborate on genetic oncology research
Sept. 4, 2014
NICE reverses course, says 'yes' to Alexion's pricey Soliris
Sept. 4, 2014
Roche cuts jobs in Spain in response to price controls
Sept. 4, 2014
EU expands use of Allergan's Ozurdex again
Sept. 4, 2014
AstraZeneca's Brilinta falls short in phase IV study
Sept. 3, 2014
Florida researchers: Marijuana may be key to Alzheimer's treatment
Sept. 3, 2014
Belgium-based Ablynx pens development deal with China's Eddingpharm
Sept. 3, 2014
BI's Ohio plant plagued by continuing woes
Sept. 3, 2014
Novo Nordisk walks away from inflammatory disease R&D
Sept. 3, 2014
Exelixis prostate cancer drug falls flat in trials, prompts massive layoffs
Sept. 2, 2014
AZ's PD-1 immunotherapy drug advances in colorectal cancer studies
Sept. 2, 2014
Novartis soars on groundbreaking heart failure drug trial results
Sept. 2, 2014
Sanofi, Regeneron reveal positive data from alirocumab cholesterol trials
Sept. 2, 2014
10-year data show no link between Actos and bladder cancer risk
Sept. 2, 2014
Amgen files first-in-class cholesterol drug with FDA
Aug. 29, 2014
Amgen scores priority review for chronic heart failure drug
Aug. 29, 2014
Could low-dose aspirin be a cheaper alternative to anti-clotting drugs?
Aug. 29, 2014
Final guidance: NICE recommends Biogen Idec's Tecfidera for RRMS
Aug. 29, 2014
NICE sounds costs concerns over BI's Jardiance, requests more data
Aug. 29, 2014
The biosimilars are coming: Tackling uncertainty and interchangeability
Aug. 28, 2014
EU approves BMS's Daklinza for hep C combo therapy
Aug. 28, 2014
Does Gilead have its sights set on Achillion Pharma?
Aug. 28, 2014
Velphoro wins EU approval for treating hyperphosphalemia
Aug. 28, 2014
GSK's Promacta scores FDA approval for rare bone marrow disorder
Aug. 28, 2014
Alexion reprimanded for lax manufacturing practices
Aug. 27, 2014
The biosimilars are coming: Why Basaglar and Zarzio are harbingers of a new pharma landscape
Aug. 27, 2014
Pfizer, Merck team up to develop metastatic cancer immunotherapy
Aug. 27, 2014
AZ, Illumina join forces to develop companion diagnostic tests for cancer drugs
Aug. 27, 2014
FDA approves Iroko's Zorvolex for treatment of osteoarthritis pain
Aug. 27, 2014
MultiCell Tech scores patent for cancer-fighting immunotherapy platform
Aug. 27, 2014
Alexion vies to add another eculizumab indication with kidney graft trial
Aug. 27, 2014
Mylan introduces generic of Upsher-Smith's Klor-Con
Aug. 26, 2014
J&J's Janssen buys Covagen
Aug. 26, 2014
EMA prepares to review new Cubist antibiotic
Aug. 26, 2014
Merck, Advaxis partner up on prostate cancer research
Aug. 26, 2014
Actavis, UCB Pharma butt heads over generic Neupro
Aug. 26, 2014
Pfizer, GSK's Viiv Healthcare nabs FDA approval for 3-in-1 HIV drug
Aug. 25, 2014
Experts call for an end to alternative medicine clinical trials
Aug. 25, 2014
Auxilium's CCH reduces cellulite in phase IIa trial
Aug. 25, 2014
J&J pursues stem cell diabetes deal with ViaCyte
Aug. 25, 2014
Lilly's psoriasis drug scores big in phase III trials
Aug. 25, 2014
Migalastat generates positive phase III results in Fabry patients
Aug. 22, 2014
Novartis-funded study shows 75% of asthmatics are at risk
Aug. 22, 2014
Jordan-based Hikma Pharma posts strong results amidst regional turmoil
Aug. 22, 2014
Illumina to provide personalized oncology diagnostics for big-pharma studies
Aug. 22, 2014
Pfizer, BMS score FDA hat-trick with another Eliquis approval
Aug. 22, 2014
FDA approves GSK asthma inhaler Arnuity Ellipta
Aug. 21, 2014
Novartis buys stake in Israeli stem-cell company
Aug. 21, 2014
NICE reverses course, recommends Celgene's Revlimid for rare MDS form
Aug. 21, 2014
Apricus Biosciences launches topical ED treatment in Germany
Aug. 20, 2014
Amgen kidney drug for dialysis patients hits phase III targets again
Aug. 20, 2014
Lilly, Boehringer win tentative FDA approval for Sanofi diabetes biosimilar
Aug. 20, 2014
Novo hit with fine for stalling Tresiba rejection disclosure
Aug. 20, 2014
Analysts: Transition to generic antidepressants will be offset by new options
Aug. 20, 2014
Pfizer files NDA for breast cancer breakthrough therapy
Aug. 19, 2014
Sanofi gears up for mass production of malaria drug
Aug. 19, 2014
US Justice Department stops investigation of AstraZeneca's Brilinta trial
Aug. 19, 2014
Eisai files thyroid cancer drug in US, EU
Aug. 19, 2014
Advocates slam NICE, Janssen over prostate cancer drug 'fiasco'
Aug. 19, 2014
Jilting generics: Part 2 of an exclusive interview with GPhA CEO Ralph Neas
Aug. 17, 2014
FDA committee recommends approval of Boehringer COPD drug
Aug. 17, 2014
Turkish citizens arrested for selling fake cancer drugs
Aug. 17, 2014
Amgen's multiple myeloma drug fails in phase III single-drug study
Aug. 15, 2014
Word on the street: IPF drug maker InterMune is taking bids
Aug. 15, 2014
UK's NICE gives Gilead's Sovaldi a qualified 'yes'
Aug. 15, 2014
FDA approves Avastin for treatment of metastatic cervical cancer
Aug. 15, 2014
Debt-ridden Dendreon struggles to stay afloat
Aug. 14, 2014
AstraZeneca's severe asthma drug breezes into phase III trials
Aug. 14, 2014
Roche backs out of $600 million development deal with Chiasma
Aug. 14, 2014
Jilting generics: Part 1 of an exclusive interview with GPhA CEO Ralph Neas
Aug. 14, 2014
Pfizer, 23andMe team up to study the genetics of bowel disease
Aug. 14, 2014
Celltrion submits FDA filing for biosimilar Remicade
Aug. 14, 2014
AstraZeneca drug routs gout in phase III trials
Aug. 13, 2014
Indiana University research team discovers new heart molecule
Aug. 13, 2014
Falling sales, Sovaldi force Vertex to ditch hep C drug
Aug. 13, 2014
Boehringer to slash global workforce as earnings fall
Aug. 13, 2014
Intercept Pharma's shares fly high on positive liver drug results
Aug. 12, 2014
Boehringer sales fall, but long-term prospects look good
Aug. 12, 2014
Does faster regulatory approval translate into safety problems?
Aug. 12, 2014
FDA green lights J&J's 2-in-1 diabetes drug
Aug. 12, 2014
EU launches landmark decentralized generic drug approval pilot program
Aug. 11, 2014
UK regulators say Roche's Kadcyla is too expensive
Aug. 11, 2014
Astellas, Cancer Research Technology team up for pancreatic cancer research
Aug. 11, 2014
Sex, drugs, and bribes: More on GSK's Chinese misadventures
Aug. 11, 2014
Another perspective on Sovaldi: Spend more now, save much more later
Aug. 8, 2014
EMA green lights Pfizer bid to broaden pneumonia vaccine use
Aug. 8, 2014
Sarepta Therapeutics urges government to approve its Ebola drug
Aug. 8, 2014
AbbVie-Shire, other inversions on the chopping block as government mulls action
Aug. 8, 2014
FDA approves another antibacterial drug for skin infections
Aug. 8, 2014
Actelion focusing on patient experience through PatientsLikeMe initiative
Aug. 7, 2014
Cytori's stock plummets as stem-cell clinical trials are halted
Aug. 7, 2014
Pfizer to pay $35 million in Rapamune settlement
Aug. 7, 2014
Pfizer's Enbrel approved in the EU for rare inflammatory disease
Aug. 7, 2014
EU approves Avastin for recurrent ovarian cancer
Aug. 7, 2014
Can an aspirin a day keep the cancers away?
Aug. 6, 2014
Australia's drug regulator says Pradaxa safety advice will not change
Aug. 6, 2014
Roche to buy Santaris, add gene-silencing research to its portfolio
Aug. 6, 2014
UK to fund Roche's cash-saving cancer injection
Aug. 6, 2014
AbbVie's glioblastoma drug granted orphan status in US, EU
Aug. 6, 2014
Prevention efforts critical as HIV stigma falls
Aug. 5, 2014
Pfizer locks out workers at Indian manufacturing plant
Aug. 5, 2014
Amgen's multiple myeloma drug meets phase III targets
Aug. 5, 2014
Analysts: Pfizer may have its sights set on GSK
Aug. 5, 2014
EU broadens target population for life-saving cystic fibrosis drug
Aug. 5, 2014
BMS and Allied Minds team up to turn academic research into a clinical reality
Aug. 5, 2014
Postdoctoral fellow admits to faking Novartis brain tumor study results
Aug. 4, 2014
High-dose estrogen birth control may increase breast cancer risk, study finds
Aug. 4, 2014
FDA expands use of Genzyme's Pompe disease treatment for young children
Aug. 4, 2014
FDA approves Boehringer/Eli Lilly Alliance type 2 diabetes drug
Aug. 4, 2014